Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,low-density lipoprotein particle binding (GO:0030169),0.8097275655058974,1.9451928005050876,0.0035650623885918,0.2962471394800171,0.221,7/16,3.57%,STAB1;MSR1;PLTP;COLEC12;LDLR;CD36;SCARF1
prerank,lipoprotein particle binding (GO:0071813),0.7677796980634314,1.9130901692626645,0.0034482758620689655,0.24345061957268735,0.323,7/20,3.57%,STAB1;MSR1;PLTP;COLEC12;LDLR;CD36;SCARF1
prerank,clathrin adaptor activity (GO:0035615),0.8111503478574706,1.9056089887797356,0.0,0.17989925301756812,0.351,3/15,0.32%,DAB2;AP2A2;HIP1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7565209127238369,1.8995582651680298,0.0,0.14714585640839134,0.377,7/18,5.94%,PDLIM5;RAB10;S100A11;TMOD3;PDLIM1;STXBP6;ANXA2
prerank,protein kinase C binding (GO:0005080),0.6496867778813322,1.8888278426138476,0.0015698587127158557,0.1366843237600871,0.416,11/43,7.51%,HDAC9;NELL1;PDLIM5;GRK5;HINT1;ADAM9;UGT1A10;UGT1A7;RACK1;HSPB1;PRKCB
prerank,phospholipase activity (GO:0004620),-0.49299227442451915,-1.85846288242232,0.0,0.34992132693982353,0.26,14/67,6.25%,PLCL1;PNPLA7;ABHD12;PLCB2;MGLL;PLD4;ENPP2;PLCB4;SMPD4;PLA2G6;LYPLA2;LIPH;LPL;PITPNM3
prerank,retinoic acid binding (GO:0001972),0.8178339075625322,1.8453631722890032,0.001736111111111111,0.204667990751871,0.618,9/12,13.77%,UGT1A10;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;CYP26C1;CYP26B1;RARA
prerank,glutamate receptor activity (GO:0008066),-0.6308069401335564,-1.8063466240840065,0.004728132387706856,0.33905098986033194,0.437,6/19,3.88%,GRID2;GRM7;GRIA2;GRIK2;GRM3;GRIA4
prerank,glucuronosyltransferase activity (GO:0015020),0.7124704600715868,1.8014767781193382,0.008635578583765112,0.2856319661653159,0.785,8/19,3.64%,EXT1;LARGE2;UGT1A10;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1
prerank,retinoid binding (GO:0005501),0.7097424975574453,1.7985911941053276,0.0065252854812398045,0.25640532121661547,0.796,13/22,18.33%,UGT1A10;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;CYP26C1;CYP26B1;RARA;RBP4;NR2F2;RBP1;ABCA4
prerank,lysophospholipase activity (GO:0004622),-0.633190916090689,-1.7938628737477695,0.007075471698113208,0.257782279313657,0.479,6/20,5.00%,PNPLA7;ABHD12;MGLL;ENPP2;PLA2G6;LYPLA2
prerank,death receptor activity (GO:0005035),0.8042351500464887,1.7607875511305904,0.009242144177449169,0.3281857749795129,0.9,3/11,3.97%,TNFRSF25;TNFRSF1B;TNFRSF11A
prerank,monocarboxylic acid binding (GO:0033293),0.7102082592285546,1.732619869970834,0.008680555555555556,0.3801349433327744,0.94,9/18,10.01%,NR1H4;UGT1A10;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;CYP26C1;CYP26B1
prerank,mannose binding (GO:0005537),0.7729022822485404,1.7321365283147157,0.011385199240986717,0.34806594605572966,0.94,4/12,8.49%,CLEC6A;CLN5;ACR;CLEC4D
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.5428519247582441,-1.7218093767163765,0.008356545961002786,0.4399898341698964,0.752,8/35,3.41%,PLCL1;MPPED2;PLCB2;PLD4;PLCXD3;ENPP2;PLCB4;SMPD4
prerank,endonuclease activity (GO:0004519),0.5733788331997216,1.7210832464045922,0.004580152671755725,0.3546655110441459,0.956,16/49,13.54%,ENDOG;ANG;RPS3;ENDOU;ERN1;NYNRIN;RNASEK;SND1;SMG6;RNASEL;CPSF3;ZRANB3;LACTB2;ZC3H12D;ZC3H12A;PIWIL2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4621565474581239,1.7023095613163532,0.0,0.38589593111753434,0.975,65/254,16.67%,RBPJ;ETV1;TCF4;IRF4;MEF2A;ZBTB16;RREB1;TFEC;ESR1;TCF12;MEF2C;NR1H4;MITF;KLF6;HOXD8;RAX;ALX1;HOXA10;NR3C1;CLOCK;GRHL2;NFIC;SMAD4;NR4A1;FOSL2;KLF4;YY1;REL;SATB2;CEBPG;NR4A2;IRF2;KLF10;ATF6;FOXC2;ESRRB;MDM2;FOXJ3;MLXIP;STAT6;SP1;CREBRF;ELF1;TFDP1;MYBL2;FOXK2;NFIA;HINFP;FOXO3;FOXO1;CREB1;NR1H2;STAT3;KLF5;MYC;MTF1;NR2C2;SMARCD1;ELK1;HOXB3;ZFP62;CREB3L1;RELA;NFATC3;GLIS2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7414522298654471,-1.7002894449288368,0.008213552361396304,0.4362628614569279,0.829,7/10,17.52%,GNAS;DLG4;SHANK1;IGSF11;SHANK2;SHISA7;SQSTM1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.7092125032958053,1.6910057365309363,0.019642857142857142,0.39737063263585515,0.983,4/16,3.68%,CD38;BST1;RPS3;DNPH1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7726476445302861,1.6849372424191416,0.016333938294010888,0.390237981092819,0.987,4/10,15.14%,CYBB;NCF2;CYBA;NOX4
prerank,phosphatidylinositol binding (GO:0035091),0.5148642539224053,1.6826984445865938,0.004076086956521739,0.3734253855945513,0.988,14/91,3.81%,DENND1A;SNX2;HIP1;SNX9;WDFY3;FCHO2;SNX8;SESTD1;ANKFY1;SNX24;MTM1;DENND1B;PITPNA;SNX27
prerank,hyaluronic acid binding (GO:0005540),0.7727661447408387,1.658395344896397,0.023529411764705882,0.4266856004275377,0.995,2/10,2.34%,LYVE1;CD44
prerank,phosphatidylglycerol binding (GO:1901611),0.71668590596646,1.6578023759455127,0.01926444833625219,0.40482763669684035,0.995,3/13,4.55%,PLTP;PITPNA;GSDME
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7510686118647452,1.6460055682086492,0.026168224299065422,0.4215488217162237,0.997,4/11,9.15%,EGFR;MAP3K5;MAP3K1;MAP3K20
prerank,acylglycerol lipase activity (GO:0047372),-0.7014575156207605,-1.644857946814265,0.010822510822510822,0.6147779526068003,0.943,5/11,17.01%,ABHD12;MGLL;ABHD15;ABHD16A;FAAH
prerank,solute:proton symporter activity (GO:0015295),-0.6230203175767114,-1.6412211993975427,0.013245033112582781,0.5424815837765312,0.947,7/16,12.70%,SLC2A9;SLC36A1;SLC25A3;SLC11A2;SLC2A13;SLC17A5;CTNS
prerank,ribonuclease activity (GO:0004540),0.5392834876517024,1.6405084431667878,0.0058309037900874635,0.4185590772653311,0.997,20/56,15.27%,ENDOG;ANG;RNASE4;ENDOU;ERN1;NYNRIN;RNASEK;SND1;SMG6;RNASEL;CPSF3;RNASE6;LACTB2;ZC3H12D;ZC3H12A;EXOSC8;DIS3L2;PIWIL2;EXOSC1;SAMHD1
prerank,cell adhesion mediator activity (GO:0098631),-0.5414833774767634,-1.6364000535029375,0.018912529550827423,0.4939532932430867,0.951,8/24,8.15%,SIRPA;LRRC4C;PALLD;CNTN4;CNTN6;BSG;CNTN2;NTNG1
prerank,voltage-gated chloride channel activity (GO:0005247),0.7694024085291745,1.6362675645628442,0.019157088122605363,0.41082583039001586,0.997,4/10,5.29%,CLCN5;ANO6;CLCNKB;ANO1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.688404338289819,-1.6317269704799233,0.033185840707964605,0.4566691873606507,0.954,4/10,11.79%,CACNB2;CACNB4;CACNA1D;CACNA1C
prerank,triglyceride lipase activity (GO:0004806),-0.5681962118747199,-1.6282009172596381,0.021176470588235293,0.42332198398134274,0.955,3/20,5.87%,DAGLB;LIPH;LPL
prerank,retinoid X receptor binding (GO:0046965),0.7377864028234371,1.624457182255093,0.022222222222222223,0.42774958258253293,0.998,5/11,8.47%,RARG;ARID5A;NR4A2;NRIP1;NCOA6
prerank,chemokine activity (GO:0008009),0.5936523997195782,1.6210557448302307,0.017350157728706624,0.42028920476954074,0.999,8/31,17.11%,PF4;CCL8;CCL19;CXCL16;CCL24;CKLF;CCL5;CCL25
prerank,cation:chloride symporter activity (GO:0015377),-0.6772859102433827,-1.616789807396903,0.022271714922048998,0.4263430906501884,0.968,7/10,25.15%,SLC12A2;SLC12A9;SLC12A6;SLC6A1;SLC12A4;SLC12A5;SLC12A1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6264640640971008,-1.6162581574098354,0.028384279475982533,0.39262622260925467,0.968,7/14,24.40%,SLC1A3;SLC38A7;SLC1A1;SLC25A22;SLC1A2;SLC17A6;SLC25A13
prerank,endoribonuclease activity (GO:0004521),0.5779703529482716,1.6130447804971217,0.02403846153846154,0.42656817897349547,1.0,13/32,13.54%,ENDOG;ENDOU;ERN1;NYNRIN;RNASEK;SND1;SMG6;RNASEL;CPSF3;LACTB2;ZC3H12D;ZC3H12A;PIWIL2
prerank,voltage-gated cation channel activity (GO:0022843),-0.39816280149001076,-1.5979920641320535,0.0040650406504065045,0.41745279832010806,0.979,21/97,14.51%,KCNMA1;CACNB2;KCND2;KCNH7;PTK2B;CACNB4;KCNQ3;CACNA2D1;CACNA2D3;GRIN3A;CACNA1D;CACNA1E;KCNQ5;KCNA2;KCNA1;CACNG7;GRIN2A;CACNA1C;CACNG8;KCNS3;HVCN1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4863854941529333,-1.5926069849627795,0.002976190476190476,0.4049385431788829,0.982,13/37,19.40%,CACNB2;CACNB4;CACNA2D1;CACNA2D3;CACNA1D;CACNA1E;CACNG7;CACNA1C;CACNG8;CACNG4;NCS1;ITGAV;CACNG2
prerank,CXCR chemokine receptor binding (GO:0045236),0.7203031176273998,1.5844967796702119,0.04371584699453552,0.5042654279148965,1.0,1/11,0.26%,PF4
prerank,amyloid-beta binding (GO:0001540),0.49020652759258837,1.579668102152171,0.012413793103448275,0.5013413129661828,1.0,15/79,4.94%,MSR1;FCGR2B;APOE;ITM2B;C1QA;LDLR;ADRB2;CD36;LILRB1;LILRB3;CD74;TLR4;TLR2;TM2D1;INSR
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5921704948444304,-1.576038602417181,0.013392857142857142,0.4342613390740374,0.99,6/17,11.01%,PTK2B;GRIA2;GRIK2;GRIA4;GRIN3A;GRIN2A
prerank,3'-5' DNA helicase activity (GO:0043138),-0.5999681722033222,-1.5656944434492972,0.0350109409190372,0.44141333069221084,0.992,4/16,8.88%,NAV2;HELQ;BLM;RECQL5
prerank,rRNA binding (GO:0019843),0.5441699811048156,1.5626015735595347,0.028481012658227847,0.5423774178134331,1.0,14/42,9.28%,RPL23;ANG;RPS3;RPS13;ERAL1;RPL12;NOP53;RPLP0;RPL5;RPS14;RPS9;MDM2;RPS5;MRPS11
prerank,cytokine activity (GO:0005125),0.4455286620225935,1.5427468216505589,0.011152416356877323,0.5954623372881579,1.0,16/131,8.24%,PF4;IL16;IL15;TSLP;KITLG;BMP2;CCL8;WNT2;GDF3;CCL19;GDF10;FAM3C;TNF;WNT6;CXCL16;CCL24
prerank,CCR chemokine receptor binding (GO:0048020),0.5780408690483858,1.5424073944313261,0.025682182985553772,0.5759068665753558,1.0,7/28,8.24%,CCL8;MSMP;NES;CCL19;CCRL2;CCR2;CCL24
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5891415333361948,-1.5299978683318403,0.0420353982300885,0.5471098505442699,0.998,8/15,27.67%,SLC1A3;SLC38A7;SLC1A1;SLC25A22;SLC1A2;SLC17A6;SLC25A13;SLC1A4
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6188516399877273,-1.527903013536922,0.04967602591792657,0.5247094453767275,0.998,6/12,18.80%,TGFBR1;BMPR1B;ACVR1;TGFBR3;TGFBR2;ENG
prerank,BMP binding (GO:0036122),-0.6390237942334782,-1.527859985793251,0.03319502074688797,0.49725662249343344,0.998,4/11,32.09%,ENG;GREM1;GREM2;BMPR2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4557045877902809,1.5217581179860837,0.020435967302452316,0.6337211911098936,1.0,15/100,7.14%,IQGAP2;DENND1A;HIP1;IQGAP1;ARHGAP9;SESTD1;ANKFY1;ARAP1;SNX24;FCHSD2;DENND1B;SNX27;SNX3;KIF16B;WIPI1
prerank,cGMP binding (GO:0030553),0.6952492905523097,1.517286588455653,0.06060606060606061,0.631445116526075,1.0,4/11,10.68%,CNGA3;RAPGEF2;PDE2A;PDE5A
prerank,lipase activity (GO:0016298),-0.4450354713125318,-1.5166723614845892,0.03188405797101449,0.5116305318747361,0.998,11/43,18.55%,ABHD12;MGLL;DAGLB;LIPH;LPL;PITPNM3;ABHD15;DDHD1;ABHD16A;FAAH;SMPD2
prerank,voltage-gated anion channel activity (GO:0008308),0.6463241774731205,1.5158584627505514,0.05454545454545454,0.6175787366243385,1.0,4/15,5.29%,CLCN5;ANO6;CLCNKB;ANO1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5304400589217393,1.511094776492994,0.05956112852664577,0.6159297712421318,1.0,4/38,5.94%,SERPINB8;APP;SERPINB2;ANXA2
prerank,sequence-specific DNA binding (GO:0043565),0.38926569065901784,1.5061305449057163,0.0,0.616016911467766,1.0,131/590,18.69%,RBPJ;ZEB2;MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;FLI1;MEF2A;AHR;FOXN2;TFEC;KMT2A;ESR1;ZBTB20;RARG;TCF12;MEF2C;NR1H4;CEBPB;OSR1;KLF6;TBX15;HOXD8;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR2C1;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;DMRTA2;NFIC;SMAD4;ARID5A;SMG6;ELF2;THRB;MBNL2;IRX2;CBFB;NR4A1;TCF7;BCL2;KLF3;ZNF148;KLF4;YY1;CEBPG;NR4A2;LHX5;IRF2;KLF10;IRX5;ATF6;TET3;FOXC2;ESRRB;HIVEP1;OLIG2;FOXJ3;ATF7;NFATC2;NR2F1;RFX2;SP1;ZNF296;ELF1;ETS2;CENPB;SREBF2;BCL11B;MYBL2;FOXK2;XPA;FOXO3;FOXK1;TERF2IP;SP3;FOXO1;NFIX;CREB1;KLF13;RARA;JUND;KLF5;MBD1;TERF1;USF1;PRMT1;MTF1;NR2C2;HDAC4;KDM2A;RUNX3;ELK1;E2F8;KDM1A;CREB3L1;ZGPAT;ARNT;TBX2;NFATC3;ZNF177;GLIS2;FOXP2;ZBTB7A;NR5A2;SP8;LHX1;NR2F2;XBP1;MEF2B;NR6A1;GMEB1;ZNF32;GZF1;HSF5;BATF;ZBTB12;RFX3;MAFB;LONP1;ATF2;ZBTB14
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.647360641209866,-1.5052314229717147,0.05394190871369295,0.5294174598487975,0.999,6/10,27.06%,ANKRD13B;DNAJB2;ANKRD13D;ANKRD13A;IDE;FAAP20
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.577472845084468,-1.5021150328410742,0.053613053613053616,0.4924735320360958,0.999,7/16,12.24%,TCIRG1;ATP6V1C1;ATP6V1D;ATP6V0A2;ATP6V0B;ATP6V0D2;ATP6V0C
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.577472845084468,-1.5021150328410742,0.053613053613053616,0.4924735320360958,0.999,7/16,12.24%,TCIRG1;ATP6V1C1;ATP6V1D;ATP6V0A2;ATP6V0B;ATP6V0D2;ATP6V0C
prerank,gated channel activity (GO:0022836),-0.5903841689796883,-1.5017772881347584,0.0410958904109589,0.4729027992161348,1.0,10/14,32.35%,PIEZO1;TMC7;PACC1;PIEZO2;TMEM63A;TMC6;TMC8;TMC1;TMC4;TMC3
prerank,microtubule binding (GO:0008017),-0.33417336817394566,-1.498952457338681,0.0,0.4624759028714733,1.0,86/222,24.83%,NAV3;DST;MAP4K4;MAP2;KIF21B;CCDC88B;DNM3;CLASP2;EML3;NEFM;CAMSAP1;MAP1B;CCDC66;FGF13;KIF1A;MTCL1;NEFH;KIF5A;CLIP2;MACF1;KIF6;KIF5C;CRIPT;MAPT;PRNP;HAUS8;FMR1;FMN1;TUBGCP5;ARHGEF2;CENPE;MAP6;IRAG2;MAPRE3;KRIT1;CEP44;TPPP;KIF1C;KIF3A;MTUS1;EML6;TOGARAM1;HAUS7;NUMA1;CKAP5;KIF15;TUBGCP3;EML1;SGIP1;EML2;MAPRE1;MAP1LC3A;KIF3B;DLGAP5;MAP4;CLIP3;KIFC2;APC2;REEP1;KIF2A;NUSAP1;EML5;GOLGA2;SKA2;FSD1;KIFC1;GAPDH;TUBGCP6;CLIP4;ARL3;HDAC6;REEP2;KATNB1;FNTA;MAP9;TOGARAM2;CETN3;REEP4;GAS2L3;BIRC5;KIF14;HOOK2;DCTN1;HDGFL3;HAUS6;S100A9
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5236230106614439,-1.4964163474178818,0.03614457831325301,0.45193525953197505,1.0,8/22,12.33%,TCIRG1;ATP6V1C1;ATP6V1D;ATP6V0A2;ATP6V0B;ATP6V0D2;ATP6V0C;ATP2C1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6508043187755672,1.495267503746814,0.051418439716312055,0.637720504213985,1.0,6/14,22.14%,CYBB;NCF2;CYBA;NOX4;AIFM1;KMO
prerank,epidermal growth factor receptor binding (GO:0005154),0.5695862083826326,1.488461786289355,0.06176961602671119,0.6464857818282295,1.0,3/25,1.92%,SNX2;HIP1;FER
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.41432152103699443,1.4862847224188966,0.013447432762836185,0.6368877491523837,1.0,44/181,16.55%,RBPJ;TCF7L2;MDFIC;MEF2A;RBBP8;NCOA3;NR1H4;NCOA2;PIAS1;BCL10;HEY2;SPI1;GSK3B;RB1;NCOA7;ACTB;TRIM32;DMAP1;PIAS2;HSPB1;KLF4;MIER1;FIZ1;NRIP1;NCOR1;MAPK14;SPEN;SP1;MIER3;JUP;CREBBP;PSMA6;BUD31;BCAS3;CREB1;EP300;STAT3;SNW1;HDAC4;ARID1A;ELK1;KDM1A;RELA;ARNT
prerank,RNA cap binding (GO:0000339),-0.5601382920754879,-1.4785316478700044,0.04597701149425287,0.49597111154576123,1.0,12/16,36.97%,EIF4A1;CYFIP2;DCPS;NCBP1;EIF4E;LARP1;SNUPN;NCBP3;EIF4E2;EIF3D;GEMIN5;NCBP2
prerank,SH2 domain binding (GO:0042169),-0.4744238523771508,-1.4733416866348752,0.05263157894736842,0.4947482328594441,1.0,6/31,4.14%,PAG1;ARHGAP5;BLNK;JAK2;SRC;LAT2
prerank,kinase inhibitor activity (GO:0019210),0.5322463232691951,1.4723930024494039,0.059870550161812294,0.6745450109212792,1.0,16/33,22.79%,LRP6;SH3BP5;GMFG;DNAJC3;SMCR8;SH3BP5L;PARVA;GMFB;TRIB1;SNCA;DUS2;CDKN1C;NPM1;CDKN1B;QARS1;NCK1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.4728423765203408,-1.4690802083466434,0.04336734693877551,0.4920389358510087,1.0,9/29,17.08%,GRID2;GRIA2;GRIK2;GABRB3;GRIA4;GABRB1;GABRA2;GABRG2;GLRA3
prerank,transferrin receptor binding (GO:1990459),0.6846169658160024,1.4689578364146103,0.10299625468164794,0.6708868324976506,1.0,2/10,7.65%,SNX2;HFE
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.5003389976026295,1.4662231356569055,0.054945054945054944,0.6644050945004806,1.0,7/38,7.14%,DENND1A;HIP1;SESTD1;SNX27;SNX3;KIF16B;WIPI1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.6074692254101095,-1.4660012158880604,0.06502242152466367,0.4855417228839563,1.0,9/12,32.35%,PIEZO1;TMC7;PIEZO2;TMEM63A;TMC6;TMC8;TMC1;TMC4;TMC3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5209054549983028,1.4551854581409962,0.06907378335949764,0.6895979054562614,1.0,6/34,5.80%,IQGAP2;IQGAP1;ARHGAP9;ARAP1;FCHSD2;KIF16B
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.4271699750501098,-1.45268937606538,0.03289473684210526,0.5113900820222865,1.0,10/46,11.74%,HEXB;LARGE1;MGAT4C;GCNT2;MGAT5;B3GALT1;B3GALT5;MGAT4B;POMGNT1;B3GALT2
prerank,GDP binding (GO:0019003),0.4663676322310408,1.4492986055607295,0.053237410071942444,0.695154178779842,1.0,12/63,8.98%,RAP1B;RAB31;RAP2B;NRAS;KRAS;GNAI3;RAB8B;RAB10;RAP1A;GEM;RAB7A;RAB14
prerank,carboxy-lyase activity (GO:0016831),-0.49546929077546853,-1.4486735289626025,0.05789473684210526,0.5090617676958323,1.0,9/23,12.72%,PPCDC;AZIN1;BCKDHA;UMPS;GGCX;CSAD;UXS1;PCK2;DDC
prerank,protein kinase binding (GO:0019901),0.37687975636873405,1.4456477848207923,0.0,0.6930395894812281,1.0,102/479,14.60%,BANK1;HDAC9;AP2A2;NELL1;PDLIM5;NEDD9;SPRED1;PTPRJ;TCF7L2;IQGAP1;SASH1;PRKAG2;ESR1;CLTC;GRK5;DNAJC3;HINT1;ITGB1;RPS3;IRAK3;OXSR1;CASS4;EEF1A1;MYH6;PRKAG3;CDC42;GDF3;AXIN1;ADAM9;MAP3K1;CRK;RGCC;UGT1A10;UGT1A7;RHOA;UTRN;PRKN;BCL10;DUSP1;NR3C1;GCH1;PGAM1;DOK7;GSK3B;PAK2;RACK1;GPRC5B;MAPKAPK2;PTPRK;TBC1D14;ACTB;WNK1;VRK2;FOXM1;HSPB1;CCND3;DUSP22;PRKCB;DUSP2;IFNAR2;RHOBTB1;TRIM68;MSN;MAPK8IP2;VRK1;TRIM27;RCC2;MAPK4;SMCR8;RPS7;SH2B3;ATF7;CCND2;CACUL1;ACSL3;RPS6;CALM1;MAML1;SPRED2;SHC1;IL15RA;FOXO3;KCNQ1;MAP3K11;TRIB2;STK38;CDKN2C;NOD2;RBBP6;EXOC2;RND3;CTBP2;CNTLN;FAM83B;RARA;STAT3;IBTK;CAVIN3;ITGB2;RHOC;USF1;PRKD2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5207804889723353,-1.4356765084932541,0.060810810810810814,0.5341994221921565,1.0,7/18,18.80%,TGFBR1;BMPR1B;ACVR1;TGFBR3;TGFBR2;ACVR1B;ENG
prerank,phosphatidate phosphatase activity (GO:0008195),-0.5803654486439399,-1.4353884277079427,0.07606263982102908,0.5195229446786694,1.0,6/13,21.94%,LPIN2;PLPP3;PLPPR1;PLPP4;PLPP2;PLPP5
prerank,chemokine receptor binding (GO:0042379),0.5090840574389919,1.4339604540007609,0.06717557251908397,0.7229523464583225,1.0,6/35,8.24%,PF4;CCL8;CCL19;CCRL2;CXCL16;CCL24
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6431448163151652,1.43359867839102,0.10646387832699619,0.7082772643864377,1.0,1/11,0.54%,PADI4
prerank,double-stranded DNA binding (GO:0003690),0.37032610786405834,1.4314849108448189,0.0,0.7007654031178192,1.0,115/531,18.27%,MAF;ETV1;EGFR;KLF2;TCF4;RBMS1;IRF4;FOXP1;FLI1;AHR;FOXN2;TFEC;ESR1;ZBTB20;RBBP8;RARG;RPS3;TCF12;MEF2C;CEBPB;DDX60;OSR1;KLF6;TBX15;HOXD8;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR2C1;NR1D1;MND1;NR3C1;HEY2;CLOCK;DMRTA2;NFIC;ELF2;THRB;MBNL2;NR4A1;TCF7;KLF3;KLF4;YY1;DDX11;CEBPG;NR4A2;LHX5;IRF2;KLF10;IRX5;ATF6;FOXC2;ESRRB;HIVEP1;OLIG2;FOXJ3;ATF7;NFATC2;NR2F1;PURA;POLG2;RFX2;SP1;ZNF296;ELF1;PCID2;ETS2;SREBF2;BCL11B;MYBL2;XPA;FOXO3;FOXK1;SP3;NFIX;CREB1;KLF13;RARA;KIN;JUND;KLF5;MBD1;TERF1;USF1;RAD51B;MTF1;NR2C2;FBH1;RUNX3;ELK1;E2F8;CREB3L1;ARNT;TBX2;NFATC3;ZNF177;GLIS2;ZBTB7A;NR5A2;SP8;LHX1;XBP1;MEF2B;NR6A1;DMC1;GMEB1;ZNF32;HSF5;BATF;ZBTB12;APTX;RFX3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5884437067127135,-1.4304414881478411,0.09808102345415778,0.5206817513205169,1.0,4/12,8.66%,ITGB3;VEGFB;ITGA5;CADM4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4100172811474339,1.4300743326972403,0.022167487684729065,0.6910561037515742,1.0,28/147,9.99%,ITSN1;VAV3;DENND1A;FGD4;RASGRP4;SBF2;FGD6;RGL1;DOCK2;SH3BP5;RIN2;DOCK1;DENND1B;RAPGEF2;RIC1;RAP1A;DOCK11;GAPVD1;MYCBP2;NUCB2;NGEF;FNIP1;DENND4C;DENND5A;SMCR8;DENND2C;EEF1D;CYTH1
prerank,1-phosphatidylinositol binding (GO:0005545),0.6132874494255038,1.4249145324872081,0.10412926391382406,0.6959893089172652,1.0,3/15,1.62%,SNX9;WDFY3;SESTD1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5284480725057837,1.4225152289052378,0.08652246256239601,0.6915027187862512,1.0,10/29,16.19%,PTPRJ;DUSP1;GCH1;MAPKAPK2;DUSP2;MAPK14;ATF7;PRMT1;DUSP7;MAPK7
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5929247864636393,1.4207243316416955,0.09982486865148861,0.6842233437323617,1.0,4/18,4.72%,TNFAIP8;GAS6;RPS6KA3;BIRC3
prerank,tubulin binding (GO:0015631),-0.3087821388199916,-1.4202873910336558,0.0,0.5372764752807958,1.0,108/295,24.83%,NAV3;DST;MAP4K4;MAP2;UNC5C;KIF21B;CCDC88B;DNM3;TRAPPC14;CLASP2;PAK1;TTLL11;TBCD;EML3;NEFM;CAMSAP1;MAP1B;IFT81;CCDC66;DIP2B;FGF13;KIF1A;ALDOA;MTCL1;NEFH;KIF5A;CLIP2;KIF6;KIF5C;TTLL7;CRIPT;APPL1;NCALD;MAPT;PRNP;HAUS8;FMR1;FMN1;TUBGCP5;ARHGEF2;CENPE;MAP6;BRCA1;IRAG2;MAPRE3;STMN3;VBP1;KRIT1;CEP44;TPPP;BRCA2;KIF1C;STMN4;KIF3A;MTUS1;EML6;TOGARAM1;NUMA1;TTLL1;CKAP5;KIF15;TUBGCP3;EML1;GPAA1;SGIP1;EML2;MAP1LC3A;KIF3B;GABARAPL1;DLGAP5;MAP4;CLIP3;KIFC2;APC2;REEP1;KIF2A;NUSAP1;EML5;GOLGA2;SKA2;FSD1;B9D2;EMD;KIFC1;PRUNE1;GAPDH;TUBGCP6;BBS4;SETD2;ARL3;HDAC6;REEP2;KATNB1;BRSK1;FNTA;MAP9;TOGARAM2;RITA1;CETN3;REEP4;GAS2L3;BIRC5;KIF14;HOOK2;DCTN1;HDGFL3;HAUS6;S100A9
prerank,muscle alpha-actinin binding (GO:0051371),0.6053208552287739,1.4190618761335914,0.09565217391304348,0.6766351380280335,1.0,6/15,17.31%,PDLIM5;NRAP;PDLIM1;PKD2;PKD2L1;PDLIM2
prerank,symporter activity (GO:0015293),0.6532361115209459,1.4145627357454535,0.1252408477842004,0.6794355567561499,1.0,4/10,17.29%,SLC28A2;SLC4A4;MFSD2A;SLC5A6
prerank,PDZ domain binding (GO:0030165),-0.3880829065101909,-1.4139230150889643,0.02280130293159609,0.5436007948014465,1.0,14/61,7.68%,CADM1;F11R;GRID2;DOCK4;NLGN1;DLG4;GNG12;PLEKHA1;TBC1D10A;CIT;SYNJ2;CRIPT;SDC2;TGFBR3
prerank,protein kinase activator activity (GO:0030295),0.46002783002540626,1.4137224685099812,0.0746054519368723,0.6693277888880664,1.0,16/60,10.64%,IQGAP1;PRKAG2;GAS6;ABI1;RPLP1;RGCC;GHRL;PAK2;GPRC5B;INCENP;STK3;WNK1;FAM20A;PARP16;MARK2;CALM1
prerank,phospholipase C activity (GO:0004629),-0.46623103091284535,-1.410782689060833,0.05489260143198091,0.5393485292298105,1.0,8/25,11.20%,PLCL1;PLCB2;PLCB4;PLCG1;CHRM3;EDNRA;PLCB1;PLCH1
prerank,GTPase activator activity (GO:0005096),0.37705706562059105,1.4081515853217061,0.007616974972796518,0.6756723353572472,1.0,46/313,6.92%,ITSN1;ARHGAP15;STARD8;VAV3;IQGAP2;DENND1A;NRP1;FGD4;RASGRP4;SBF2;GNAQ;FGD6;IQGAP1;ARHGAP9;RGL1;TBC1D5;TBC1D4;DOCK2;SH3BP5;OPHN1;ARAP1;EVI5;RIN2;RASA1;DOCK1;USP6NL;ARHGAP10;DENND1B;ARHGAP18;ARHGEF10L;ARHGAP31;RAPGEF2;RIC1;NPRL3;RAP1A;DOCK11;OCRL;TBC1D14;RGS8;ARHGAP29;GAPVD1;MYCBP2;NUCB2;NGEF;STXBP5;TBC1D2B
prerank,calcium:sodium antiporter activity (GO:0005432),-0.6094011608799158,-1.4034647954296116,0.10151187904967603,0.5483481148987964,1.0,4/10,7.41%,SLC24A3;SLC24A2;SLC8A1;SLC24A4
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.6564702221160805,1.4013415875668467,0.12617702448210924,0.6869058335821986,1.0,3/10,16.01%,SLC10A6;SLC10A3;SLC6A11
prerank,hexosaminidase activity (GO:0015929),-0.5636043248048002,-1.3977063392623126,0.09429824561403509,0.5523425324129271,1.0,3/12,10.75%,HEXB;HEXD;HYAL1
prerank,ligand-gated anion channel activity (GO:0099095),-0.5233255448803601,-1.3925406404452054,0.08520179372197309,0.5553593350205281,1.0,12/17,29.39%,GABRB3;GABRB1;GLRB;GABRA2;GLRA1;GABRG2;GLRA3;CFTR;GLRA2;GABRA4;GABRG3;GABRE
prerank,phosphatidic acid binding (GO:0070300),0.5596144829068147,1.390454680352556,0.11423841059602649,0.7139751604134735,1.0,5/19,11.83%,PLTP;SESTD1;RAPGEF2;PACSIN2;GRAMD1B
prerank,neuropeptide binding (GO:0042923),-0.5058511045868678,-1.390267579310785,0.09619686800894854,0.5498270723245776,1.0,10/18,47.77%,SORL1;GPR149;OPRL1;OPRD1;OPRK1;MC4R;SSTR2;OPRM1;GPR37;NMUR1
prerank,histone deacetylase binding (GO:0042826),0.42663228785526636,1.3878405846255384,0.05962059620596206,0.7104888405073121,1.0,28/88,17.44%,HDAC9;MEF2A;MEF2C;HOXA10;PRKN;HEY2;SPI1;PKN2;BRMS1L;MIER1;SATB2;GMNN;NCOR1;LCOR;SP1;MIER3;ZMYND15;YWHAE;BCOR;KPNA2;USF1;HDAC4;SFPQ;HSP90AB1;TOP2B;RELA;NACC1;MEF2B
prerank,SH3 domain binding (GO:0017124),0.4438277925188321,1.384855888315025,0.06620689655172414,0.7095501647315852,1.0,11/62,4.80%,AFAP1L1;PTPN12;ABI1;PTPN22;WASF2;SYNJ1;ADAM9;CBL;CRK;PRKN;WIPF1
prerank,growth factor receptor binding (GO:0070851),0.4212876453155906,1.383195112680099,0.06929347826086957,0.7034895992171889,1.0,15/95,9.45%,SNX2;HIP1;PTPRJ;FER;TSLP;FGF23;ERN1;PIBF1;FRS2;PDGFRA;SDCBP;PSEN1;FYN;IL6R;PDGFC
prerank,cadherin binding (GO:0045296),0.37110757603292327,1.3823539639557445,0.016519823788546256,0.6948119791137761,1.0,87/315,16.08%,AHNAK;SNX2;PDLIM5;EGFR;PTPRJ;EHD4;CTNNA1;IQGAP1;SNX9;EPS15;ITGB1;ABI1;WASF2;EIF3E;SPTBN1;RPL23A;ARHGAP18;SWAP70;CD46;CBL;TMPO;RAB10;S100A11;EHD1;GOLGA3;RPL24;TMOD3;SND1;PKN2;PAK2;RACK1;TXNDC9;PDLIM1;STXBP6;CTNND1;STK24;ANXA2;SFN;GAPVD1;CNN2;BAG3;EPN2;PSEN1;FLNB;RPL14;VASN;VCL;DCHS1;RPL34;LRRFIP1;CDH12;RAB1A;SERBP1;EEF1D;RTN4;RPL6;AHSA1;PACSIN2;CHMP5;MARK2;DDX6;PPP1CA;JUP;CEMIP2;PLCB3;YWHAE;SNX5;RPL15;NIBAN2;STK38;CAST;VAPA;DIAPH3;GLOD4;CAPZA1;ADD1;TAGLN2;RARS1;PARVA;EIF5;BZW2;FXYD5;TRIM25;UBAP2;HCFC1;HSP90AB1;IDH1
prerank,acid-thiol ligase activity (GO:0016878),-0.5577439887685058,-1.3819917160250466,0.12385321100917432,0.5616942725681906,1.0,7/13,33.68%,AASDH;ACSS1;ACSS3;SLC27A2;ACSF3;ACSS2;AACS
prerank,mannosyltransferase activity (GO:0000030),-0.48461212292769096,-1.3819270021657382,0.06940874035989718,0.549187311195698,1.0,11/21,23.12%,DPY19L4;TMTC4;ALG1;DPY19L1;TMTC2;ALG12;DPY19L3;ALG8;ALG3;TMTC1;PIGB
prerank,actin binding (GO:0003779),0.38931957228802533,1.3804405297519926,0.04197530864197531,0.6898488818492635,1.0,32/170,14.82%,EPS8;IQGAP2;MTSS1;PDLIM5;FLII;PHACTR2;ANG;ITGB1;TMOD1;NRAP;SYNE2;UTRN;LCP1;PRKN;SSH2;PDLIM1;CXCR4;FLNB;VCL;FHDC1;SYNPO;PARVB;FHL3;NOD2;CORO7;SLC6A2;SPEF1;CAPZA1;ADD1;SPTBN5;PARVA;VPS16
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.5943126148407549,-1.373841163133009,0.12320328542094455,0.562427789592233,1.0,3/10,6.17%,CYLD;OTUD5;STAMBP
prerank,RNA methyltransferase activity (GO:0008173),-0.4929053803047505,-1.3709142700667956,0.10232558139534884,0.5594960244226919,1.0,9/19,22.26%,TRDMT1;FTSJ3;TRMT12;MEPCE;TGS1;BCDIN3D;TRMT9B;MRM2;METTL3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.584944250134625,1.3677555288321706,0.1534195933456562,0.72323978270904,1.0,8/14,21.89%,MTM1;SYNJ1;MTMR3;MTMR1;PTEN;MTMR6;MTMR11;MTMR12
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.563652933857153,-1.367435487385028,0.11255411255411256,0.5587815826393959,1.0,7/11,18.30%,TRPC4;TRPC1;TRPC3;ITPR2;TRPC5;CYTH2;RPH3A
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5375593980761811,1.3650097168983182,0.12216404886561955,0.7211334187342424,1.0,5/23,7.14%,HIP1;SESTD1;SNX3;KIF16B;WIPI1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5683446991078005,1.3561524062765327,0.14335060449050085,0.74194692776021,1.0,2/16,1.41%,ALOX5;ALOX15
prerank,GTPase inhibitor activity (GO:0005095),0.5840833486286386,1.3555697630671975,0.1532976827094474,0.7326231619961265,1.0,2/13,1.00%,IQGAP2;IQGAP1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.5035214878140916,-1.353651753505133,0.10633484162895927,0.5909667380517237,1.0,14/19,39.27%,DNA2;HELQ;RFC2;MCM6;DHX9;RAD51;CHTF18;MCM2;MCM7;POLQ;DSCC1;PIF1;MCM5;RFC5
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5717404563699303,1.352940621272416,0.15753424657534246,0.7307073908386501,1.0,5/15,11.98%,CCR1;CMKLR1;CCRL2;CCR2;GPR17
prerank,Wnt-activated receptor activity (GO:0042813),-0.5195548540184534,-1.3502473218416,0.12304250559284116,0.5899138612176557,1.0,10/15,41.16%,LRP5;TSPAN12;FZD4;FZD6;FZD2;FZD5;PKD1;FZD8;FZD1;FZD10
prerank,double-stranded RNA binding (GO:0003725),0.4173743886431527,1.3477739165443392,0.07994186046511628,0.736874811840941,1.0,17/70,13.30%,TLR8;MBNL1;OAS2;CLTC;DDX60;PRKRA;RFTN1;VIM;RC3H1;DROSHA;STAU2;MSN;LRRFIP1;ILF3;EIF4B;DHX33;MRPL44
prerank,retinoic acid receptor binding (GO:0042974),0.5663308466472986,1.347066768598195,0.13756613756613756,0.7285258352898945,1.0,6/17,9.56%,RARG;ARID5A;NR4A2;NRIP1;NCOA6;ASXL1
prerank,DNA-binding transcription factor binding (GO:0140297),0.3739110407644731,1.3446582921501984,0.049939098660170524,0.7268235888691825,1.0,25/189,10.53%,RBPJ;HDAC9;TCF7L2;MEF2A;TLE4;RBBP8;TCF12;MEF2C;PIAS1;HEY2;SPI1;GSK3B;RB1;DMAP1;BCL2;PIAS2;HSPB1;KLF4;MIER1;FIZ1;NCOR1;PURA;SPEN;SP1;MIER3
prerank,tRNA methyltransferase activity (GO:0008175),-0.4993129384486205,-1.3437329993819815,0.13392857142857142,0.5982826474512544,1.0,7/16,15.34%,TRDMT1;METTL2A;METTL2B;TRMT12;ALKBH8;BCDIN3D;TRMT9B
prerank,protein kinase inhibitor activity (GO:0004860),0.4658875760444594,1.342788457063463,0.12580645161290321,0.7228933027311535,1.0,20/42,22.79%,SPRED1;SH3BP5;GMFG;DNAJC3;RACK1;SMCR8;SPRED2;SH3BP5L;IBTK;PARVA;GMFB;SPRY2;TRIB1;SNCA;DUS2;CDKN1C;NPM1;CDKN1B;QARS1;NCK1
prerank,endodeoxyribonuclease activity (GO:0004520),0.5319675005377567,1.341706974726581,0.13961605584642234,0.7164297717002449,1.0,5/20,10.58%,ENDOG;RBBP8;RPS3;DCLRE1C;ZRANB3
prerank,glutathione transferase activity (GO:0004364),0.5138801323858103,1.339316586848773,0.1352253756260434,0.7147220247640145,1.0,4/23,9.00%,LTC4S;ALOX5AP;MGST3;MGST1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.560844886270036,-1.3370626613389147,0.1279826464208243,0.6075209115126486,1.0,2/11,1.46%,SRRM2;EHMT2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.34592380251021576,1.3361904741508095,0.007253886010362694,0.7154450787442268,1.0,127/597,18.07%,MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;FLI1;AHR;FOXN2;TFEC;ESR1;ZBTB20;RARG;TCF12;MEF2C;CEBPB;OSR1;ORC5;ARID4B;KLF6;TBX15;HOXD8;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR2C1;NR1D1;NR3C1;HEY2;CLOCK;DMRTA2;SPI1;NFIC;SMAD4;ARID5A;ELF2;THRB;MBNL2;NR4A1;ORC2;TCF7;MCM9;ZNF568;TNF;KLF3;KLF4;YY1;DDX11;TBL1XR1;CEBPG;NR4A2;LHX5;NCOR1;IRF2;KLF10;IRX5;ATF6;FOXC2;ESRRB;ASH2L;HIVEP1;OLIG2;TBL1X;FOXJ3;ATF7;NFATC2;BEND3;NR2F1;RFX2;SP1;ZNF296;ELF1;ETS2;CENPB;SREBF2;BCL11B;MYBL2;FOXK2;XPA;HINFP;FOXO3;DHX33;FOXK1;SP3;NFIX;CREB1;KLF13;PSPC1;RARA;KAT7;STAT3;JUND;KLF5;BCOR;USF1;MTF1;NR2C2;HDAC4;SFPQ;RUNX3;ELK1;E2F8;MCM8;CREB3L1;RELA;PER1;ARNT;TBX2;NFATC3;ZNF177;GLIS2;ZBTB7A;NR5A2;SP8;LHX1;XBP1;MEF2B;NR6A1;ARID4A;GMEB1;ZNF32;HSF5;BATF;ZBTB12
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.47132803318604904,1.3358572819832835,0.1338709677419355,0.706833889389972,1.0,10/35,11.12%,PEAK1;LYN;FER;FRK;SYK;ZAP70;FYN;DYRK1A;STYK1;SLA
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.51063218357212,1.334614065668755,0.14521452145214522,0.7009031331697514,1.0,4/25,5.80%,HIP1;SESTD1;FCHSD2;KIF16B
prerank,filamin binding (GO:0031005),-0.5587888310377076,-1.3339069118073008,0.10685483870967742,0.6063896094636518,1.0,3/11,6.83%,FBLIM1;TMEM67;NEBL
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.5478349772498605,-1.3330342015902454,0.15,0.5975071714727176,1.0,9/12,36.97%,CYFIP2;DCPS;NCBP1;EIF4E;LARP1;NCBP3;EIF4E2;GEMIN5;NCBP2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.48374132963263355,-1.3327601901259087,0.13215859030837004,0.5874966657212334,1.0,9/18,23.06%,TGFBR1;SMAD7;FERMT2;TGFBR3;TGFBR2;ENG;TGFB2;TGFB1;BAMBI
prerank,channel activity (GO:0015267),0.4544656792420603,1.331049262975712,0.1104199066874028,0.7030916672746819,1.0,4/41,8.47%,MCUB;SLC14A1;BCL2;TRPV3
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5776874749318135,-1.329852551203886,0.1497005988023952,0.5862452785121465,1.0,3/10,1.99%,DPP10;NAALAD2;DPP6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6099767872026003,1.3293820343488345,0.14922480620155038,0.6997887939232225,1.0,1/10,0.19%,GDA
prerank,nuclease activity (GO:0004518),0.43048037290566554,1.327965847798325,0.11420204978038068,0.6955427571552285,1.0,17/52,19.84%,ENDOG;ANG;RNASE4;SND1;DNASE1L1;RNASEL;RNASE6;ZC3H12A;DIS3L2;SAMHD1;RNASE3;RNASE12;MRE11;ENPP1;APEX1;ERN2;REXO5
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.428608853721699,-1.3258930099426767,0.09090909090909091,0.5877746549410793,1.0,16/28,31.88%,SGK1;MAPK10;RPS6KA1;MAP2K7;RPS6KA2;MAP2K2;MAP3K9;PAK3;MAP2K4;MAP2K5;RPS6KB1;AURKB;AKT1;TTK;MAP2K3;AURKA
prerank,ligand-gated ion channel activity (GO:0015276),-0.43123363520838276,-1.321136464911379,0.1096938775510204,0.5919566016621368,1.0,6/30,5.35%,GRID2;GRIA2;GRIK2;GRIA4;GRIN3A;GABRB1
prerank,cytokine receptor binding (GO:0005126),0.4091399578744233,1.3201459276669112,0.11294765840220386,0.713087173938239,1.0,22/83,17.76%,LIFR;SPRED1;TSLP;KITLG;PIBF1;CCL19;TGFBRAP1;SYK;CCRL2;SDCBP;USP15;IL6R;SH2B3;PXDN;SPRED2;JAK1;CRLF2;IL13RA1;ERAP1;CCL5;CCL25;IL6
prerank,cytokine receptor activity (GO:0004896),0.4105506557554906,1.3169917527878952,0.1039136302294197,0.7145251241625082,1.0,20/83,11.98%,LIFR;CCR1;CMKLR1;IFNAR1;CD44;CD74;IL17RB;IL17RD;IL17RC;IL17RA;IL10RB;GFRA3;CCRL2;CCR2;IL20RB;IFNAR2;IL6R;IL1RL1;IL15RA;GPR17
prerank,chemokine binding (GO:0019956),0.4902030249051095,1.316943885837365,0.15118110236220472,0.7058728138227568,1.0,6/30,7.60%,ITGA4;CCR1;ITGB1;CCRL2;CXCR4;CCR2
prerank,frizzled binding (GO:0005109),0.4678555827937151,1.316551176922911,0.13787638668779714,0.698385402107504,1.0,6/34,10.05%,LRP6;WNT2;ZNRF3;SDCBP;WNT6;SFRP1
prerank,semaphorin receptor activity (GO:0017154),0.6002438899111995,1.3156470901345338,0.18058252427184465,0.6930220569361949,1.0,3/11,6.56%,NRP1;PLXNC1;PLXNA4
prerank,chemorepellent activity (GO:0045499),-0.4418963006728647,-1.3129344191714674,0.116751269035533,0.6070074762927248,1.0,5/25,5.56%,SEMA4D;NRG3;EPHA7;SEMA4C;SEMA4G
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6170630057236087,1.3101912914211011,0.19029126213592232,0.7019399748790425,1.0,2/10,7.28%,DSE;FUOM
prerank,metal ion:proton antiporter activity (GO:0051139),0.56439127544589,1.3091030352561828,0.18198529411764705,0.6968680527376182,1.0,4/13,14.03%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,potassium:proton antiporter activity (GO:0015386),0.6009327509421227,1.306675807659956,0.1839080459770115,0.696234210948489,1.0,4/10,14.03%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5894076493849979,1.3045147590489965,0.19301470588235295,0.695345226212457,1.0,4/12,10.42%,SLC25A17;SLC25A24;SLC35B3;SLC25A5
prerank,Tat protein binding (GO:0030957),0.6022447067732732,1.3038193931015716,0.15356489945155394,0.689443444092896,1.0,3/10,5.91%,MDFIC;ACTB;TRIM32
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5436844145874499,-1.3025169615444876,0.15466101694915255,0.6288301370746393,1.0,5/11,19.37%,CASP7;CFLAR;CASP6;PYCARD;CASP12
prerank,ligand-gated channel activity (GO:0022834),-0.431236976339585,-1.3019336032474425,0.12020460358056266,0.6205582112125617,1.0,6/29,5.35%,GRID2;GRIA2;GRIK2;GRIA4;GRIN3A;GABRB1
prerank,CoA-ligase activity (GO:0016405),-0.5133507380306228,-1.2981545341435732,0.15349887133182843,0.6216712681058171,1.0,7/14,33.68%,ACSS1;ACSS3;SLC27A2;ACSBG1;ACSF3;ACSS2;AACS
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3327142515571102,1.2965895495672257,0.00815494393476045,0.7036679746450482,1.0,157/732,18.27%,RBPJ;ZEB2;MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;MEF2A;AHR;ZBTB16;RREB1;FOXN2;TFEC;HIVEP2;ESR1;ZBTB20;RARG;TCF12;MEF2C;NR1H4;CEBPB;MITF;KLF6;TBX15;FOXA3;RAX;HOXA10;NR2C1;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;PBX3;DMRTA2;SPI1;RBPJL;KLF9;NFIC;SMAD4;BATF2;ZFP2;THRB;IRX2;NR4A1;FOSL2;TCF7;ZBTB25;KDM6A;ZNF235;ZNF568;KLF3;ZNF148;LYL1;KLF4;ZSCAN25;YY1;THAP11;REL;SATB2;STAT4;CEBPG;E2F5;NR4A2;ZBTB5;NRIP1;IRF2;KLF10;IRX5;ATF6;ZNF628;FOXC2;ESRRB;BACH1;HIVEP1;OLIG2;ESR2;LRRFIP1;FOXJ3;ATF7;NFATC2;MLXIP;STAT6;NR2F1;H3-3A;ZNF205;RFX2;SP1;ZNF296;ELF1;ETS2;SREBF2;BCL11B;MYBL2;FOXK2;NFIA;HINFP;FOXO3;FOXK1;CHD2;SP3;FOXO1;NFIX;CREB1;KLF13;ZBTB7C;NR1H2;RARA;HIF3A;STAT3;JUND;PROX2;KLF5;USF1;MYC;MTF1;MYT1;NR2C2;HDAC4;POU5F2;RUNX3;ELK1;E2F8;ZNF569;HOXB3;ZFP62;ZGPAT;RELA;PER1;ARNT;TBX2;NFATC3;GLIS2;FOXP2;ZBTB7A;NR5A2;NACC1;SP8;CARF;NR2F2;XBP1;MEF2B;NR6A1;MECOM;ZFP28;GMEB1;ZNF32;GZF1;ZBTB41;HSF5;BATF;ZBTB12;ZBTB40;ZBTB1;RFX3
prerank,protein tyrosine kinase binding (GO:1990782),0.40446836546115394,1.2964550790261622,0.11065573770491803,0.6962079364816962,1.0,11/71,9.29%,BANK1;NEDD9;GAS6;ITGB1;CASS4;CBL;CRK;RACK1;DUSP22;FIZ1;SH2B3
prerank,microtubule minus-end binding (GO:0051011),-0.5224361565186801,-1.2960092293009136,0.16452991452991453,0.6182065893917296,1.0,6/13,12.79%,CAMSAP1;MACF1;TUBGCP5;HAUS7;NUMA1;TUBGCP3
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5703811420805988,1.293778222139579,0.17702448210922786,0.697302999288891,1.0,4/12,14.03%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,transcription cis-regulatory region binding (GO:0000976),0.33601299000524637,1.2887156872862695,0.04962243797195254,0.7056327151382614,1.0,88/406,17.78%,TRPS1;TCF7L2;FOXP1;FLI1;MEF2A;AHR;RREB1;FOXN2;NFXL1;ZBTB20;RPS3;TCF12;MEF2C;NR1H4;CEBPB;OSR1;ARID4B;HOXD8;PHOX2A;FOXA3;ALX1;NR1D1;NR3C1;GRHL2;SPI1;RB1;SMAD4;ARID5A;FOSL2;TCF7;FOXM1;ZNF568;TNF;KLF4;YY1;SATB2;TBL1XR1;LHX5;ZBTB5;NCOR1;IRF2;KLF10;ATF6;FOXC2;ESRRB;ASH2L;TBL1X;MLXIP;STAT6;PURA;SP1;CREBRF;TFDP1;FOXK2;HINFP;FOXO3;FOXK1;ZBTB8B;ZFP3;SP3;PEG3;PSPC1;ZBTB10;RARA;HIF3A;STAT3;JUND;BCOR;MYC;MTF1;NR2C2;HDAC4;SFPQ;RUNX3;ELK1;E2F8;CREB3L1;RELA;PER1;ARNT;ZNF177;GLIS2;NR5A2;LHX1;ZNF22;XBP1;ARID4A;ZBTB8A
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4742143507023382,-1.2886058843468675,0.15065502183406113,0.6214694646681342,1.0,7/16,15.88%,PTPRM;PTPRE;PTPRD;PTPRT;PTPRN2;PTPRG;PTPRB
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4742143507023382,-1.2886058843468675,0.15065502183406113,0.6214694646681342,1.0,7/16,15.88%,PTPRM;PTPRE;PTPRD;PTPRT;PTPRN2;PTPRG;PTPRB
prerank,MAP-kinase scaffold activity (GO:0005078),0.5795686495093454,1.2884086048657513,0.1784313725490196,0.699086058199464,1.0,3/11,8.54%,IQGAP1;SH3RF1;MAPK8IP2
prerank,chemokine receptor activity (GO:0004950),0.5043247909235471,1.2879146934126853,0.1824212271973466,0.693084338854397,1.0,5/24,7.60%,CCR1;CMKLR1;CCRL2;CXCR4;CCR2
prerank,sodium:proton antiporter activity (GO:0015385),0.5808046588710533,1.2878286539475827,0.2018867924528302,0.6860768823747223,1.0,4/11,14.03%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,histone acetyltransferase activity (GO:0004402),0.4694619817917375,1.2860554157203683,0.16267123287671234,0.6843891476181817,1.0,13/30,18.68%,NCOA3;CLOCK;EPC1;EPC2;ARRB1;CREBBP;HAT1;EP300;KAT7;KAT6A;USP22;SRCAP;ATF2
prerank,sodium channel regulator activity (GO:0017080),-0.3803166419932861,-1.2859841133325032,0.11142061281337047,0.619776449486088,1.0,7/37,4.10%,FGF14;FGF12;YWHAH;SCN1B;SNTA1;SGK1;FGF13
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3301848305945587,1.2855378702606306,0.013251783893985729,0.6789160738598902,1.0,158/731,18.27%,RBPJ;ZEB2;MAF;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;MEF2A;AHR;ZBTB16;RREB1;TFEC;HIVEP2;ESR1;ZBTB20;RARG;TCF12;MEF2C;NR1H4;CEBPB;MITF;KLF6;TBX15;FOXA3;RAX;HOXA10;NR2C1;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;PBX3;DMRTA2;SPI1;RBPJL;KLF9;NFIC;SMAD4;BATF2;ZFP2;THRB;IRX2;NR4A1;FOSL2;TCF7;ZBTB25;KDM6A;TRIM24;ZNF235;ZNF568;KLF3;ZNF148;LYL1;KLF4;ZSCAN25;YY1;THAP11;REL;SATB2;STAT4;CEBPG;E2F5;NR4A2;ZBTB5;NRIP1;IRF2;KLF10;IRX5;ATF6;ZNF628;FOXC2;ESRRB;BACH1;HIVEP1;OLIG2;ESR2;LRRFIP1;FOXJ3;ATF7;NFATC2;MLXIP;STAT6;NR2F1;H3-3A;ZNF205;RFX2;SP1;ZNF296;ELF1;ETS2;SREBF2;BCL11B;MYBL2;FOXK2;NFIA;HINFP;FOXO3;FOXK1;CHD2;SP3;FOXO1;NFIX;CREB1;KLF13;ZBTB7C;NR1H2;RARA;HIF3A;STAT3;JUND;PROX2;KLF5;USF1;MYC;MTF1;MYT1;NR2C2;HDAC4;POU5F2;RUNX3;ELK1;E2F8;ZNF569;HOXB3;ZFP62;CREB3L1;ZGPAT;RELA;PER1;ARNT;TBX2;NFATC3;GLIS2;FOXP2;ZBTB7A;NR5A2;NACC1;SP8;CARF;NR2F2;XBP1;MEF2B;NR6A1;MECOM;ZFP28;GMEB1;ZNF32;GZF1;ZBTB41;HSF5;BATF;ZBTB12;ZBTB40;ZBTB1;RFX3
prerank,ephrin receptor binding (GO:0046875),0.5008621109620917,1.2851237988505009,0.15630550621669628,0.6731356754851564,1.0,6/21,11.32%,LYN;ANKS1A;CBL;CRK;FYN;SHC1
prerank,phosphatase binding (GO:0019902),0.38393720983407986,1.2850012484554005,0.0941336971350614,0.6666918573483186,1.0,22/105,12.64%,EGFR;MAP3K5;SPRED1;CTSC;IQGAP1;RCAN3;MTMR3;AP3B1;SNX3;RACK1;WNK1;CDC27;CD33;MAPK14;NFATC2;PPP1R3C;STAT6;CHCHD3;PXN;JUP;JAK1;TERF2IP
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.32929701909862147,1.2848969527660508,0.008130081300813009,0.6603573613075854,1.0,178/831,18.27%,RBPJ;ZEB2;MAF;TRPS1;ETV1;KLF2;TCF7L2;TCF4;IRF4;FOXP1;MEF2A;ZBTB16;RREB1;TFEC;HIVEP2;NFXL1;ESR1;ZBTB20;RARG;RPS3;TCF12;MEF2C;NR1H4;CEBPB;MITF;OSR1;KLF6;TBX15;HOXD8;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR2C1;NR1D1;NR3C1;HEY2;CLOCK;GRHL2;PBX3;DMRTA2;SPI1;RBPJL;KLF9;RB1;NFIC;SMAD4;BATF2;ZFP2;THRB;IRX2;NR4A1;FOSL2;TCF7;ZBTB25;KDM6A;FOXM1;ZNF235;ZNF568;KLF3;ZNF148;LYL1;KLF4;ZSCAN25;YY1;THAP11;REL;SATB2;STAT4;CEBPG;E2F5;NR4A2;LHX5;ZBTB5;NRIP1;IRF2;KLF10;IRX5;ATF6;ZNF628;FOXC2;ESRRB;BACH1;HIVEP1;OLIG2;ESR2;LRRFIP1;FOXJ3;ATF7;NFATC2;MLXIP;STAT6;NR2F1;PURA;H3-3A;ZNF205;RFX2;SP1;ZNF296;CREBRF;ELF1;TFDP1;ETS2;SREBF2;BCL11B;MYBL2;FOXK2;NFIA;HINFP;FOXO3;FOXK1;ZBTB8B;CHD2;ZFP3;SP3;FOXO1;NFIX;CREB1;KLF13;GTF2A1;PEG3;ZBTB7C;NR1H2;ZBTB10;RARA;HIF3A;STAT3;JUND;PROX2;KLF5;USF1;MYC;MTF1;MYT1;NR2C2;HDAC4;POU5F2;RUNX3;ELK1;E2F8;ZNF569;HOXB3;ZFP62;ZGPAT;GTF2B;RELA;PER1;ARNT;TBX2;NFATC3;ZNF177;GLIS2;FOXP2;ZBTB7A;NR5A2;NACC1;SP8;CARF;LHX1;NR2F2;ZNF22;XBP1;MEF2B;NR6A1;MECOM;ZFP28;ZBTB8A;GMEB1;ZNF32;GZF1;ZBTB41;HSF5;BATF;ZBTB12;ZBTB40;ZBTB1;RFX3
prerank,titin binding (GO:0031432),-0.504009465958791,-1.2837958601487784,0.18143459915611815,0.6172092689810013,1.0,5/13,20.92%,CAPN3;CALM2;ACTN2;CAMK2D;CALM3
prerank,transaminase activity (GO:0008483),-0.5396983841171363,-1.2832143349349454,0.19438444924406048,0.6096659840915692,1.0,5/11,35.25%,ABAT;AGXT;BCAT1;GOT1;PSAT1
prerank,death domain binding (GO:0070513),0.5827148234721113,1.2816649858571945,0.21070811744386875,0.6631510077469063,1.0,4/11,6.29%,RIPK1;MCL1;RACK1;BCL2
prerank,5'-3' exonuclease activity (GO:0008409),0.5475504996443274,1.2816555108168726,0.18231046931407943,0.6566495272787993,1.0,6/14,21.18%,DCLRE1C;CPSF3;DCP2;DXO;MRE11;TRIR
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.40549900473262485,1.2813389976029368,0.15595075239398085,0.6512140330317246,1.0,17/75,14.65%,KCNAB2;SORD;DHRS3;HMGCR;EHHADH;HIBADH;HSD3B7;ABCC4;IMPDH2;HSD17B7;DHDH;CRYL1;HADHA;HADH;HADHB;KCNAB3;CBR3
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3952910051014315,-1.2778622740858712,0.1452513966480447,0.6163359327577826,1.0,16/31,28.62%,SLC12A2;TMEM38B;SLC12A9;KCNA2;KCNA1;SLC12A6;KCNK9;ABCC9;SLC12A4;SLC12A5;ABCC8;KCNC4;TMEM175;SLC12A1;KCNK10;KCNK3
prerank,WW domain binding (GO:0050699),0.47107568198867733,1.2762734547794428,0.1734860883797054,0.6597120705087179,1.0,8/26,14.72%,KIF20B;RAPGEF2;NDFIP1;TCEAL6;PMEPA1;TCEAL8;NDFIP2;DAZAP2
prerank,anion transmembrane transporter activity (GO:0008509),-0.5203510965779791,-1.272335962135588,0.19310344827586207,0.6234577179628886,1.0,3/12,12.16%,SLCO2B1;SLC4A2;ABCG2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.5393662730985491,-1.2717844591174614,0.17697228144989338,0.6160005574121128,1.0,3/10,14.52%,SIRPA;CD200;CXADR
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4753008423918812,1.2713689442667648,0.18923327895595432,0.6670146579403446,1.0,7/30,12.60%,TNFAIP8;GAS6;RPS6KA3;BIRC3;BIRC6;CARD16;CAST
prerank,transcription coactivator binding (GO:0001223),0.5040125151689586,1.2709681487002904,0.20567375886524822,0.6619211492155322,1.0,5/20,5.63%,AHR;ESR1;RPL23;SMAD4;THRB
prerank,O-methyltransferase activity (GO:0008171),-0.5464546052716606,-1.2673639854513563,0.1921487603305785,0.6206226118234732,1.0,5/10,21.86%,COMT;FTSJ3;MEPCE;BCDIN3D;ASMT
prerank,I-SMAD binding (GO:0070411),-0.5098950806358862,-1.267061575347664,0.175054704595186,0.6128511997382133,1.0,3/13,2.02%,TGFBR1;CTNNB1;SMAD7
prerank,protein heterodimerization activity (GO:0046982),0.35539983014463566,1.2658195329403628,0.09700598802395209,0.670437220256248,1.0,42/178,18.37%,SNX2;HIP1;EXT1;CYBB;TCF4;MEF2A;AHR;ITGB1;IRAK3;MEF2C;TLR4;KRT10;MCL1;BCL2L2;NR4A1;BCL2;SDCBP;NR4A2;ATF6;GTF2A2;ADRA1A;PPP2CA;YWHAE;KCNB1;RALGAPA2;VAPA;GTF2A1;PAFAH1B1;ATP1A1;ADD1;USF1;CYBA;HEXA;ZHX1;TOP2B;PAFAH1B2;ARNT;XBP1;RALGAPB;ZBTB1;RRAGC;DGKD
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.4649218189046348,-1.265338882099722,0.17142857142857143,0.6092494206587832,1.0,8/17,25.43%,ACOT9;PLA2G6;PPT1;ACOT7;THEM4;ACOT11;ACOT8;ACOT1
prerank,manganese ion binding (GO:0030145),-0.3606084437982888,-1.265201184651793,0.10355029585798817,0.6013520836870851,1.0,16/48,17.12%,LARGE1;MPPED2;MGAT5;GALNT3;PPM1M;FAM20C;PRIMPOL;DYRK2;POMGNT1;PCK2;XPNPEP1;ADPRM;ATP13A2;XXYLT1;B4GALT7;MGAT1
prerank,guanyl ribonucleotide binding (GO:0032561),0.35181715840034444,1.2650317137154354,0.10438908659549229,0.6664564819166331,1.0,31/196,10.68%,RAP1B;RAB31;RAP2B;GBP3;ATL1;MFHAS1;NRAS;KRAS;GNAI3;EEF1A1;CNGA3;CDC42;RAB8B;ARL8A;RAB10;RHOA;RAPGEF2;PDE2A;GCH1;RAP1A;INSR;GBP7;GTPBP10;GEM;RHOBTB1;RAB7A;ADSS2;RAB14;ARL4A;TUBB6;PDE5A
prerank,calcium channel activity (GO:0005262),-0.32247698274689995,-1.2637699998608525,0.07539682539682539,0.5973371006703716,1.0,25/84,19.40%,CACNB2;CACNB4;SLC24A3;SLC24A2;TRPC4;CACNA2D1;CACNA2D3;ORAI2;CACNA1D;TRPC1;SLC24A4;CACNA1E;TRPC3;CACNG7;CACNA1C;CACNG8;ANXA9;TRPC5;SEC61A1;CACNG4;NCS1;SLC24A5;ITGAV;ORAI3;CACNG2
prerank,nuclear receptor binding (GO:0016922),0.37335934515346203,1.262570799288148,0.1279229711141678,0.6672758940581328,1.0,41/111,19.98%,TCF7L2;FOXP1;ESR1;NCOA3;NR1H4;NCOA2;NCOA7;ARID5A;NR4A1;WIPI1;PRKCB;MED16;NR4A2;NRIP1;NCOR1;TRIM68;NCOA6;LCOR;ASXL1;JMJD1C;RNF14;JUP;GAS2L1;BUD31;STRN;BCAS3;EP300;MMS19;SNW1;ARID1A;KDM1A;PPARGC1B;GTF2B;MED17;ZBTB7A;GTF2H1;KDM4C;THRAP3;RNF6;MED14;CNOT1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5547030211689277,1.2620977724150566,0.2122905027932961,0.6626940961701504,1.0,5/12,6.04%,PDE7B;PDE2A;PDE8A;PDE4D;PDE7A
prerank,E-box binding (GO:0070888),0.453770106429484,1.2604971755765733,0.18799368088467613,0.6610575273682181,1.0,4/34,4.52%,TCF4;AHR;MITF;CLOCK
prerank,G protein-coupled receptor binding (GO:0001664),0.36371794160492127,1.2604127675224135,0.10779220779220779,0.6553734675996666,1.0,19/132,10.50%,LRP6;GNAQ;GNAI3;WNT2;CCL19;ADM;PRKN;ZNRF3;GHRL;GPRC5B;S1PR2;CCRL2;SDCBP;WNT6;ARHGEF12;HOMER1;SFRP1;ARRB1;S1PR1
prerank,protein homodimerization activity (GO:0042803),0.32807998661609294,1.2599077009194515,0.03319502074688797,0.6510272939015429,1.0,93/589,12.10%,SNX2;HIP1;NLRC4;LRP6;EXT1;APOE;FGFR1;MAP3K5;SNX9;AHR;ZBTB16;CPQ;KIF20B;KMT2A;GBP3;DPYD;ANG;ST6GAL1;IRAK3;CEBPB;ADRB2;S100A1;GYG1;XDH;RIPK1;LILRB1;PRKRA;ERN1;SNX6;AXIN1;STARD3NL;UGT1A10;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;CLN6;S100A11;HMOX1;S100A10;B2M;PDE2A;AOC1;NQO2;MGAT2;NPR3;XPNPEP3;GCH1;MCL1;GNPTG;SMAD4;RACK1;BCL2L2;ANO1;GUCY2D;PDGFRA;DROSHA;BCL2;PEX7;CR2;CACYBP;HSPB1;BST2;VPS4B;AOX1;RABEP1;IL6R;TRIM68;GTF2A2;TKT;ZDHHC3;TRIM27;PLN;MAPK4;LRRFIP1;PDGFC;LHPP;RIPK2;SP1;ATG7;KYAT1;CRYL1;ACHE;JUP;STK10;CRYAB;XPA;PANK1;BANF1;SLC8B1;MAP3K11;RBM11
prerank,tau-protein kinase activity (GO:0050321),0.5001976631892733,1.2575412937416544,0.19185059422750425,0.6518003113120786,1.0,6/20,11.89%,GSK3B;ROCK1;FYN;DYRK1A;MARK2;ROCK2
prerank,P-type ion transporter activity (GO:0015662),0.5683768052697538,1.2557145190066048,0.22030651340996169,0.6513611233784482,1.0,4/12,14.29%,ATP2B1;ATP7A;ATP2B4;ATP2A2
prerank,endopeptidase inhibitor activity (GO:0004866),0.3877993006247657,1.2555458385724914,0.14266117969821673,0.6461505123141308,1.0,12/82,12.60%,SERPINB8;APP;SERPINB2;RARRES1;ROCK1;ANXA2;BST2;BIRC6;CARD16;PROS1;USP14;CAST
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5320509742047754,-1.2553467900500936,0.19616204690831557,0.6135338121056388,1.0,5/10,29.16%,ASH1L;SETD3;SETD2;PRDM9;SMYD2
prerank,pre-mRNA binding (GO:0036002),-0.4051142447598856,-1.2515100793579246,0.16112531969309463,0.6164697902681107,1.0,14/28,31.85%,DDX5;HNRNPU;CELF4;U2AF1;HNRNPA1;TARBP2;U2AF2;CELF5;SLBP;SRSF6;TRA2B;SNRPC;U2AF1L4;PTBP1
prerank,aspartic-type peptidase activity (GO:0070001),-0.5375689436575541,-1.2508341817832669,0.204,0.6104643267816053,1.0,2/10,5.45%,CTSD;CTSE
prerank,GTPase regulator activity (GO:0030695),0.3468837616451216,1.2505234269707712,0.09490740740740741,0.6550345060867288,1.0,32/212,7.73%,ARHGAP15;STARD8;VAV3;IQGAP2;NRP1;GNAQ;IQGAP1;ARHGAP9;TBC1D5;TBC1D4;OPHN1;ARAP1;EVI5;RIN2;RASA1;DOCK1;USP6NL;ARHGAP10;ARHGAP18;ARHGEF10L;ARHGAP31;ITGB1BP1;RAPGEF2;NPRL3;OCRL;TBC1D14;RGS8;ARHGAP29;STXBP5;TBC1D2B;RABGAP1L;SGSM1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.5530029333059191,1.2414955352428483,0.21691176470588236,0.674365341923676,1.0,4/13,9.45%,PTPRJ;ERN1;PDGFRA;PDGFC
prerank,vinculin binding (GO:0017166),0.5646366891948702,1.2395956015875245,0.2390057361376673,0.6739977768561922,1.0,3/11,10.64%,CTNNA1;UTRN;PXN
prerank,MHC protein binding (GO:0042287),0.4885763928838692,1.2389414017520541,0.2204585537918871,0.6703528506011519,1.0,3/20,4.55%,LILRB1;CD74;KIR3DL2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.4414625491562618,-1.237013272785815,0.1766109785202864,0.6410288228817469,1.0,5/20,5.06%,SENP2;OTULINL;OTUD5;SENP5;USP50
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.48057273558243463,1.2341837633578014,0.20603907637655416,0.6786704168253038,1.0,6/21,6.04%,PDE7B;PDE2A;PDE8A;PDE6A;PDE4D;PDE7A
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.45156778189015867,1.2266586177688592,0.22613065326633167,0.6945531255022086,1.0,8/27,14.75%,SLC9A9;SLC9A4;SLC8B1;SLC9A7;SLC9A6;SLC23A1;PKD2L1;CNNM4
prerank,heme binding (GO:0020037),0.39336052081793266,1.2263956825120956,0.16338028169014085,0.6896614965672608,1.0,11/65,10.63%,CYBB;NR1D1;HMOX1;THAP4;CYP27A1;RSAD1;HMOX2;BACH1;CYCS;CYP26B1;PXDN
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5521577803335709,1.226162520250974,0.2580037664783427,0.6847620322389429,1.0,3/11,12.32%,SASH1;MAP3K11;STK38
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.5261100755573971,-1.2231052500708792,0.22787610619469026,0.6733397368096485,1.0,5/11,23.20%,NAA40;NAA60;NAA25;NAA80;NAA30
prerank,G protein-coupled receptor activity (GO:0004930),0.33306724977399227,1.222835588122348,0.11059371362048893,0.6884196893516626,1.0,23/239,8.68%,ADGRE5;HRH1;ADGRG6;ADGRE1;CMKLR1;C5AR1;C3AR1;CYSLTR1;CALCRL;GPR65;ADRB2;DRD1;P2RY6;NPR3;TM2D1;S1PR2;P2RY10;ADCYAP1R1;RRH;GPR52;CXCR4;ADRA1D;ADRA1A
prerank,"DNA binding, bending (GO:0008301)",-0.47084980355511996,-1.2222323441478653,0.22943722943722944,0.6676853721724151,1.0,9/14,34.62%,TOP2A;SAP30L;TFAM;FOXC1;HMGB1;LEF1;HMGB3;FOXD1;HMGA2
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5192806606438,-1.2216637747704313,0.21927710843373494,0.6612599011329268,1.0,1/11,0.07%,KCNMA1
prerank,solute:sodium symporter activity (GO:0015370),0.4522332092521861,1.2215193550688506,0.20949263502454993,0.6868668943499437,1.0,6/27,18.05%,SLC28A2;SLC4A4;SLC4A5;SLC5A6;SLC5A11;SLC5A3
prerank,pyridoxal phosphate binding (GO:0030170),-0.43728365084931214,-1.221086423073466,0.20689655172413793,0.654939368181231,1.0,13/20,36.93%,ABAT;ACCS;PYGL;PLPBP;PYGB;AGXT;SHMT2;PYGM;CBS;THNSL2;CTH;PSAT1;GLDC
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.384246849533893,1.22028962751832,0.16547788873038516,0.6849536263043082,1.0,10/72,6.84%,HIP1;FLII;FCHO2;ALOX15;SESTD1;GSDME;STXBP6;ANXA2;PLCD1;SDCBP
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5294192274231471,-1.2187456302436077,0.23736263736263735,0.6535389618074818,1.0,3/10,15.27%,SLCO2B1;SLCO4A1;SLCO4C1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5038752058885381,-1.2148748990429774,0.20950323974082075,0.6573965757597277,1.0,4/12,11.60%,SLC36A1;SLC38A7;SLC36A4;SLC7A8
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4028617141975292,1.2147526827257795,0.19818456883509833,0.6950014110717769,1.0,10/53,10.12%,CYBB;DPYD;XDH;DAO;NQO2;AGPS;AOX1;ETFA;ETFDH;SDHA
prerank,phosphate ion binding (GO:0042301),0.5677902527534447,1.2125293520520035,0.2644787644787645,0.695805987667587,1.0,4/10,16.45%,PDE2A;ADSS2;ADSS1;RELA
prerank,mRNA 5'-UTR binding (GO:0048027),0.45846039475722,1.2116804397728609,0.23429541595925296,0.6929656050913758,1.0,7/24,9.28%,RPL26;RPS13;RPL41;RPL5;RPS14;RPS7;MRPS11
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.4705884280154391,1.210089750382925,0.24872231686541738,0.6919001099814824,1.0,2/22,1.61%,APOE;CLTC
prerank,deoxyribonuclease activity (GO:0004536),0.5202905477509543,1.206063433796954,0.2664298401420959,0.697887331956863,1.0,5/14,19.46%,RPS3;DNASE1L1;ZRANB3;MRE11;APEX1
prerank,calcium channel regulator activity (GO:0005246),0.42239535360965247,1.2029591555706896,0.21608832807570977,0.7015276935054973,1.0,7/37,11.64%,MCUB;SGK3;STIM2;STIM1;GEM;CALM1;YWHAE
prerank,alpha-actinin binding (GO:0051393),0.46049618659219466,1.2007763513746883,0.2507987220447284,0.7023483977721897,1.0,7/24,17.31%,PDLIM5;NRAP;PDLIM1;RARA;PKD2;PKD2L1;PDLIM2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.45673112791104387,1.2005277318103629,0.24912891986062718,0.6978410798615456,1.0,6/23,6.04%,PDE7B;PDE2A;PDE8A;PDE6A;PDE4D;PDE7A
prerank,antiporter activity (GO:0015297),0.48294384950661423,1.2004773617066682,0.24793388429752067,0.692839298685866,1.0,5/20,16.08%,SLC25A16;SLC35E3;TMEM241;ATP1A3;SLC25A30
prerank,GTPase binding (GO:0051020),0.33777327112664585,1.1995986973147854,0.16132858837485173,0.690379797620339,1.0,26/194,8.88%,EPS8;IQGAP2;FGD4;MYO5A;FGD6;IQGAP1;ANKFY1;EVI5;RASA1;USP6NL;SPTBN1;RILP;EXPH5;EHD1;LCP1;RIC1;PAK2;OCRL;AP3M1;MYCBP2;EXOC4;RABGAP1L;SGSM1;GNB1;RANBP9;RCC2
prerank,GTP binding (GO:0005525),0.3372211723001179,1.1993738788963988,0.15598548972188633,0.6859509206800539,1.0,25/172,10.06%,RAP1B;RAB31;RAP2B;GBP3;ATL1;MFHAS1;NRAS;KRAS;EEF1A1;CDC42;ARL8A;RAB10;RHOA;GCH1;RAP1A;INSR;GBP7;GTPBP10;GEM;RHOBTB1;RAB7A;ADSS2;RAB14;ARL4A;TUBB6
prerank,cyclic nucleotide binding (GO:0030551),0.4669286060485188,1.1989693239082804,0.24834437086092714,0.6821414473878145,1.0,6/21,14.10%,CNGA3;RAPGEF2;PDE2A;PDE4D;PDE5A;POPDC3
prerank,phospholipase A2 activity (GO:0004623),0.4456400251479123,1.1973049807366631,0.22413793103448276,0.681584914470326,1.0,5/26,14.72%,PLA2G7;PNPLA8;PLA2G2D;PLAAT1;PLAAT3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.5053724206379365,-1.194607396878135,0.2558139534883721,0.7104963064990822,1.0,4/11,21.11%,AKR1B1;RDH14;DHRS13;AKR1B10
prerank,small GTPase binding (GO:0031267),0.34107102284163215,1.1939661919735127,0.17632850241545894,0.6860704591740366,1.0,26/169,11.14%,EPS8;IQGAP2;FGD4;MYO5A;FGD6;IQGAP1;ANKFY1;EVI5;USP6NL;RILP;EXPH5;EHD1;RIC1;PAK2;OCRL;AP3M1;MYCBP2;EXOC4;RABGAP1L;SGSM1;RANBP9;RCC2;DOCK7;MYO1C;PDE6D;CHM
prerank,neuropeptide receptor activity (GO:0008188),-0.3854241798262945,-1.1936161385455741,0.24120603015075376,0.7052331987039597,1.0,4/29,10.58%,SORCS1;HCRTR2;SORCS3;TACR3
prerank,metal ion binding (GO:0046872),0.3131631178253181,1.1934976024012318,0.09100418410041841,0.6825334144357973,1.0,65/477,12.45%,ITSN1;AOAH;MCTP1;NLRC4;APOE;PADI4;MAP3K5;CHP2;IQGAP1;PPP3CA;CLEC6A;CDC42BPG;TPT1;S100A4;IRAK3;CALML4;OXSR1;RCN3;S100A1;STIM2;THBS4;ERN1;MOV10L1;S100A11;RAPGEF2;S100A10;LCP1;PDE2A;AOC1;CAMKK2;SLC25A24;ACER3;STK3;ANXA2;PAM;NUDT22;NUCB2;PLA2G2D;STIM1;CANX;MCTP2;GEM;TKT;CLYBL;TRIM27;DCHS1;MAP3K20;CDH12;MAST1;TESMIN;CETN2;MARK2;CALM1;TRPM2;SLIT3;SLIT1;CEMIP2;FOXK2;PLSCR4;GJB2;PRKACB;MICU3;STK38;NUCB1;LOXL2
prerank,telomeric DNA binding (GO:0042162),-0.37473285547306867,-1.1929019775207328,0.1970074812967581,0.6992897254784174,1.0,9/32,13.31%,XRCC5;CTC1;NCL;HNRNPA2B1;STN1;BLM;UPF1;TERF2;XRCC6
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3298670231810623,1.190300744854734,0.14583333333333334,0.6862658757651401,1.0,54/232,15.75%,WWP1;RNF150;SMURF2;ARIH1;PIAS1;SH3RF1;SIAH2;CDC42;CBL;PELI1;PRKN;TRIM56;ZNRF3;BIRC3;RC3H1;TRIM32;ANKIB1;MYCBP2;PIAS2;TRIM24;NSMCE2;DTX2;TRIM68;SHPRH;TRIM27;RNF19B;MDM2;RNF121;UBE2D3;COP1;UHRF2;CUL3;RNF38;MKRN1;RNF14;ZNRF2;RNF111;AMFR;UBE3B;RNF185;TRIM71;CBLB;MKRN3;RNF115;RBBP6;RNF187;RNF19A;BFAR;ASB12;NEDD4L;MKRN2;RNF122;RNF41;TRIM25
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.48691964041872576,-1.1901025341841438,0.26905829596412556,0.6999008151267283,1.0,2/13,1.12%,LPCAT2;LPCAT1
prerank,lipoprotein particle receptor binding (GO:0070325),0.449447525593897,1.1898651941629985,0.23567921440261866,0.6827019131535507,1.0,2/27,1.61%,APOE;CLTC
prerank,TBP-class protein binding (GO:0017025),0.4735497027198868,1.1894438158181622,0.25309734513274335,0.6791399086930083,1.0,7/21,18.93%,AHR;ESR1;GTF2A2;GTF2A1;GTF2B;TAF12;THRA
prerank,calcium ion binding (GO:0005509),0.31841233060417945,1.189056534308654,0.11964873765093303,0.6754793721477093,1.0,44/323,12.45%,ITSN1;AOAH;MCTP1;PADI4;CHP2;IQGAP1;PPP3CA;CLEC6A;TPT1;S100A4;CALML4;RCN3;S100A1;STIM2;THBS4;S100A11;RAPGEF2;S100A10;LCP1;AOC1;CAMKK2;SLC25A24;ACER3;ANXA2;PAM;NUCB2;PLA2G2D;STIM1;CANX;MCTP2;TKT;DCHS1;CDH12;CETN2;CALM1;TRPM2;SLIT3;SLIT1;CEMIP2;PLSCR4;GJB2;MICU3;NUCB1;LOXL2
prerank,kinase binding (GO:0019900),0.31057063763554527,1.187397539755743,0.10883620689655173,0.6754402854811111,1.0,86/434,14.52%,AP2A2;EGFR;SPRED1;PTPRJ;TCF7L2;IQGAP1;SASH1;PRKAG2;ESR1;CLTC;DNAJC3;RPS3;IRAK3;PTPN22;OXSR1;EEF1A1;MYH6;MYOM2;PRKAG3;CDC42;GDF3;AXIN1;MAP3K1;CRK;RGCC;RHOA;UTRN;PRKN;BCL10;NR3C1;PDE8A;PGAM1;DOK7;GSK3B;RB1;PAK2;GPRC5B;PTPRK;TBC1D14;ACTB;WNK1;VRK2;FOXM1;HSPB1;CCND3;MOB1B;IFNAR2;RHOBTB1;TRIM68;MSN;MAPK8IP2;VRK1;TRIM27;RCC2;MAPK4;SMCR8;RPS7;CARD16;CCND2;CACUL1;ACSL3;PIP5K1A;RPS6;PARP16;CALM1;SP100;MAML1;SPRED2;SHC1;IL15RA;FOXO3;CDKN2C;NOD2;RBBP6;EXOC2;RND3;CTBP2;CNTLN;FAM83B;STAT3;IBTK;ATP1A4;ITGB2;RHOC;CNOT9;USF1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5097475145066197,-1.1848575963745913,0.2620545073375262,0.7078832524178106,1.0,4/10,19.37%,CASP7;CFLAR;CASP6;CASP12
prerank,histone demethylase activity (GO:0032452),0.45270018584525007,1.1828048219400447,0.25925925925925924,0.6831441596117334,1.0,9/27,15.92%,PHF8;JARID2;KDM7A;KDM6A;KDM4D;JMJD1C;KDM5C;KDM2A;KDM1A
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5465632100906261,1.1816084954412611,0.3048327137546468,0.6817614746870183,1.0,3/11,10.33%,SLC25A17;SLC25A24;SLC35B3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.4626592423102533,-1.1811057608265532,0.26973684210526316,0.7106845494701812,1.0,2/14,1.05%,CAPN15;CAPN3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5045972090344735,-1.1789981875885673,0.25948103792415167,0.7090700621665861,1.0,4/10,4.65%,PRKAG1;PRKAR1A;PKIG;PRKAR1B
prerank,FMN binding (GO:0010181),-0.49551746920695783,-1.1787917843265519,0.24782608695652175,0.7020467775271015,1.0,1/11,0.55%,PPCDC
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3561141233604803,1.1742021988202802,0.21891891891891893,0.6966859296660425,1.0,13/91,7.14%,HIP1;FLII;FCHO2;ALOX15;SESTD1;GSDME;SNX3;STXBP6;KIF16B;ANXA2;PLCD1;SDCBP;WIPI1
prerank,receptor ligand activity (GO:0048018),0.3207129829727559,1.172048935798305,0.1728538283062645,0.6976923484884113,1.0,27/245,10.43%,IL16;SEMA4A;IL15;GAS6;JAG1;TSLP;METRNL;KITLG;BMP2;FGF23;WNT2;C1QTNF12;ENDOU;GRN;GDF3;THPO;GDF10;FAM3C;TNF;EDA;WNT6;CCL24;TNFSF12;IGF1;CCK;DAND5;METRN
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.5324077161803701,1.1687795239720375,0.2862669245647969,0.7017537437682583,1.0,3/10,15.74%,DPYSL2;CRMP1;DPYSL5
prerank,phospholipid transfer activity (GO:0120014),0.46297134509846455,1.1663033908552505,0.2708688245315162,0.7037554999847884,1.0,2/21,3.71%,PLTP;PITPNA
prerank,endopeptidase activator activity (GO:0061133),0.5453174536527114,1.1651300800520576,0.29693486590038315,0.702188635737192,1.0,1/10,0.36%,NLRC4
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.4566374052345872,-1.1642448646460275,0.28,0.7368150161652126,1.0,2/15,1.12%,LPCAT2;LPCAT1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.372063796563596,-1.1617864933835522,0.24517906336088155,0.7365130140525685,1.0,12/29,20.98%,HEXD;NEU1;GAA;HPSE2;GBA2;ABHD10;HPSE;ACER2;IDUA;OVGP1;ADPRS;PARG
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4666899631789125,-1.1595445735035665,0.27906976744186046,0.7353869306792544,1.0,9/13,29.39%,GLRB;GABRA2;GLRA1;GABRG2;GLRA3;GLRA2;GABRA4;GABRG3;GABRE
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5427226600494502,1.1586519721045778,0.3132969034608379,0.7146075201650517,1.0,7/10,28.33%,CDKN2C;HEXIM2;INCA1;CDKN1B;KAT2B;HEXIM1;CDKN1A
prerank,cholesterol transfer activity (GO:0120020),0.48700274830875667,1.1567909565084324,0.296229802513465,0.7153226499410229,1.0,1/16,0.21%,PLTP
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.4704287671631324,-1.1559696654938822,0.2671081677704194,0.7384571649779292,1.0,4/12,15.24%,B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,disordered domain specific binding (GO:0097718),0.44790883281406735,1.1547181233696446,0.3020833333333333,0.7157857983190002,1.0,9/23,16.03%,CLTC;NCOA3;RB1;BCL2L2;FYN;MDM2;CALM1;FN1;HSP90AB1
prerank,actin monomer binding (GO:0003785),0.4541687984359807,1.1532958223450311,0.2837370242214533,0.7149435916564996,1.0,1/22,0.25%,MTSS1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.32018561805108575,1.1528648606323262,0.2078720787207872,0.7114801466757145,1.0,49/188,19.65%,TCF7L2;FLI1;AHR;ZBTB20;TCF12;MEF2C;CEBPB;ARID4B;FOXA3;NR1D1;SPI1;SMAD4;ARID5A;TCF7;ZNF568;TNF;KLF4;YY1;TBL1XR1;NCOR1;ATF6;FOXC2;ASH2L;TBL1X;LIN54;SP1;FOXK2;HINFP;FOXO3;FOXK1;PSPC1;STAT3;JUND;BCOR;HDAC4;SFPQ;ELK1;CREB3L1;RELA;PER1;GLIS2;NR5A2;ARID4A;RFX3;ZBTB14;THRA;GABPB1;CTCF;CREBZF
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.47977793722799283,1.151685167045508,0.28835489833641403,0.7102170747950698,1.0,8/16,21.89%,MTM1;SYNJ1;MTMR3;MTMR1;PTEN;MTMR6;MTMR11;MTMR12
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.32606061804332037,1.1494678800451519,0.21497584541062803,0.711951415272098,1.0,42/173,19.31%,ZEB2;TRPS1;FOXP1;ZBTB16;TFEC;ZBTB20;CEBPB;MITF;NR1D1;NR3C1;HEY2;IRX2;ZBTB25;ZNF148;YY1;THAP11;ZBTB5;BACH1;LRRFIP1;NR2F1;ETS2;SREBF2;FOXK2;FOXO3;FOXK1;PEG3;MYC;E2F8;CREB3L1;ZGPAT;RELA;TBX2;NFATC3;ZNF177;FOXP2;NACC1;GZF1;ZBTB12;ZBTB1;ZBTB14;CTCF;ZNF3
prerank,DNA binding (GO:0003677),0.2947580089733138,1.1486873154314108,0.12487100103199174,0.7098319492890585,1.0,134/694,17.58%,RBPJ;ZEB2;EGFR;APP;KLF2;TCF7L2;TCF4;RBMS1;IRF4;FLI1;TLR8;MEF2A;AHR;ZBTB16;HIVEP2;NUPR1;RBBP8;ANG;RARG;RPS3;LIG4;NR1H4;CEBPB;DDX60;RYBP;TSHZ3;NR2C1;RPS15;MND1;HEY2;CLOCK;FAM111A;GRHL2;SMAD4;ARID5A;DCLRE1C;THRB;IRX2;CBFB;DNASE1L1;NR4A1;MCM9;ACR;BCL2;WDR76;CR2;ZNF148;TSHZ1;LYL1;YY1;THAP11;PDS5B;DDX11;TIPIN;CEBPG;RPA1;NR4A2;IRF2;ATF6;FOXC2;ESRRB;ARID3A;BRIP1;GTF3C3;GTF3C6;ESR2;LRRFIP1;FOXJ3;RAD52;NFATC2;NHEJ1;NR2F1;PURA;ILF3;RPL6;POLG2;RFX2;SP1;TRIM16;PCID2;ETS2;CENPB;CREBBP;FOXK2;XPA;HINFP;FOXO3;BANF1;ZC3H12A;RPA3;CHD2;FOXO1;XRCC4;GTF2A1;XPC;NR1H2;EP300;KIN;STAT3;MBD1;CRLF3;POLR2D;SMARCAD1;TERF1;USF1;KAT6A;RAD51B;MYC;SAMHD1;MTF1;NR2C2;HDAC4;SFPQ;ARID1A;FBH1;MCM8;ZGPAT;RELA;ARNT;TBX2;RBM6;FOXP2;ZBTB7A;NR5A2;MPG;CARF;TAF12;NR2F2;ZNF22;XBP1;RFC3;NR6A1;MECOM;ARID4A
prerank,miRNA binding (GO:0035198),0.41268097690988526,1.1477622352053205,0.28503937007874014,0.708026404605919,1.0,7/30,12.36%,TUT7;PUM2;RC3H1;TUT4;RBM4;TRIM71;ZC3H12A
prerank,C-C chemokine receptor activity (GO:0016493),0.45813810933522375,1.146321225494077,0.31433224755700323,0.7073040554251829,1.0,4/21,7.60%,CCR1;CCRL2;CXCR4;CCR2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4362287830532102,-1.1461062266895878,0.2882882882882883,0.7597087376789461,1.0,7/16,27.67%,SLC38A7;SLC1A1;SLC25A14;SLC25A22;SLC25A10;SLC25A13;SLC1A4
prerank,ferrous iron binding (GO:0008198),-0.4016327760634728,-1.1454931410738618,0.2555831265508685,0.7539067642220917,1.0,7/21,11.23%,CDO1;PHYH;FECH;ALKBH2;ISCU;EGLN2;FXN
prerank,iron ion binding (GO:0005506),0.3774101780511737,1.1437950872396652,0.2599118942731278,0.7099206128549337,1.0,10/48,11.39%,ALOX5;ALOX15;AGMO;PHF8;FTL;KDM7A;FBXL5;AOX1;FTH1;ETHE1
prerank,poly(U) RNA binding (GO:0008266),0.4474792167023443,1.1424038430240897,0.2862129144851658,0.7093663611243743,1.0,5/20,12.73%,RBMS1;HNRNPC;ATXN1;RBM11;DIS3L2
prerank,ubiquitin protein ligase activity (GO:0061630),0.31661607756776455,1.141522109438797,0.20677570093457945,0.7073785227104813,1.0,52/228,15.75%,WWP1;RNF150;SMURF2;ARIH1;SH3RF1;SIAH2;CDC42;CBL;PELI1;PRKN;TRIM56;ZNRF3;BIRC3;RC3H1;TRIM32;ANKIB1;MYCBP2;TRIM24;DTX2;TRIM68;SHPRH;TRIM27;RNF19B;MDM2;RNF121;UBE2D3;UBE2K;COP1;UHRF2;CUL3;RNF38;MKRN1;RNF14;ZNRF2;RNF111;AMFR;UBE3B;RNF185;TRIM71;CBLB;MKRN3;RNF115;RBBP6;RNF187;RNF19A;BFAR;ASB12;NEDD4L;MKRN2;RNF122;RNF41;TRIM25
prerank,thyroid hormone receptor binding (GO:0046966),0.4210633674690699,1.141177527350991,0.29743589743589743,0.7040699932086373,1.0,12/28,20.74%,NCOA3;ARID5A;MED16;NCOR1;NCOA6;JMJD1C;GAS2L1;GTF2B;MED17;GTF2H1;THRAP3;TRIP12
prerank,tropomyosin binding (GO:0005523),0.4868509055744742,1.1408227065424086,0.3357271095152603,0.7007311944702505,1.0,3/16,4.82%,TMOD1;TNNT1;TMOD3
prerank,ubiquitin protein ligase binding (GO:0031625),0.31054326727992376,1.140786792110023,0.21264367816091953,0.6966955150908622,1.0,72/254,20.32%,EGFR;SNX9;FBXW7;TXNIP;RPL23;MFHAS1;ARIH1;PTPN22;RPS27A;CCDC50;TNFRSF1B;SLC22A18;RIPK1;AXIN1;PRKN;BCL10;GSK3B;RB1;SPOP;CD40;BCL2;UBXN7;CXCR4;RPL5;VCL;SPOPL;SHPRH;MDM2;UBE2K;CUL3;RTN4;ARRB1;SLC25A5;WFS1;CASP8;YWHAE;JAK1;PRKACB;TRIB2;FOXO1;UBE2N;RALB;PSMD1;PSMA3;RPL11;AMBRA1;ASB4;NLK;GPI;USP25;UBE2W;GABARAP;HSP90AB1;FANCL;RELA;PER1;MID1;CUL5;PA2G4;GLMN;UBE2A;ATXN3;TNK2;TRAF6;SUMO1;TRIB1;TMBIM6;SMC6;DTX1;USP7;SMAD5;DNM1L
prerank,sterol transfer activity (GO:0120015),0.4759617090621082,1.1383464518415645,0.31438721136767317,0.6991393611900012,1.0,1/17,0.21%,PLTP
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.36306840287278064,1.1383056463235546,0.2733918128654971,0.695159863159677,1.0,6/60,5.36%,NRP1;EGFR;FGFR1;CRIM1;INSR;PDGFRA
prerank,RNA binding (GO:0003723),0.28702764719404195,1.1355678340301716,0.07823470411233702,0.6982399098726917,1.0,344/1321,19.18%,AHNAK;DHX34;DHX8;MYO5A;RBMS1;CTNNA1;TLR8;MBNL1;OAS2;DIAPH1;FNDC3A;RPS23;TPT1;ZCCHC24;MRPL23;RPL17;RPL23;CLTC;ZFP36L2;MRPS12;RPS12;S100A4;ANG;RPS16;RPS3;RBM47;RPS27A;EIF3E;NOL6;DDX60;NCOA5;RCAN3;RPL39;RPS18;RPS21;SPTBN1;EEF1A1;RPL23A;PRKRA;ENDOU;ADK;PPHLN1;MOV10L1;RPS15;HNRNPC;GRN;RPL37;ANKRD17;KCTD12;SAMD4A;AGFG1;RPL26;TUT7;ZFP36L1;RPS10;FNDC3B;NYNRIN;RPS20;RPS13;RFTN1;ERAL1;RPSA;SNU13;LARP7;VIM;RPL41;RPS28;TRIM56;PTBP3;NKAP;RPL13;MRPL13;RPS24;RPL24;RSL24D1;RPL12;SND1;RPL36A;GTPBP10;PKN2;RPUSD3;RACK1;SMG6;RPS8;RPL18A;PUM2;RC3H1;TENT5A;NUFIP2;DROSHA;TBCA;RPL37A;MBNL2;MANF;RPS11;RPL28;NMD3;TRIM32;RNASEL;ANXA2;WDR36;FARS2;NOP53;DARS1;RPL30;HNRNPF;RPL8;RPL35A;RPS4X;RPS15A;RPS17;RPL38;GLRX3;RPLP0;HSPB1;ZGRF1;CPSF3;BST2;SF3B5;YY1;IBA57;SRSF4;RPL5;DDX11;RPL36;CANX;FLNB;CELF3;LARP4B;RPL14;PTBP2;DCP1A;TUT4;PNO1;RBM4;STAU2;RPS14;RPL9;RO60;EIF1;TDRD7;SNRPG;MSN;ACO1;COL14A1;RPS9;KMT2C;GRSF1;SCAF8;RCC2;SELENOH;RPS5;CCT6A;ASCC3;RPS7;MAP3K20;RPL34;LRRFIP1;ZCCHC7;RPL27;MRPS11;APOBEC1;MTREX;SERBP1;ZNF106;PURA;ILF3;POLR2B;RTN4;HEATR1;RPL6;MKRN1;RPL22L1;RPS6;HELZ;SPEN;RBM15;SRP68;SEC63;SLC25A5;NSRP1;MRPL1;RARS2;RPL4;MARK2;FAU;EIF4B;NSUN2;PCID2;RPP38;DDX6;EIF3I;RBM27;SEPSECS;GTF2E2;DNAJC21;ASS1;SCAF4;DUSP14;DCP2;RPL22;ZC3H18;PSMA6;YWHAE;LACTB2;CDK13;NANOS3;ROCK2;MRPL16;DHX40;RPL15;RPL10;DDX10;LBR;PDIA4;RBM11;DHX33;ZC3H14;RPL32;DEK;ZC3H12D;ZC3H12A;ETF1;NUP98;CAST;POLR1G;MKRN3;CHD2;ELP5;GTPBP1;ESF1;LSM4;VIRMA;GPATCH1;R3HDM1;DDX42;RBPMS2;RBBP6;UBE2N;PRPF38B;MRPL44;MAGOHB;PSPC1;AQR;LARP4;LSM2;RPP30;HADHB;ZNF326;ANKHD1;RPL19;CTU1;KIN;RPL31;STAT3;ADD1;RAMAC;MRPS14;KPNA2;POLR2D;EXOSC1;HMGN5;EIF3H;TPD52L2;RPL11;RTRAF;PRMT1;SNW1;RALY;PPIA;RPL7L1;MKRN2;NOVA1;SRBD1;EIF5;SAMHD1;WDR33;SF3B6;PINX1;SFPQ;TRIM25;NOP58;UBAP2;HEXIM2;KDM1A;HSP90AB1;NOP10;PPARGC1B;HSP90B1;TUT1;CPSF2;CSDE1;MTHFSD;CCT3;RPL35;RBM6;SYNCRIP;GPATCH4;TLR7;GDI2;DGCR8;TRAP1;SMNDC1;RBM20;PYM1;CLNS1A;ARCN1;PA2G4;MRPS30;RRS1;MSI1;DDX28;FDPS;DHX38;JAKMIP1;NPM3;APTX;EIF2S2;TBL2;RRP1B;EIF2AK2;MRPS31;MRPS15;CNOT4;SCAF11;STIP1;TEFM;RPL7;KPNB1;LONP1;CSTF2T;PHF5A;FAM120A;DIDO1;POP5;DDX56;DDX21;SUMO1;DXO;MRPL4;EIF2AK4;SPATS2L;THRAP3;TRNAU1AP
prerank,C-C chemokine binding (GO:0019957),0.4500170148748521,1.1355038732400033,0.300163132137031,0.6944293223443327,1.0,4/22,7.60%,CCR1;CCRL2;CXCR4;CCR2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4254298313951058,1.1310192823808796,0.3024054982817869,0.7020708022343686,1.0,9/27,18.62%,TENT2;POLR1A;POLR1B;MED20;POLR2B;POLR1D;POLR2D;CRCP;POLR2F
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.405324925092796,-1.1309740037744125,0.25783132530120484,0.7897765759839738,1.0,4/19,14.06%,GRID2;GRIK2;GABRA2;GABRG2
prerank,histone deacetylase activity (GO:0004407),0.44802395703129655,1.129335731586063,0.3221830985915493,0.7025314702820448,1.0,1/19,0.10%,HDAC9
prerank,MAP kinase kinase activity (GO:0004708),-0.426922990393163,-1.1258552632389391,0.3130434782608696,0.797691062895042,1.0,7/15,25.23%,MAPK10;MAP2K7;MAP2K2;MAP3K9;PAK3;MAP2K4;MAP2K5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.36552207614019966,1.125691895460268,0.2903703703703704,0.7076434999255287,1.0,10/54,12.85%,HDAC9;HINT1;ACER3;HINT3;ACR;DARS1;MIER1;MIER3;NGLY1;GLS2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.4881539721765174,-1.1255840259713026,0.32505643340857787,0.7908550839373508,1.0,2/10,2.37%,EHMT2;ASH1L
prerank,ion channel inhibitor activity (GO:0008200),0.40244435494327846,1.12551899211608,0.2834138486312399,0.7040964108240715,1.0,8/35,14.33%,MCUB;RASA1;RACK1;WNK1;STX7;CALM1;SCN3B;NEDD4L
prerank,cysteine-type peptidase activity (GO:0008234),-0.29626598629576173,-1.1249583328561996,0.23076923076923078,0.785167010299253,1.0,19/73,15.15%,USP35;CAPN3;OTULINL;LGMN;USP12;USP50;OTULIN;CTSS;USP46;CASP7;UCHL1;CTSF;USP40;CASP6;USP49;USP34;USP29;USP5;CTSO
prerank,kinase activator activity (GO:0019209),0.4103167155177795,1.121744544880391,0.3,0.7095249261289198,1.0,8/30,10.63%,PRKAG2;RPLP1;RGCC;BCL10;GPRC5B;WNK1;MOB1B;MARK2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.47077828834573815,1.1159168228119014,0.3385964912280702,0.7203846144762975,1.0,2/17,3.71%,PLTP;PITPNA
prerank,potassium channel activity (GO:0005267),-0.27856952715882816,-1.1142937228065346,0.2196078431372549,0.8103876110845497,1.0,17/89,17.96%,KCNMA1;KCND2;KCNH7;GRIK2;TMEM38B;KCNQ3;KCNQ5;KCNK2;KCNA2;KCNA1;KCNK12;KCNS3;KCNK9;KCNN2;ABCC9;KCNK6;KCNT1
prerank,adenylyltransferase activity (GO:0070566),0.4398075963366353,1.113347051286005,0.3204903677758319,0.7225301520651243,1.0,6/21,16.41%,OAS2;TENT2;NMNAT3;NMNAT2;PAPOLA;TUT1
prerank,protein phosphatase binding (GO:0019903),0.3263518286773863,1.1121305062882216,0.2842242503259452,0.7215363225796891,1.0,24/117,12.86%,EGFR;MAP3K5;IQGAP1;MFHAS1;LILRB1;MTMR3;AP3B1;SNX3;RACK1;CDC27;CD33;MAPK14;IGBP1;PPP1R3C;STAT6;PPP1R3D;PXN;JUP;ARPP19;JAK1;KCNQ1;STRN;ATP2B4;FOXO1
prerank,calcium channel inhibitor activity (GO:0019855),0.49509008913685626,1.1117453947346456,0.33935018050541516,0.7185605290848422,1.0,1/11,0.56%,MCUB
prerank,inward rectifier potassium channel activity (GO:0005242),-0.3798164854550108,-1.1109358360615744,0.29949238578680204,0.8132688287208905,1.0,14/24,33.73%,KCNJ2;KCNN2;ABCC9;KCNK6;KCNJ3;KCNJ10;KCNJ13;KCNJ9;ABCC8;KCNH2;KCNJ12;KCNJ16;KCNN1;KCNJ6
prerank,DNA secondary structure binding (GO:0000217),0.40291321954305487,1.1089574367996315,0.3296,0.7218925129358086,1.0,7/31,14.73%,KMT2A;RBBP8;MEF2C;YY1;LIN54;XPC;RAD51B
prerank,ubiquitin-specific protease binding (GO:1990381),0.4436420653719173,1.1075548410525113,0.3321554770318021,0.7215894332920005,1.0,8/19,19.02%,CLTC;PRKN;RHBDD2;LCOR;AMFR;DERL2;PTEN;SUMO1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.336772643375233,-1.1068813646493632,0.30726256983240224,0.8179025232569103,1.0,19/40,36.03%,DNMT3A;METTL2A;METTL2B;COMT;AS3MT;SETD3;MEPCE;DNMT1;LCMT1;ASMT;PCMT1;PEMT;RRP8;METTL18;PRMT8;FBL;THUMPD3;LRTOMT;PRMT7
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.29535671666693675,-1.1048289514042682,0.28524590163934427,0.816441169362471,1.0,19/60,16.18%,MERTK;EPHA7;BMPR1B;ACVR1;FGFR2;FLT1;NTRK3;EPHB1;AXL;EPHA10;ALK;FLT3;CSF1R;ERBB4;EPHA3;TGFBR2;TYRO3;ACVR1B;EPHB2
prerank,carbohydrate kinase activity (GO:0019200),0.5033962431163644,1.10200712551761,0.3622350674373796,0.7321233070662071,1.0,3/11,12.24%,POMK;FGGY;GALK2
prerank,GTPase activity (GO:0003924),0.31125748693516925,1.1010742056342926,0.2985781990521327,0.7307178476657261,1.0,45/192,18.33%,GNAQ;RAP1B;RAB31;RAP2B;GBP3;ATL1;NRAS;KRAS;GNAI3;EEF1A1;CDC42;RAB8B;ARL8A;RHOA;GCH1;RAP1A;GBP7;GTPBP10;GEM;GNB1;RHOBTB1;RAB7A;RAB14;RAB1A;RAB23;GNG5;GTPBP1;AGAP3;RND3;RALB;RAB11A;RHOC;GNA11;ARHGDIB;RAB3B;GNA13;LSG1;HBS1L;RAB32;RHOF;EFL1;RAB22A;RHEB;RRAGC;ABCA4
prerank,protein tyrosine kinase activator activity (GO:0030296),0.43388332418126574,1.0978017514315555,0.34563758389261745,0.7349075867951719,1.0,4/19,5.11%,GAS6;ABI1;GHRL;PAK2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3675619620730909,1.0969014866405498,0.3024602026049204,0.7333936335275377,1.0,12/51,17.64%,SLC25A16;SLC28A2;SLC16A10;MCU;SLC4A4;SLC35E3;SLCO5A1;TMEM241;MFSD2A;SLC25A30;SLC5A6;SLCO2A1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.4620403023447178,1.096827264999973,0.35753176043557167,0.7297137721226907,1.0,1/15,0.51%,P2RX7
prerank,peptidase activator activity (GO:0016504),0.42857975189916064,1.0957451801195415,0.3589315525876461,0.7286626157890898,1.0,4/22,11.62%,NLRC4;PCOLCE;CLPX;EBAG9
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.4240425359900228,-1.0952503777399463,0.3295711060948081,0.8378307511100537,1.0,4/15,18.61%,ALDH1L2;ALDH1A1;ALDH1A2;ALDH4A1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.47979186528758766,1.0950041210959718,0.3590733590733591,0.7265021124748191,1.0,8/14,24.56%,USP9X;MINDY3;USP15;MINDY2;ATXN3;USP7;USP13;MINDY1
prerank,adenylate cyclase binding (GO:0008179),-0.47489581436694644,-1.0942572213559605,0.3516260162601626,0.833667948287717,1.0,5/10,25.42%,CALM2;AKAP6;CALM3;AKAP5;ADCY5
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.49403300890003204,1.093962943813203,0.3663551401869159,0.7253569087441004,1.0,1/11,3.05%,CNGA3
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.4750006461449466,1.093744352476066,0.34870848708487084,0.7221017725126114,1.0,2/12,7.25%,RRH;GPR52
prerank,microtubule plus-end binding (GO:0051010),-0.3852379707534265,-1.092850920359412,0.3333333333333333,0.83054081060943,1.0,7/20,15.90%,DST;CLASP2;CLIP2;MAPRE3;NUMA1;MAPRE1;CLIP3
prerank,cell-cell adhesion mediator activity (GO:0098632),0.36744948867760113,1.0913973089821902,0.3373676248108926,0.7242449108313451,1.0,7/42,5.94%,PDLIM5;RAB10;S100A11;TMOD3;PDLIM1;STXBP6;ANXA2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3928619710810126,1.0911895750066725,0.3375594294770206,0.7210236754011018,1.0,9/33,13.74%,RPS3;ARIH1;SIAH2;PRKN;ANKIB1;RNF19B;RNF14;RNF185;RNF19A
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3539544264237899,1.0893709486399539,0.3294460641399417,0.7221480001537814,1.0,16/60,16.30%,PPP3CA;MTMR3;DUSP1;CTDSP1;PPM1B;CTDSP2;PPP1R3C;PPP2CA;PPP2CB;PPP1R3D;PPEF1;PPP1CA;LRRK1;CTDSPL2;PTEN;PPM1A
prerank,voltage-gated potassium channel activity (GO:0005249),-0.27955070404275556,-1.0881654190700132,0.26148409893992935,0.8370485987757434,1.0,9/80,9.29%,KCNMA1;KCND2;KCNH7;KCNJ2;KCNQ3;KCNQ5;KCNK2;KCNA2;KCNA1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5010315888808188,1.0871712705563732,0.34386617100371747,0.7237893283255403,1.0,4/10,18.63%,PHF8;KDM7A;KDM2A;KDM4C
prerank,actinin binding (GO:0042805),0.4383978582541383,1.0860267695385415,0.36538461538461536,0.7229625077092564,1.0,5/21,16.45%,PDLIM5;RARA;PKD2;PKD2L1;RELA
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.4338411792550587,-1.0855160469309024,0.36129032258064514,0.8382823124166753,1.0,4/13,18.61%,ALDH1L2;ALDH1A1;ALDH1A2;ALDH4A1
prerank,RNA polymerase II complex binding (GO:0000993),0.39196682387122306,1.0845635120665114,0.35058430717863104,0.7228234660646095,1.0,12/32,16.66%,NCOA3;WAC;CDC73;ESRRB;SCAF8;RPRD2;ELOF1;ELP4;ZNF326;RTRAF;GTF2B;BRD4
prerank,androgen receptor binding (GO:0050681),0.4106540579946273,1.084137274757426,0.357504215851602,0.7202925991668958,1.0,12/25,19.38%,FOXP1;ARID5A;WIPI1;PRKCB;TRIM68;RNF14;EP300;SNW1;KDM1A;ZBTB7A;KDM4C;RNF6
prerank,N-acyltransferase activity (GO:0016410),-0.3396337806264482,-1.0836210305258038,0.3258426966292135,0.8365258050713323,1.0,10/32,19.85%,SAT1;TGM2;SMARCE1;SIRT7;CERS4;CERS5;CERS1;TLCD3B;NAA80;CERS2
prerank,general transcription initiation factor binding (GO:0140296),0.4119964471137391,1.0824896103409218,0.3747841105354059,0.7208312541473141,1.0,8/25,18.93%,AHR;ESR1;GTF2A2;GTF2A1;GTF2B;RELA;TAF12;THRA
prerank,damaged DNA binding (GO:0003684),0.3729315315761539,1.0818003453333924,0.36875,0.7188697474738479,1.0,14/44,20.29%,RBBP8;RPS3;DCLRE1C;RPA1;CREBBP;XPA;RPA3;XPC;EP300;MPG;APTX;APEX1;SMC6;PCNA
prerank,adrenergic receptor binding (GO:0031690),-0.407835952581088,-1.0817481947591445,0.3431372549019608,0.8348636828670158,1.0,6/16,7.63%,GNAS;MAGI2;DLG4;GRK2;UCHL1;APLP1
prerank,diacylglycerol kinase activity (GO:0004143),-0.4534554820359429,-1.0817153302553701,0.3651804670912951,0.827631005716817,1.0,7/11,30.49%,DGKI;DGKB;DGKZ;AGK;DGKG;DGKA;DGKQ
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4685099529279412,1.0776568049659874,0.35551330798479086,0.7254153649358769,1.0,6/13,17.19%,ITGB1BP1;ARHGDIA;ARHGDIB;RGS14;EIF5;GDI2
prerank,water transmembrane transporter activity (GO:0005372),-0.451687314924181,-1.076998646578933,0.3709016393442623,0.8348650920369769,1.0,5/11,49.84%,PDPN;AQP4;AQP1;SLC5A1;SLC4A11
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.39625382165717415,-1.0744698681066656,0.37168141592920356,0.8283302136287624,1.0,6/17,18.86%,EPHA7;EPHB1;EPHA10;EPHA3;EPHB2;EPHA6
prerank,ephrin receptor activity (GO:0005003),-0.39625382165717415,-1.0744698681066656,0.37168141592920356,0.8283302136287624,1.0,6/17,18.86%,EPHA7;EPHB1;EPHA10;EPHA3;EPHB2;EPHA6
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.42054529009752706,1.0738432682541685,0.3696027633851468,0.731353418716304,1.0,2/21,7.46%,P2RX7;CHRNA4
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.44028639544360015,-1.0693732723454665,0.38613861386138615,0.83615033003929,1.0,5/11,15.59%,CTC1;HNRNPA2B1;STN1;TERF2;HNRNPA1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.46239382683753605,-1.0680836331955603,0.4039301310043668,0.8328144835671101,1.0,3/10,9.54%,PIK3CB;ATM;PIK3C2B
prerank,sequence-specific mRNA binding (GO:1990825),-0.45273814116545363,-1.0679084763864857,0.40772532188841204,0.8264878561233574,1.0,4/10,18.46%,FMR1;SHFL;TYMS;DHX9
prerank,cation channel activity (GO:0005261),-0.26993881867785435,-1.0671715352574669,0.30303030303030304,0.8216057036482843,1.0,23/94,16.45%,CACNB2;SLC24A3;SLC24A2;TRPM3;TMEM38B;PIEZO1;CACNA1D;TRPC1;NALCN;SLC24A4;CACNA1E;TRPC3;KCNA2;KCNA1;PIEZO2;ANXA9;TRPC5;TMEM63C;SEC61A1;HVCN1;KCNK9;ABCC9;TMEM63A
prerank,transcription corepressor binding (GO:0001222),0.407488530339984,1.0671437003318889,0.3658119658119658,0.7439116984677241,1.0,8/27,16.91%,ZBTB16;ESR1;NR1D1;LCOR;CTBP2;EHMT1;PER1;ZBTB7A
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2796707530485719,1.0663577150337542,0.3084311632870864,0.742334751096385,1.0,66/431,14.01%,NLRC4;P2RX7;MAP3K5;RAP1B;STK17B;OAS2;PEAK1;CDC42BPG;PRKAG2;RAB31;RAP2B;GBP3;ATL1;MFHAS1;DAPK1;IRAK3;LIG4;NRAS;KRAS;OXSR1;EEF1A1;ERN1;MOV10L1;CDC42;ARL8A;RAB10;RHOA;CDK6;GCH1;RAP1A;INSR;PNPLA8;GBP7;GTPBP10;ATP7A;STK3;WNK1;NOL9;ZAP70;GEM;RHOBTB1;RAB7A;ADSS2;RAB14;MAP3K20;MAST1;MTREX;PMVK;ARL4A;TUBB6;CLPX;MARK2;PSMA6;HSPA13;STK36;PRKACB;MKNK1;STK38;GLUD1;RND3;LATS2;ADSS1;UHMK1;RALB;ATP1A3;ATP1A1
prerank,LRR domain binding (GO:0030275),-0.4179580358469816,-1.0659633440303098,0.3854389721627409,0.8188313920080034,1.0,4/14,19.54%,ROBO1;DDIT3;PAWR;ATF4
prerank,protein kinase C activity (GO:0004697),-0.415550597766719,-1.0655314826954654,0.36899563318777295,0.813471907068495,1.0,3/14,8.68%,PRKCD;PRKCE;CCL3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4427869003992486,1.0654878357481408,0.3790186125211506,0.7407212606870407,1.0,2/17,1.74%,BLVRB;DPYD
prerank,potassium channel regulator activity (GO:0015459),0.35817389332948035,1.0650929185460813,0.358974358974359,0.7381688873167813,1.0,14/49,19.21%,SGK3;RASA1;ADRB2;KCNAB2;KCNMB1;WNK1;ARPP19;YWHAE;KCNAB3;NEDD4L;KCNE3;SLC5A3;SUMO1;KCNIP1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3517402812397051,-1.0650605654470884,0.3613861386138614,0.8081816095648502,1.0,9/26,16.43%,SLC16A6;SLC16A3;MPC2;SLC16A1;ABCG2;MPC1;SLC16A4;SLC6A1;SLC16A9
prerank,tau protein binding (GO:0048156),0.3666861891553186,1.0642299401796098,0.35877862595419846,0.7364602391517847,1.0,14/40,17.84%,APOE;GSK3B;ROCK1;ACTB;FYN;DYRK1A;PPP2CA;PPP2CB;MARK2;ROCK2;EP300;HSP90AB1;MARK3;PICALM
prerank,protein kinase regulator activity (GO:0019887),0.3214662695098313,1.0638583093334952,0.36648501362397823,0.7337622710975419,1.0,21/95,15.22%,PRKAG2;SH3BP5;GMFG;DNAJC3;PRKAG3;RPLP1;RGCC;GPRC5B;WNK1;CCND3;CCNYL1;SMCR8;CCND2;CCNJ;MARK2;SH3BP5L;ELP4;CCNQ;CCNY;PARVA;GMFB
prerank,protease binding (GO:0002020),0.3221943928809602,1.0636697241527187,0.36015831134564646,0.7307346427111008,1.0,16/99,10.08%,NLRC4;LDLR;CLTC;ITGB1;PRKN;BCL10;GSK3B;RIOK3;ANXA2;BCL2;TNF;STIM1;CARD16;RHBDD2;LCOR;RIPK2
prerank,GABA-A receptor activity (GO:0004890),-0.39396626763642634,-1.0624655293409198,0.4026258205689278,0.809712757754901,1.0,8/18,29.39%,GABRB3;GABRB1;GABRA2;GABRG2;GABRA4;GABRR2;GABRG3;GABRE
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.27842228530959323,-1.0623268088054594,0.3368055555555556,0.8036712878365154,1.0,27/78,23.35%,USP35;CAPN15;CAPN3;LGMN;USP12;CTSS;USP46;CASP7;UCHL1;CTSF;USP40;CFLAR;CASP6;USP49;GPAA1;USP34;USP29;USP5;CTSO;USP33;PIGK;PYCARD;CASP12;CTSK;ESPL1;CAPN11;USP10
prerank,transcription coregulator binding (GO:0001221),0.3555707001223388,1.0621036130991808,0.3660030627871363,0.7309164537405453,1.0,14/50,16.91%,AHR;ZBTB16;ESR1;RPL23;NR1D1;SMAD4;THRB;LCOR;CTBP2;EHMT1;VGLL4;RELA;PER1;ZBTB7A
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.28776439539194515,1.061860979571868,0.33752860411899316,0.728131444329436,1.0,73/269,20.32%,EGFR;SNX9;FBXW7;TXNIP;RPL23;MFHAS1;ARIH1;PTPN22;RPS27A;CCDC50;TNFRSF1B;SLC22A18;RIPK1;AXIN1;PRKN;BCL10;GSK3B;RB1;SPOP;CD40;BCL2;UBXN7;CXCR4;RPL5;VCL;SPOPL;SHPRH;MDM2;UBE2K;CUL3;RTN4;ARRB1;SLC25A5;WFS1;CASP8;YWHAE;JAK1;PRKACB;TRIB2;FOXO1;UBE2N;RALB;PSMD1;PSMA3;RPL11;AMBRA1;ASB4;NLK;GPI;USP25;UBE2W;GABARAP;HSP90AB1;FANCL;STAM;RELA;PER1;MID1;CUL5;PA2G4;GLMN;UBE2A;ATXN3;TNK2;TRAF6;SUMO1;TRIB1;TMBIM6;SMC6;DTX1;USP7;SMAD5;DNM1L
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.35966574051729594,-1.0617551369363076,0.36255924170616116,0.7989778633910517,1.0,7/23,11.20%,PLCB2;PLCB4;PLCG1;CHRM3;EDNRA;PLCB1;PLCH1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.4597809519953613,-1.0596012165634687,0.387308533916849,0.7985945902127173,1.0,6/10,27.06%,ANKRD13B;DNAJB2;ANKRD13D;ANKRD13A;IDE;FAAP20
prerank,metalloexopeptidase activity (GO:0008235),0.35536890984784003,1.0573849908641486,0.37712519319938176,0.7353404704612438,1.0,7/51,10.29%,PEPD;CPQ;XPNPEP3;LNPEP;ZMPSTE24;RNPEP;ENPEP
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.4637280013521724,-1.0562097426950194,0.4229934924078091,0.8017371322181778,1.0,4/10,23.20%,NAA60;NAA25;NAA80;NAA30
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.3268046667052552,-1.0554128409831145,0.3659217877094972,0.797742861615555,1.0,10/35,15.37%,AARS1;QTRT1;TRDMT1;TARS2;DUS1L;TRMT12;BCDIN3D;QTRT2;TRMT9B;MTFMT
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3902955163313726,1.0509568653809804,0.3996683250414594,0.7470544614665228,1.0,7/27,13.74%,ARIH1;SIAH2;PRKN;ANKIB1;RNF19B;RNF14;RNF19A
prerank,pentosyltransferase activity (GO:0016763),-0.32452704349670614,-1.0492691559012888,0.38481675392670156,0.8089146436087157,1.0,13/36,19.56%,LARGE1;QTRT1;UPP2;PARP1;UMPS;SIRT2;PARP10;PARP3;PARP4;QTRT2;SIRT5;SIRT4;PARP9
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3967006834456996,1.0485145641723765,0.39,0.74962677868423,1.0,4/28,7.36%,BABAM2;RIPK1;TNF;EDA
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4471189944526298,1.0477261783972842,0.4139194139194139,0.7481031860875159,1.0,4/15,8.97%,KMT2A;ASH2L;KMT2C;WDR82
prerank,protein serine/threonine kinase activity (GO:0004674),0.27889830601813,1.0470856218616942,0.3710762331838565,0.7462274231346411,1.0,59/334,12.32%,EGFR;MAP3K5;STK17B;SGK3;CDC42BPG;CASK;GRK5;DAPK1;IRAK3;ALPK1;OXSR1;RIPK1;ERN1;CAMK1D;MAP3K1;CDK12;RPS6KA3;CDK6;TRIO;GSK3B;PKN2;PAK2;MAPKAPK2;ROCK1;RIOK3;STK24;STK3;WNK1;PIKFYVE;VRK2;ACVR2A;RPS6KC1;SYK;CHEK1;MAP3K8;FAM20A;NRK;PRKCB;HTATIP2;ULK2;CDK14;CDK20;VRK1;MAPK4;SBK3;MAPK14;MAP3K20;DYRK1A;MAST1;RPS6KA6;RIPK2;MARK2;STK10;CDK13;ROCK2;STK36;MAP3K11;MKNK1;STK38
prerank,SUMO transferase activity (GO:0019789),0.43597923680899087,1.0465237805840715,0.42123893805309737,0.7440709544212544,1.0,4/16,8.74%,PIAS1;PIAS2;NSMCE2;MDM2
prerank,chloride channel regulator activity (GO:0017081),0.44109870523653144,1.045063826147257,0.4206081081081081,0.7443760725697659,1.0,3/14,8.32%,SGK3;WNK1;STX7
prerank,motor activity (GO:0003774),-0.28685221343595974,-1.0447210207178608,0.391025641025641,0.8151157092396115,1.0,17/60,17.09%,KIF21B;KIF1A;DYNLRB1;KIF5A;KIF6;KIF5C;MYO6;CENPE;DYNC2H1;KIF1C;KIF3A;KIF11;KIF15;KIF3B;DNAH8;KIFC2;KIF2A
prerank,AMP binding (GO:0016208),-0.44339537273944174,-1.0431180122355523,0.4135667396061269,0.8131815628747723,1.0,5/11,9.37%,MPPED2;PFKL;PRKAG1;PYGL;PFKP
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.4374607385278506,-1.0423782811412663,0.4188034188034188,0.8093589034967327,1.0,7/12,29.39%,GABRB3;GABRB1;GABRA2;GABRG2;GABRA4;GABRG3;GABRE
prerank,DNA replication origin binding (GO:0003688),0.39490273688067506,1.0348870055546275,0.3993453355155483,0.7653997987766646,1.0,6/23,15.93%,ORC5;ORC2;MCM9;DDX11;KAT7;MCM8
prerank,mRNA methyltransferase activity (GO:0008174),0.4450496289274947,1.0346697650803824,0.41229656419529837,0.7625155582729675,1.0,6/12,23.28%,NSUN2;TRMT61B;CMTR2;TRMT61A;METTL16;PCIF1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.37761797086097354,-1.0330333190551704,0.3972602739726027,0.83008116725011,1.0,5/18,21.11%,AKR1B1;ALDH18A1;ALDH1A1;ALDH1A2;AKR1B10
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.46262726240459934,1.0321541510174257,0.4075471698113208,0.7652265440735154,1.0,6/12,18.63%,PHF8;KDM7A;KDM4D;JMJD1C;KDM1A;KDM4C
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.32266094839123693,1.0282210602817803,0.40625,0.7715722527790438,1.0,6/73,5.85%,EDNRB;CYSLTR1;CALCRL;NPR3;S1PR2;ADCYAP1R1
prerank,translation elongation factor activity (GO:0003746),0.43977975989438217,1.0255945380749871,0.43253234750462105,0.7742451306764172,1.0,2/14,3.73%,EEF1A1;EEFSEC
prerank,GABA receptor activity (GO:0016917),-0.3592100299752671,-1.0252041954861892,0.43946188340807174,0.8465487533313322,1.0,8/21,29.39%,GABRB3;GABRB1;GABRA2;GABRG2;GABRA4;GABRR2;GABRG3;GABRE
prerank,RNA polymerase core enzyme binding (GO:0043175),0.36111613819096405,1.0230050747803259,0.4117647058823529,0.7769375300606692,1.0,11/33,16.36%,NCOA3;WAC;CDC73;ESRRB;SCAF8;RPRD2;ELOF1;ELP4;ZNF326;RTRAF;GTF2B
prerank,insulin-like growth factor I binding (GO:0031994),0.4452487018865712,1.0216603983681394,0.4394213381555154,0.7766817483443446,1.0,2/13,4.94%,IGFBP4;INSR
prerank,anion channel activity (GO:0005253),0.3316822201058061,1.0207156140004034,0.42584434654919234,0.7753821753493579,1.0,9/61,10.44%,CLCN5;ANO6;LRRC8D;CLIC4;ANO1;CLCC1;TTYH3;BEST1;GABRA3
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.35486831417674763,-1.02023135087548,0.4251207729468599,0.85515568946054,1.0,6/21,12.49%,AKAP8L;AKAP6;AKAP7;ARFGEF1;AKAP8;WASF1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2817473987893521,1.0195503063839204,0.42365097588978184,0.774880324581933,1.0,52/248,18.33%,GNAQ;RAP1B;ATP2B1;KIF20B;RAB31;RAP2B;GBP3;ATL1;NRAS;KRAS;GNAI3;EEF1A1;CDC42;RAB8B;ARL8A;RHOA;GCH1;RAP1A;GBP7;GTPBP10;VPS4B;GEM;GNB1;RHOBTB1;RAB7A;RAB14;RAB1A;RAB23;CLPX;GNG5;MYO1E;GTPBP1;AGAP3;RND3;RALB;RAB11A;RHOC;GNA11;ARHGDIB;RAB3B;GNA13;LSG1;HBS1L;RAB32;RHOF;ABCB10;TOR1B;EFL1;RAB22A;RHEB;RRAGC;ABCA4
prerank,ATPase binding (GO:0051117),0.3165137088089639,1.0174943478832374,0.40575539568345326,0.7765244766168161,1.0,19/71,15.78%,EGFR;PPP3CA;ESR1;S100A1;SNU13;ATP6V0A1;PDE4D;PEX26;VCPKMT;PSEN1;PLN;WFS1;SNX10;NR1H2;RALB;PKD2;USP25;NCSTN;NOP58
prerank,hormone activity (GO:0005179),0.3368778045070667,1.016246539576621,0.4292168674698795,0.7763802423729036,1.0,8/54,14.46%,METRNL;C1QTNF12;GHRL;IGF1;CCK;METRN;NPPC;TRH
prerank,transition metal ion binding (GO:0046914),0.2687805776724386,1.01499584462021,0.4264069264069264,0.7759602973504549,1.0,71/397,15.55%,GDA;ALOX5;RPS29;CRIP1;ALOX15;KMT2A;ANG;AGMO;ARIH1;GYG1;SORD;PHF8;LARGE2;ENDOU;SMPDL3A;PRKN;PDE2A;DUSP12;AOC1;NQO2;AFM;MGAT2;XPNPEP3;GCH1;MOXD1;FTL;KDM7A;GLO1;LNPEP;RC3H1;ACER3;ATP7A;CRIP2;FBXL5;ACR;MYCBP2;PAM;TRIM24;PITRM1;KLF4;THAP11;ESCO1;AOX1;RNPEP;TET3;MDM2;USP16;ZNF205;ENPEP;FTH1;RASSF1;ETHE1;LACTB2;CBLB;SEC24D;KDM5C;LOXL2;SHMT1;TET2;MBD1;XYLT2;KAT6A;ARG2;PAPOLA;ZDHHC20;SAMHD1;MELTF;MYT1;HDAC4;KDM2A;CHORDC1
prerank,mRNA binding (GO:0003729),-0.2230972214008309,-1.0147487894980454,0.4205607476635514,0.8643314475765097,1.0,56/249,16.47%,DDX5;SNRNP70;SRRM2;LUC7L3;CPSF6;EIF4G1;ELAVL2;RBM25;NCL;RBFOX1;SRRM4;SRSF5;HNRNPA2B1;EIF4A1;FXR2;TARDBP;TP53;PKM;HNRNPU;ZC3H12B;HNRNPLL;ELAVL4;FUBP1;CPEB2;SECISBP2;RIDA;FMR1;PPIE;CELF4;RBMS3;KHDRBS3;CSTF2;RNPS1;CLUH;SHFL;UNK;TYMS;CIRBP;ADARB1;MYH10;UPF3B;NOVA2;C1QBP;UTP23;SF3B1;QKI;NCBP1;CARHSP1;N4BP1;PCBP1;PCBP2;SLC4A1AP;SNIP1;PARK7;RBM5;ANGEL2
prerank,microtubule motor activity (GO:0003777),-0.2891876485564751,-1.013267619027212,0.425,0.8622469688046768,1.0,15/51,17.09%,KIF21B;KIF1A;DYNLRB1;KIF5A;KIF6;KIF5C;CENPE;KIF1C;KIF3A;KIF11;KIF15;KIF3B;DNAH8;KIFC2;KIF2A
prerank,protein phosphatase activator activity (GO:0072542),-0.4061254701900453,-1.0127575700288043,0.4588744588744589,0.8575928680997593,1.0,6/13,21.25%,CALM2;PPP2R5C;PPP2R5A;PTPA;CALM3;IGFBP3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.27227241397290963,1.012236750917647,0.44600431965442766,0.7789617600002616,1.0,71/346,15.87%,WWP1;RNF150;SMURF2;ARIH1;SH3RF1;UBE2E3;SIAH2;CDC42;SEL1L2;CBL;PELI1;RMND5A;PRKN;TRIM56;ZNRF3;BIRC3;RNF141;RC3H1;KLHL13;UBE2Q2;TRIM32;FBXL5;ANKIB1;MYCBP2;TRIM24;TRIM47;DTX2;BIRC6;TRIM68;SHPRH;TRIM27;RNF19B;MDM2;RNF121;UBE2D3;UBE2K;COP1;UHRF2;CUL3;RNF38;MKRN1;FBXO11;RNF14;ZNRF2;RNF111;AMFR;UBE3B;RNF185;TRIM71;CBLB;MIB1;FBXO10;MKRN3;RNF115;UBE2R2;RBBP6;UBE2N;RNF187;RNF19A;BFAR;ASB12;BCOR;ANKRD39;NEDD4L;MKRN2;RNF122;ASB4;RNF41;TRIM25;FBXW2;UBE2W
prerank,magnesium ion binding (GO:0000287),0.29602345108274525,1.0089564891336762,0.4466750313676286,0.7835810687806607,1.0,24/135,16.08%,NLRC4;MAP3K5;CDC42BPG;IRAK3;OXSR1;ERN1;MOV10L1;PDE2A;STK3;GEM;TKT;CLYBL;MAP3K20;MAST1;MARK2;FOXK2;PRKACB;STK38;DIS3L2;XYLT2;NUDT18;PAPOLA;NLK;IDH1
prerank,protein tyrosine kinase activity (GO:0004713),0.29731340364035747,1.0068375711139432,0.44047619047619047,0.7854103764180316,1.0,18/108,11.88%,EGFR;FGFR1;PEAK1;LYN;FER;FRK;INSR;CAMKK2;PDGFRA;SYK;ZAP70;FYN;DDR2;DYRK1A;EPHB4;STYK1;SLA;JAK1
prerank,MHC class I protein binding (GO:0042288),0.4312386699103585,1.0066238338931954,0.45794392523364486,0.7825336980920121,1.0,1/13,2.75%,LILRB1
prerank,nucleotide diphosphatase activity (GO:0004551),-0.39540077549079417,-1.0056442658300457,0.4518348623853211,0.8721859793136517,1.0,6/14,26.13%,ENPP5;NUDT6;FHIT;NUDT13;NUDT12;NUDT11
prerank,dynactin binding (GO:0034452),0.4497275114629327,1.0044235054561728,0.4594594594594595,0.7844054386231852,1.0,5/12,14.55%,SNX6;GSK3B;SNX5;PAFAH1B1;SPTBN5
prerank,regulatory RNA binding (GO:0061980),0.34589580651685853,1.0041163395229262,0.4608294930875576,0.7819824861588189,1.0,8/38,13.54%,TUT7;PUM2;RC3H1;TUT4;RBM4;TRIM71;ZC3H12A;PIWIL2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.30827327284471856,-1.0015589063987749,0.4483695652173913,0.8778005331676803,1.0,20/37,30.00%,FARSA;AARS1;CARS1;TARS2;NARS1;TARS1;YARS1;IARS2;SARS1;DARS2;AARS2;SARS2;PARS2;HARS2;FARSB;WARS1;VARS2;VARS1;KARS1;NARS2
prerank,amino acid:sodium symporter activity (GO:0005283),-0.42252521710730906,-1.001216663478188,0.46028513238289204,0.8727831025880926,1.0,4/11,18.58%,SLC1A3;SLC1A1;SLC6A1;SLC1A2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.4198467015273024,-1.0001723543213883,0.45358649789029537,0.8697983214265876,1.0,4/11,23.70%,KCND2;KCNK2;KCNT1;KCND1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.39398276586549036,0.9999978209926141,0.4562937062937063,0.788521728143738,1.0,6/22,16.09%,MTMR3;DUSP12;DUSP1;DUSP2;DUSP23;DUSP7
prerank,poly-pyrimidine tract binding (GO:0008187),0.3778538755004773,0.9996080062426372,0.4518900343642612,0.7861707704596441,1.0,5/23,12.73%,RBMS1;HNRNPC;ATXN1;RBM11;DIS3L2
prerank,chemoattractant activity (GO:0042056),-0.33737092500094945,-0.9992870416090496,0.46786632390745503,0.8663013381203934,1.0,13/26,39.38%,FGF2;VEGFB;CCL3;MIF;HMGB1;DEFB130A;FGF7;CX3CL1;BMP4;VEGFD;CXCL10;VEGFA;CCL15
prerank,store-operated calcium channel activity (GO:0015279),-0.432492224713902,-0.9966866160235797,0.4533898305084746,0.867612767198499,1.0,6/10,19.04%,TRPC4;ORAI2;TRPC1;TRPC3;TRPC5;ORAI3
prerank,voltage-gated ion channel activity (GO:0005244),-0.39111953978659914,-0.9960261247467629,0.4809843400447427,0.8636461824449326,1.0,5/14,14.51%,KCND2;CACNA1E;VDAC1;VDAC3;HVCN1
prerank,growth factor activity (GO:0008083),-0.26029590610778985,-0.9941316782966712,0.4645390070921986,0.8633389158275638,1.0,8/74,6.77%,TGFA;NRG3;CSF1;FGF2;VEGFB;CSPG5;OSGIN2;BDNF
prerank,omega peptidase activity (GO:0008242),-0.25565597456301425,-0.9923761367066186,0.4513888888888889,0.8624076821782782,1.0,24/89,17.16%,USP35;CYLD;USP12;OTUD5;USP50;GGT5;OTULIN;STAMBP;USP46;UCHL1;USP19;USP40;MYSM1;GGT7;USP49;PAN2;UFD1;OTUB1;USP34;JOSD2;USP29;USP5;USP33;OTUD1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3335629629259484,0.9919740918018294,0.45,0.8008239812114467,1.0,6/49,7.85%,MCTP1;CPNE2;CPNE7;ANXA2;CPNE8;MCTP2
prerank,leucine zipper domain binding (GO:0043522),-0.4344534370095433,-0.9912994383084066,0.4829787234042553,0.8597884714308666,1.0,4/10,30.89%,DDIT3;PAWR;ATF4;PMF1
prerank,metalloendopeptidase activity (GO:0004222),0.3055303744528818,0.9910262840265419,0.4748923959827834,0.7997936463328008,1.0,13/76,13.54%,ADAM19;ADAMTSL5;ADAM9;ADAMTS19;ZMPSTE24;PITRM1;ADAMTS18;ADAMTS10;ADAMTS9;MMP25;MMP24;MMP28;ADAMTS17
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.32102228025098584,-0.9901574420433936,0.4621409921671018,0.8571764800301827,1.0,15/29,43.21%,SLC38A7;SLC1A1;SLC25A14;SLC25A22;SLC25A10;SLC25A13;SLC1A4;SLC25A21;SLC13A5;SLC46A1;ABCC2;SLC1A5;SLC26A3;SLC26A4;SLC25A18
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.42737977647442327,0.9891958956812517,0.47504621072088726,0.8006109798515715,1.0,1/14,1.42%,BLVRB
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.36861494118455923,0.9890841148997523,0.47194719471947194,0.7975826199333896,1.0,6/29,12.49%,SPRED1;PRKAG2;SFN;HSPB1;SPRED2;CDKN2C
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3291586762995236,0.9882543164993757,0.4658753709198813,0.796132888602601,1.0,11/49,15.27%,PTPRJ;PTPN22;SMPDL3A;DUSP28;DUSP12;HDHD2;LHPP;PPP1CA;ACP3;DUSP23;SAMHD1
prerank,snRNA binding (GO:0017069),-0.28884454357915457,-0.9846217441885896,0.4899713467048711,0.8666970840341335,1.0,7/42,8.26%,SNRNP70;CDK9;DDX39B;HNRNPU;CCNT2;SNRPA1;PRPF4
prerank,chloride channel activity (GO:0005254),0.3248962016632289,0.9839315152651722,0.4893939393939394,0.8026313948934887,1.0,9/59,10.44%,CLCN5;ANO6;CLCNKB;CLIC4;ANO1;CLCC1;TTYH3;BEST1;GABRA3
prerank,protein tyrosine phosphatase activity (GO:0004725),0.31165934167699083,0.9836496421583618,0.47796143250688705,0.7999666248861944,1.0,10/71,7.43%,PTPRJ;PTPN18;PTPN20;PTPN12;PTPN22;MTMR3;DUSP1;PTPRK;PTPRA;DUSP22
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.3992227903991308,-0.9787114303399237,0.5040816326530613,0.8774385505809507,1.0,5/11,18.35%,UBE4A;RBX1;ANAPC11;PRPF19;STUB1
prerank,Toll-like receptor binding (GO:0035325),0.44773826482716755,0.9714225920074717,0.48863636363636365,0.8247345709754237,1.0,2/11,4.25%,CD36;TLR2
prerank,sialyltransferase activity (GO:0008373),0.3835513362251154,0.969743240947133,0.5,0.8253151991913791,1.0,3/20,3.64%,ST8SIA4;ST6GAL1;ST3GAL1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.3348420171851104,0.9694062914689708,0.5030674846625767,0.8228489932701832,1.0,7/42,11.64%,FBXW7;RASA1;CRK;SYK;ZAP70;SHC1;YWHAE
prerank,hexosyltransferase activity (GO:0016758),0.2892426846286698,0.9685377624902873,0.5012886597938144,0.8217059781873437,1.0,18/101,11.37%,EXT1;GBE1;GYG1;FUT4;LARGE2;UGT1A10;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;B4GALT6;POGLUT3;ALG9;ALG5;POGLUT1;B4GALT5;B4GALNT3
prerank,glycine binding (GO:0016594),-0.3990179593700531,-0.9674166605165372,0.5123042505592841,0.9025218420069413,1.0,5/11,22.64%,GRIN3A;GLRB;GLRA1;GLRA3;GLRA2
prerank,RNA polymerase binding (GO:0070063),-0.35095612778581603,-0.9662037977488303,0.4759825327510917,0.9003001641501733,1.0,7/18,12.80%,BIN1;PABPN1;CCNT2;TCERG1L;TCERG1;BRCA1;PHRF1
prerank,myosin II binding (GO:0045159),-0.41775059592085606,-0.9648456465899695,0.5181451612903226,0.8981661346214053,1.0,4/10,16.76%,LLGL1;SHROOM1;SHROOM4;LLGL2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3648532831149862,0.9643269041133392,0.5079646017699115,0.8280652246862097,1.0,9/27,18.62%,POLR1A;POLR1B;MED20;POLR2B;POLR1D;POLR2D;CRCP;PRIM1;POLR2F
prerank,ion channel activity (GO:0005216),-0.24806738095175515,-0.9641164447723055,0.5107142857142857,0.894512765170602,1.0,14/80,12.42%,GRID2;GRIA2;GRIK2;GRIA4;TRPM3;GRIN3A;PIEZO1;TMC7;GABRB1;TRPC1;NALCN;GRIN2A;PIEZO2;TMEM120B
prerank,fibroblast growth factor receptor binding (GO:0005104),0.3799711491498833,0.9632044044113706,0.4865771812080537,0.8273186954769964,1.0,2/21,3.98%,FGF23;FRS2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.34226436673951205,0.961354242529037,0.484297520661157,0.8283302370558909,1.0,11/33,16.36%,NCOA3;WAC;CDC73;ESRRB;SCAF8;RPRD2;ELOF1;ELP4;ZNF326;RTRAF;GTF2B
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.39480455183077073,-0.9608659273730209,0.5182926829268293,0.8976964621063674,1.0,3/12,7.90%,GNS;SULF1;ARSG
prerank,chloride transmembrane transporter activity (GO:0015108),-0.358513234280328,-0.9590767930082377,0.49195402298850577,0.8969839813427118,1.0,4/16,23.66%,CLCN7;SLC1A1;CFTR;SLC12A5
prerank,zinc ion binding (GO:0008270),0.2594924906488979,0.9584864781403236,0.5597269624573379,0.8314917198426213,1.0,65/293,19.44%,GDA;RPS29;CRIP1;KMT2A;ARIH1;SORD;PHF8;SMPDL3A;PRKN;PDE2A;DUSP12;AOC1;NQO2;AFM;GCH1;KDM7A;GLO1;LNPEP;RC3H1;ACER3;CRIP2;ACR;MYCBP2;PAM;TRIM24;PITRM1;KLF4;THAP11;ESCO1;RNPEP;TET3;MDM2;USP16;ZNF205;ENPEP;RASSF1;LACTB2;CBLB;SEC24D;KDM5C;SHMT1;TET2;MBD1;KAT6A;ZDHHC20;SAMHD1;MYT1;HDAC4;KDM2A;CHORDC1;ERAP1;RABIF;GTF2B;TAB3;MSRB3;ZNF22;KPNB1;KDM4C;PHF5A;P2RX4;EEA1;MSRB2;CTCF;ZNF3;ENPP1
prerank,R-SMAD binding (GO:0070412),-0.3491746277305093,-0.9579850715851038,0.5096359743040685,0.8941776596272919,1.0,2/18,0.37%,DDX5;LDLRAD4
prerank,adenyl ribonucleotide binding (GO:0032559),0.25864803359845134,0.9572943103786198,0.5646794150731158,0.8310106798902799,1.0,44/291,14.10%,NLRC4;P2RX7;MAP3K5;STK17B;OAS2;PEAK1;CDC42BPG;PRKAG2;DAPK1;IRAK3;LIG4;OXSR1;PRKAG3;ERN1;MOV10L1;HMGCR;RAPGEF2;PDE2A;CDK6;INSR;PNPLA8;ATP7A;STK3;PDE4D;WNK1;NOL9;ZAP70;MAP3K20;MAST1;MTREX;PMVK;CLPX;MARK2;HSPA13;STK36;PRKACB;MKNK1;STK38;GLUD1;LATS2;UHMK1;ATP1A3;ATP1A1;POPDC3
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.37217690937923054,0.9570046022892839,0.49125874125874125,0.828373304592523,1.0,4/21,17.31%,DRD1;CHRNA4;GRM1;CHRNB2
prerank,cAMP binding (GO:0030552),0.4297814806295327,0.9540818237827958,0.5163636363636364,0.8317433736752312,1.0,3/11,5.79%,RAPGEF2;PDE2A;PDE4D
prerank,hormone receptor binding (GO:0051427),-0.3687627279044918,-0.9515903918320314,0.516629711751663,0.9059828438697466,1.0,3/14,9.76%,JAK2;SOCS2;ADCYAP1
prerank,cholesterol binding (GO:0015485),-0.27228738742612807,-0.9486849525533996,0.530791788856305,0.908179666372479,1.0,9/47,14.89%,ABCG1;GRAMD1A;OSBPL6;SCARB2;STARD3;APOD;VDAC1;GRAMD1C;OSBPL2
prerank,intracellular chloride channel activity (GO:0061778),0.40085183681066006,0.9463194855691546,0.4935779816513762,0.8430998121855525,1.0,3/16,6.19%,ANO6;ANO1;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.40085183681066006,0.9463194855691546,0.4935779816513762,0.8430998121855525,1.0,3/16,6.19%,ANO6;ANO1;TTYH3
prerank,O-acyltransferase activity (GO:0008374),-0.3047285929142631,-0.9462971063040096,0.544973544973545,0.9091250494640742,1.0,5/30,16.48%,LPCAT2;LPCAT1;LPCAT3;MBOAT7;AWAT2
prerank,Hsp90 protein binding (GO:0051879),0.3336587053766839,0.9419743967340152,0.5144694533762058,0.8498269351495766,1.0,4/33,4.35%,AHR;RPS3;ERN1;NR3C1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3120622211810653,0.9417218278438714,0.5257879656160458,0.8471904606169118,1.0,8/49,10.58%,RNF169;EPS15;BABAM2;BRCC3;MINDY2;ZFAND2B;UBQLN4;ZRANB3
prerank,poly-purine tract binding (GO:0070717),-0.3090675446586899,-0.9411510697841182,0.5497630331753555,0.9175756624409838,1.0,10/27,17.39%,TIA1;HNRNPU;ELAVL4;FMR1;PPIE;HNRNPDL;RBMS3;MCRS1;DDX1;PABPC4
prerank,ATP hydrolysis activity (GO:0140603),0.3264473758575392,0.9410843680744664,0.5458579881656804,0.8453739066474846,1.0,5/41,10.66%,ATP2B1;KIF20B;VPS4B;CLPX;MYO1E
prerank,nucleotidyltransferase activity (GO:0016779),0.388054874642089,0.9409594730769439,0.52,0.8424715962068003,1.0,4/19,8.61%,TUT7;TENT2;TUT4;PAPSS2
prerank,metallocarboxypeptidase activity (GO:0004181),0.36172983078395293,0.940209748002795,0.5510204081632653,0.8409474092256953,1.0,1/26,0.62%,PEPD
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.3575650067858479,-0.9391639933119665,0.5325842696629214,0.9174739118979703,1.0,3/15,4.07%,HS3ST5;HS3ST4;HS6ST1
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2446204188233173,-0.9381990951338061,0.5993265993265994,0.914589928912819,1.0,22/83,17.16%,USP35;CYLD;USP12;OTUD5;USP50;OTULIN;STAMBP;USP46;UCHL1;USP19;USP40;MYSM1;USP49;PAN2;UFD1;OTUB1;USP34;JOSD2;USP29;USP5;USP33;OTUD1
prerank,proton transmembrane transporter activity (GO:0015078),0.3297215474721512,0.9370761512755383,0.5247678018575851,0.8446234775437058,1.0,10/39,21.46%,CLCN5;ATP6V1B1;COX7A2L;COX10;SLC33A1;MFSD3;UQCRFS1;NDUFA4;CYB5A;COX5A
prerank,mRNA 3'-UTR binding (GO:0003730),0.29106000895459905,0.9368903372173388,0.5472222222222223,0.8419534577012796,1.0,16/79,13.34%,RBMS1;ZFP36L2;HNRNPC;ZFP36L1;RPL41;PUM2;RC3H1;RPL5;LARP4B;RBM4;RPS7;SERBP1;ILF3;ZC3H12A;EXOSC8;LARP4
prerank,insulin-like growth factor binding (GO:0005520),0.39702991088550355,0.9368637140826824,0.5355871886120996,0.8388853077716745,1.0,3/15,10.81%,IGFBP4;INSR;IGFALS
prerank,fibroblast growth factor binding (GO:0017134),0.3691221528409878,0.9351743027352051,0.5239669421487604,0.8393777586748442,1.0,1/21,0.60%,FGFR1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.37424188476958853,-0.9294550221442871,0.5468409586056645,0.9327907730853953,1.0,3/12,4.94%,GNAS;YWHAH;SOCS2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.26554710740918475,-0.929180761306551,0.60062893081761,0.9279635231403887,1.0,24/48,37.54%,SLC12A2;TRPM3;PIEZO1;TRPC1;NALCN;SLC12A6;PIEZO2;ABCC9;UNC80;SLC12A4;MMGT1;PKD1L3;SLC39A1;TRPM7;CALHM6;TRPV2;TRPM6;CALHM5;TRPC6;ATP6V1F;GRIN3B;TRPM1;ASIC3;SLC46A1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.328110979337146,-0.9286793551432236,0.5813397129186603,0.9237655078924789,1.0,2/20,1.12%,LPCAT2;LPCAT1
prerank,receptor tyrosine kinase binding (GO:0030971),-0.25589000770247317,-0.9260007953417337,0.5935483870967742,0.9253438764916336,1.0,8/56,7.67%,BLNK;NRG3;DOCK4;PITPNM1;TP53;ITGAX;PITPNM3;SHC3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.40682720590296134,0.9228669193639627,0.542910447761194,0.863439929160968,1.0,1/14,3.20%,DHRS3
prerank,poly(A) binding (GO:0008143),-0.3224555095380065,-0.9225342074387888,0.5736263736263736,0.9290887936064437,1.0,8/21,17.39%,TIA1;HNRNPU;ELAVL4;PPIE;HNRNPDL;RBMS3;DDX1;PABPC4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.362432155973409,0.9218378930320847,0.541038525963149,0.8624258327754569,1.0,5/22,12.51%,ZFP36L2;ZFP36L1;ILF3;ZC3H12A;EXOSC8
prerank,peptidoglycan binding (GO:0042834),0.4304445638511414,0.9217239182999843,0.581651376146789,0.859510296781957,1.0,4/10,25.39%,TLR2;NOD2;RNASE7;NLRP3
prerank,sulfotransferase activity (GO:0008146),-0.2848328095121955,-0.9198998045014288,0.5797872340425532,0.9303488547962092,1.0,6/33,10.79%,CHST11;CHST1;HS6ST1;TPST1;CHST2;GAL3ST4
prerank,NADP binding (GO:0050661),0.33154910884990185,0.9197402476650245,0.5410094637223974,0.860780244474531,1.0,8/32,20.69%,DPYD;HMGCR;GMDS;LBR;CBR3;DHCR7;DUS2;ME1
prerank,metallopeptidase activity (GO:0008237),0.2678201707829619,0.9157074766700779,0.61133069828722,0.8666379865030904,1.0,20/113,15.95%,ADAM19;ADAMTSL5;ADAM9;LNPEP;ADAMTS19;ZMPSTE24;BRCC3;PITRM1;ADAMTS18;ADAMTS10;ADAM12;RNPEP;ADAMTS9;MMP25;MMP24;MMP28;ADAMTS17;EIF3H;ERAP1;MMP11
prerank,ATP binding (GO:0005524),0.2474004634356839,0.9128737297573006,0.6514285714285715,0.8697008055507668,1.0,33/266,12.32%,NLRC4;P2RX7;MAP3K5;STK17B;OAS2;PEAK1;CDC42BPG;PRKAG2;DAPK1;IRAK3;LIG4;OXSR1;ERN1;MOV10L1;CDK6;INSR;PNPLA8;ATP7A;STK3;WNK1;NOL9;ZAP70;MAP3K20;MAST1;MTREX;PMVK;CLPX;MARK2;HSPA13;STK36;PRKACB;MKNK1;STK38
prerank,calcium-release channel activity (GO:0015278),0.37717723143468246,0.912019838691831,0.5731292517006803,0.8684000396309899,1.0,5/17,14.94%,TPCN1;TRPM2;MCOLN2;PKD2;ITPR3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3572558373234347,0.9118336434514026,0.5672413793103448,0.8656701973774292,1.0,8/24,18.87%,SESTD1;SNX3;GOLPH3L;OSBPL8;OSBPL5;GOLPH3;CERT1;ARFIP2
prerank,kinesin binding (GO:0019894),-0.29474097795845866,-0.9111064055858678,0.5721040189125296,0.9477779666544105,1.0,6/27,14.36%,PLEKHM2;NEFH;IFT88;CROCC;NEK6;AP1AR
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.3050167890301445,-0.9096087681426662,0.5925925925925926,0.9464972575217265,1.0,6/26,15.24%,CHPF2;B3GALNT2;B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,glucose transmembrane transporter activity (GO:0005355),0.3781016696604578,0.906701714916611,0.5703971119133574,0.873697248789038,1.0,5/17,20.13%,SLC2A4;SLC2A2;SLC5A11;SLC5A3;SLC2A6
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.3729430365994519,-0.9062513754570136,0.5778251599147122,0.9496898224139565,1.0,8/12,40.18%,ENTPD6;CANT1;ENTPD3;NUDT5;ENTPD2;ENTPD5;NUDT15;SLC25A42
prerank,copper ion binding (GO:0005507),0.3097537815752611,0.9062099196688436,0.6092124814264487,0.8716523861367133,1.0,6/42,6.28%,ANG;AOC1;MOXD1;ATP7A;ACR;PAM
prerank,alkali metal ion binding (GO:0031420),-0.3634828637991592,-0.9048981531075833,0.5742793791574279,0.94765241518387,1.0,1/13,1.05%,CAPN3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3856834689171692,-0.9036217968970293,0.5802469135802469,0.9458647290334689,1.0,4/11,9.02%,GNPTAB;PTDSS1;SAMD8;PTDSS2
prerank,protein phosphatase 1 binding (GO:0008157),0.3525760507299302,0.9028920939868906,0.5568561872909699,0.8757458337653526,1.0,6/21,15.60%,LILRB1;PPP1R3C;PPP1R3D;KCNQ1;AKAP11;PPP1R3B
prerank,single-stranded RNA binding (GO:0003727),0.3123427058390082,0.9026396028851176,0.5945945945945946,0.873240154944801,1.0,10/43,14.38%,TLR8;DDX60;HNRNPF;DDX11;ILF3;EIF4B;LACTB2;RBM11;AQR;POLR2D
prerank,nuclear receptor coactivator activity (GO:0030374),0.29821888009763625,0.9025522172050838,0.6140888208269525,0.870361789732618,1.0,22/52,22.74%,NCOA3;NCOA2;NCOA7;PRKCB;NCOA6;BUD31;DCAF6;SFR1;CNOT9;ENY2;USP22;ELK1;KDM1A;PPARGC1B;MED17;SS18;WDR77;THRAP3;MED14;ATXN7L3;ZMIZ1;MED24
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2862578749349733,0.9010744946027641,0.6115819209039548,0.8703163418526731,1.0,8/70,3.64%,EXT1;LARGE2;UGT1A10;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1
prerank,snoRNA binding (GO:0030515),-0.29135965630871674,-0.9004190062518517,0.596401028277635,0.9483769049995786,1.0,12/30,29.05%,XRCC5;NOP56;UTP6;NOP14;BMS1;GAR1;TSR1;NUDT1;BYSL;DHX37;NUDT16;NUDT5
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.28749719802572904,-0.9004095214870683,0.6138107416879796,0.9431369019217488,1.0,2/28,1.91%,GRID2;GRIK2
prerank,histone methyltransferase binding (GO:1990226),-0.3715836341391118,-0.8997210472518423,0.6113445378151261,0.9396592774360386,1.0,2/11,2.50%,CTNNB1;NOP56
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.34523060352333956,0.8964532600649188,0.5697674418604651,0.8771906788345946,1.0,6/24,18.39%,IP6K3;PMVK;CMPK1;AK8;AK3;AK4
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3450513564019978,-0.8963064528820921,0.6188235294117647,0.9433871238212646,1.0,4/15,9.54%,PIK3CB;PI4KA;ATM;PIK3C2B
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3162468511412585,-0.8960155337937609,0.6044444444444445,0.9390013840568553,1.0,9/21,23.13%,PRIMPOL;POLM;POLG;POLI;REV3L;POLE;POLL;POLN;POLD4
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.32561642162445614,-0.8950723432686503,0.6323907455012854,0.9363231235747972,1.0,4/18,11.68%,SOCS2;AGAP2;SOCS7;PIK3R5
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.33817727443481216,-0.8944111713567368,0.6031390134529148,0.9328511971567999,1.0,3/16,11.60%,SLC44A2;SLC25A26;SLC7A8
prerank,enoyl-CoA hydratase activity (GO:0004300),0.41542494991012135,0.893232830142144,0.5626168224299065,0.8808581773816273,1.0,4/10,19.11%,EHHADH;HADHA;HADHB;ECHDC1
prerank,ubiquitin binding (GO:0043130),-0.24141391774273527,-0.8893799245158913,0.6959459459459459,0.9399251523879876,1.0,21/73,17.52%,MVB12B;OTULINL;BIRC2;FBXO7;AUP1;UCHL1;TOM1L1;RNF168;SIRT2;DNAJB2;NSFL1C;UBXN1;OTUB1;TOP2A;NPLOC4;N4BP1;USP5;ASCC2;USP33;GGA3;SQSTM1
prerank,protein phosphatase 2A binding (GO:0051721),-0.3045891475771812,-0.8887477299029488,0.6187050359712231,0.9365153863208305,1.0,7/23,14.50%,ADCY8;TP53;GRIN3A;MAPT;CTTNBP2NL;ANKLE2;STRN4
prerank,telomerase RNA binding (GO:0070034),0.34963679429443806,0.8882845104053677,0.6054888507718696,0.8885302051070887,1.0,5/22,16.23%,HNRNPC;SMG6;DCP2;PINX1;NOP10
prerank,GABA receptor binding (GO:0050811),0.40390844944986204,0.8874509912616138,0.5992292870905588,0.8871865826557433,1.0,6/11,23.32%,PLCL2;TRAK2;GABARAP;JAKMIP1;TRAK1;ARFGEF2
prerank,endopeptidase activity (GO:0004175),0.24001537412715096,0.8871059986865701,0.7010428736964078,0.884864396024711,1.0,42/257,15.95%,CTSC;ADAM19;PSMA7;ADAMTSL5;ADAM9;RHBDD1;USP9X;CTSB;PARL;RHBDF1;ACR;HTRA3;ADAMTS19;ZMPSTE24;PITRM1;PREP;ADAMTS18;USP15;PSMB2;PSEN1;ADAMTS10;TPP2;ADAMTS9;USP16;SFRP1;F10;CASP8;USP24;PSMA6;USP14;KLK9;MMP25;MMP24;MMP28;ADAMTS17;USP9Y;PSMA3;USP28;SENP1;USP25;USP47;MMP11
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.32195105936130763,0.8857377695012586,0.617363344051447,0.8848069651366124,1.0,6/34,10.64%,IQGAP1;INCENP;STK3;FAM20A;PARP16;CALM1
prerank,estrogen receptor binding (GO:0030331),0.3198365366268288,0.8839411019143736,0.5949764521193093,0.885731002133766,1.0,9/32,16.25%,ESR1;ARID5A;WIPI1;NRIP1;NCOA6;LCOR;STRN;MMS19;PPARGC1B
prerank,metalloaminopeptidase activity (GO:0070006),0.3642065041132385,0.8838871322535474,0.6060606060606061,0.882788081783834,1.0,4/16,10.29%,XPNPEP3;LNPEP;RNPEP;ENPEP
prerank,ATPase activator activity (GO:0001671),0.3498396557561957,0.8837353571170189,0.6135957066189625,0.8801055068283606,1.0,5/20,16.67%,FXYD2;DNAJC1;AHSA1;MYBPC3;DNAJC15
prerank,DNA polymerase activity (GO:0034061),-0.30742736962427814,-0.8816617511615088,0.6391982182628062,0.9473713528275424,1.0,9/22,23.13%,PRIMPOL;POLM;POLG;POLI;REV3L;POLE;POLL;POLN;POLD4
prerank,deubiquitinase activity (GO:0101005),-0.22952712422997001,-0.8812524819911769,0.7580071174377224,0.9434159866656139,1.0,22/88,17.16%,USP35;CYLD;USP12;OTUD5;USP50;OTULIN;STAMBP;USP46;UCHL1;USP19;USP40;MYSM1;USP49;PAN2;UFD1;OTUB1;USP34;JOSD2;USP29;USP5;USP33;OTUD1
prerank,anion:anion antiporter activity (GO:0015301),0.3666307179125397,0.880407136895711,0.6096256684491979,0.8838362240042166,1.0,7/17,26.95%,SLC26A11;SLC25A5;SLC26A7;SLC25A4;SLC26A8;SLC25A11;SLC26A2
prerank,semaphorin receptor binding (GO:0030215),-0.3037688980208103,-0.8803925449921741,0.645933014354067,0.9405102821824354,1.0,10/23,28.31%,SEMA4D;SEMA4C;SEMA4G;SH3BP1;PLXNB1;SEMA4F;SEMA3B;SEMA3F;SEMA3A;SEMA3D
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3914266065587196,0.8799031540888106,0.5917602996254682,0.8819173108136111,1.0,4/12,16.41%,TENT5A;TENT2;PAPOLA;TUT1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.39790351659556195,0.8791370286516849,0.591254752851711,0.8804275520357252,1.0,2/11,17.31%,CHRNA4;CHRNB2
prerank,vitamin D receptor binding (GO:0042809),0.3873283787589085,0.878688906935116,0.6186915887850467,0.8784079431944404,1.0,10/14,27.70%,MED16;SNW1;MED17;THRAP3;MED14;MED24;MED13;TAF11;MED12;RXRA
prerank,MAP kinase activity (GO:0004707),-0.3403859037837518,-0.8759478788892472,0.6195899772209568,0.946188178649436,1.0,3/14,6.28%,MAPK10;MAPK6;MAPK3
prerank,death receptor binding (GO:0005123),0.37478488387213793,0.8735729826868402,0.609009009009009,0.8858673349551631,1.0,2/15,7.36%,RIPK1;EDA
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.28843999436419776,-0.8720586174396707,0.6741854636591479,0.9503349055487244,1.0,9/26,31.84%,MGAT5;PPP1R11;PPP1R14A;SAG;PABIR1;CABIN1;PPP1R1A;PPP1R9B;BOD1
prerank,bHLH transcription factor binding (GO:0043425),0.35514316553486835,0.8708254126316821,0.6292335115864528,0.888620430502694,1.0,5/19,15.92%,TCF12;SP1;CREBBP;USF1;KDM1A
prerank,carboxylic ester hydrolase activity (GO:0052689),0.26850259430742657,0.8705252742248277,0.6569444444444444,0.8861830685556529,1.0,14/85,17.60%,AOAH;PGAP1;PLA2G7;NOTUM;PLA2G2D;PLAAT1;ACHE;LYPLAL1;PLAAT3;NDST3;PAFAH1B2;LYPLA1;ESD;CEL
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.34276163441443513,-0.8700821240088426,0.625,0.9499542783580348,1.0,5/12,28.52%,CNOT7;PAN2;TOE1;PNLDC1;NOCT
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3843939719819571,0.8667580055525401,0.6245421245421245,0.8905701646383918,1.0,4/12,18.72%,BABAM2;TNF;TRAP1;TRAF6
prerank,phospholipase binding (GO:0043274),-0.3464429386837571,-0.8653966832695201,0.6316916488222698,0.9556024207960889,1.0,4/13,11.70%,BLNK;SRC;BTK;PDPK1
prerank,phospholipase activator activity (GO:0016004),-0.37330365699762047,-0.8642313035148761,0.6336842105263157,0.9534944705569941,1.0,4/10,11.70%,SRC;CCL3;BTK;PDPK1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.23958478318252355,-0.8636218391864002,0.7361563517915309,0.949918508606823,1.0,13/57,20.05%,CYB561A3;COX5B;NDUFS7;NDUFV3;UQCRC1;NDUFB8;NDUFB7;COX15;NDUFV1;NDUFB10;NDUFA8;UQCR10;NDUFA10
prerank,RNA stem-loop binding (GO:0035613),0.38522329046681125,0.8587375356553877,0.6528301886792452,0.90370172739834,1.0,8/12,25.35%,RC3H1;ZC3H12A;CSDE1;METTL16;EPRS1;CPEB3;RC3H2;LARP6
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.364403147319035,0.8583886718559007,0.6415094339622641,0.901387156217635,1.0,2/15,5.06%,SESTD1;SNX3
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.359842206037913,-0.8579075974720797,0.6516129032258065,0.9578036092680938,1.0,5/11,29.05%,DCPS;NUDT1;NUDT11;NUDT16;NUDT5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.39881021886054374,0.8568722607358947,0.6112185686653772,0.8986371596030097,1.0,6/10,26.51%,DUSP1;DUSP2;DUSP7;DUSP6;DUSP8;DUSP16
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.39881021886054374,0.8568722607358947,0.6112185686653772,0.8986371596030097,1.0,6/10,26.51%,DUSP1;DUSP2;DUSP7;DUSP6;DUSP8;DUSP16
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.33516912465241827,0.8562035691520579,0.627147766323024,0.8969657129354197,1.0,3/24,5.24%,DAPK1;CAMK1D;MAPKAPK2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.38985115314049945,0.8528968660304996,0.6212389380530974,0.9005217494291461,1.0,2/11,14.94%,TRPM2;ITPR3
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3365399242749457,0.8527262885599686,0.6564625850340136,0.8950791524310846,1.0,6/21,13.47%,CDK12;CDK6;CDK14;CDK20;CDK13;CDKL4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3365399242749457,0.8527262885599686,0.6564625850340136,0.8950791524310846,1.0,6/21,13.47%,CDK12;CDK6;CDK14;CDK20;CDK13;CDKL4
prerank,acetyltransferase activity (GO:0016407),0.3118478695225521,0.8522496668237438,0.6711864406779661,0.8931348206043828,1.0,9/31,16.36%,ESCO2;ESCO1;CREBBP;SAT2;EP300;KAT6A;ACAT1;PAFAH1B2;GTF2B
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3199932293519798,0.8513931823058588,0.6563517915309446,0.8918757598922132,1.0,4/25,11.49%,FMO1;CYP27A1;CYP26B1;FMO5
prerank,ribosomal large subunit binding (GO:0043023),0.38934972120663475,0.8493283681186663,0.6112115732368897,0.8929029674925759,1.0,4/11,12.12%,NMD3;MALSU1;MRRF;DHX33
prerank,translation initiation factor activity (GO:0003743),-0.26238271115564676,-0.8490204585381369,0.7008310249307479,0.9732585589112835,1.0,6/36,7.02%,EIF4G1;EIF4A1;EIF2B3;EIF4A2;EIF2D;EIF3B
prerank,lipid phosphatase activity (GO:0042577),0.3695401479144652,0.8485874090419071,0.6446124763705104,0.8914402820774867,1.0,1/14,1.54%,SGPP1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.38732726674208984,0.8462650608960189,0.6602316602316602,0.8930477163305818,1.0,3/10,19.46%,DCLRE1C;MGME1;APEX1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.35290941554273025,0.8452983917858435,0.6631944444444444,0.8921742785821739,1.0,5/17,18.39%,NOL9;CMPK1;AK8;AK3;AK4
prerank,pyrophosphatase activity (GO:0016462),0.2858124544543646,0.8436881811510901,0.6765140324963073,0.8924573479061029,1.0,8/50,11.44%,BNIPL;PRUNE2;NUDT22;RNGTT;DOLPP1;LHPP;TRPM2;DCP2
prerank,serotonin receptor activity (GO:0099589),0.3362827575590539,0.8436080117369225,0.6712564543889845,0.8842237085629234,1.0,3/22,12.63%,HRH1;HTR1D;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3362827575590539,0.8436080117369225,0.6712564543889845,0.8842237085629234,1.0,3/22,12.63%,HRH1;HTR1D;HTR6
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3362827575590539,0.8436080117369225,0.6712564543889845,0.8842237085629234,1.0,3/22,12.63%,HRH1;HTR1D;HTR6
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.34978592424301225,-0.8427732866474978,0.6628959276018099,0.9817066706142021,1.0,3/12,9.54%,PIK3CB;ATM;PIK3C2B
prerank,syntaxin binding (GO:0019905),-0.22825940956034385,-0.8421419626397483,0.793918918918919,0.9781957520284941,1.0,21/61,27.20%,UNC13C;SNAP25;SNAP47;VPS18;STX16;CPLX1;NAPA;SYT6;VAMP2;SYT8;SYT1;GOLGA2;CPLX2;BAIAP3;ABCA1;VPS11;NAPG;VAMP1;SYT5;STXBP1;SYT17
prerank,neurexin family protein binding (GO:0042043),-0.3645504808476181,-0.8418340829768821,0.6871035940803383,0.9739780818440436,1.0,3/10,17.95%,NLGN1;SYTL2;CPE
prerank,ATPase regulator activity (GO:0060590),0.29141256382717035,0.841522384345845,0.6881028938906752,0.8853224771335524,1.0,6/38,10.21%,FXYD2;BAG3;FNIP1;DNAJC1;PLN;AHSA1
prerank,glutamate receptor binding (GO:0035254),0.339807685931268,0.8415181131200097,0.6582064297800339,0.8825705548579439,1.0,1/17,0.32%,HIP1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.3206845891852264,0.8412543726821541,0.6461794019933554,0.8803549457011483,1.0,3/25,4.00%,PARP14;PARP8;PARP11
prerank,lipase activator activity (GO:0060229),-0.3619229113163181,-0.8410084640303284,0.6741803278688525,0.9709399429681833,1.0,4/10,11.70%,SRC;CCL3;BTK;PDPK1
prerank,sodium channel activity (GO:0005272),-0.253341704265063,-0.8391446326938058,0.7340720221606648,0.9698696807081336,1.0,5/37,14.24%,GRIK2;SCN1B;SHROOM2;SCN8A;SCN1A
prerank,potassium ion antiporter activity (GO:0022821),0.3556306373675769,0.8377958857342654,0.6524064171122995,0.8838982564258484,1.0,4/15,14.03%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,methyl-CpG binding (GO:0008327),-0.29374291117503526,-0.83642821522086,0.7012048192771084,0.9705099872758572,1.0,4/22,12.93%,CXXC5;ZCWPW1;LRWD1;ZBTB33
prerank,glycerophospholipid flippase activity (GO:0140333),-0.35557634149682305,-0.83434817153175,0.6993603411513859,0.9701441274418799,1.0,2/11,5.52%,ATP8A2;ATP8B1
prerank,endopeptidase regulator activity (GO:0061135),0.28723242682127115,0.8341438500043376,0.690625,0.8878089696145274,1.0,6/40,16.43%,NLRC4;PROS1;USP14;CAST;SERPIND1;TFPI
prerank,MAP kinase phosphatase activity (GO:0033549),0.36811444492131495,0.8339644351700963,0.634508348794063,0.8854563016458173,1.0,3/12,16.09%,DUSP1;DUSP2;DUSP7
prerank,protein phosphatase regulator activity (GO:0019888),-0.23142077409688372,-0.833759767186219,0.7948717948717948,0.9665805229647575,1.0,14/53,20.92%,MGAT5;CALM2;PPP1R16B;PPP2R2B;PPP1R7;PPP2R5C;ANKLE2;SAG;PPP6R1;PPP1R16A;PPP2R5A;PTPA;CABIN1;CALM3
prerank,metal ion transmembrane transporter activity (GO:0046873),0.30589428692442855,0.8308031558417864,0.6830065359477124,0.8886394483379808,1.0,5/27,14.75%,ATP2B1;TMEM165;ATP2B4;SLC23A1;CNNM4
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.2598502150611902,-0.8307023812841523,0.7216216216216216,0.9632094195500758,1.0,9/34,22.95%,NDUFS7;NDUFV3;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;NDUFS1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.2598502150611902,-0.8307023812841523,0.7216216216216216,0.9632094195500758,1.0,9/34,22.95%,NDUFS7;NDUFV3;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;NDUFS1
prerank,amino acid binding (GO:0016597),-0.2621408564511601,-0.8300444248916988,0.74,0.9600273544662836,1.0,14/31,26.63%,GRM7;AARS1;GRIN3A;GLRB;CASTOR2;GLRA1;GLRA3;DDAH1;AARS2;GLRA2;AGXT;CAD;CASTOR1;GCLC
prerank,platelet-derived growth factor binding (GO:0048407),-0.34288887006342517,-0.8298536893813356,0.6772727272727272,0.9559142724374838,1.0,7/11,30.08%,COL1A2;PDGFA;COL3A1;COL6A1;PDGFRB;COL4A1;COL5A1
prerank,hydro-lyase activity (GO:0016836),0.291774661496132,0.827731333135505,0.6990740740740741,0.8915400107287171,1.0,12/41,21.17%,HACD4;EHHADH;GMDS;ACO1;HADHA;HADHB;UROS;FAHD2A;ECHDC1;CDYL;IREB2;PCBD2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.281924054493309,0.8274597123890023,0.7123076923076923,0.8892779684391097,1.0,10/44,15.32%,KMT2A;SETDB2;ASH2L;KMT2C;WDR82;KMT5B;KMT2E;SMYD3;EHMT1;NSD3
prerank,transforming growth factor beta binding (GO:0050431),0.3208159674198944,0.8272595280442984,0.6944908180300501,0.886931608655994,1.0,3/23,8.27%,NRROS;CD36;VASN
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.30344330812012055,0.8244549092806579,0.6710097719869706,0.8891295410050266,1.0,10/31,17.83%,UBE2E3;UBE2Q2;BIRC6;UBE2D3;UBE2K;UBE2R2;UBE2N;UBE2W;UBE2U;UBE2A
prerank,FAD binding (GO:0071949),0.31373759910908244,0.8230711186747832,0.6870860927152318,0.8889097859926258,1.0,3/24,6.61%,DAO;NQO2;AGPS
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.33230787747131973,0.8229236440859182,0.6745886654478976,0.8865003345684829,1.0,2/20,1.35%,MPP1;CASK
prerank,nuclear import signal receptor activity (GO:0061608),0.3492287411948576,0.8228668090444425,0.671304347826087,0.883935061911951,1.0,7/15,23.82%,KPNA4;KPNA2;KPNB1;TNPO1;IPO4;KPNA3;RANBP6
prerank,neuropeptide receptor binding (GO:0071855),-0.32579088691263003,-0.8212659365546545,0.735357917570499,0.9683407157171631,1.0,6/14,49.99%,SHANK1;NPY;APLN;GAL;NPPA;GHRH
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.29547206842916646,0.8207891691400747,0.6798732171156894,0.8848042195447664,1.0,10/34,17.83%,UBE2E3;UBE2Q2;BIRC6;UBE2D3;UBE2K;UBE2R2;UBE2N;UBE2W;UBE2U;UBE2A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.31359934264745204,-0.820336017614297,0.6923076923076923,0.9657068774280563,1.0,7/15,34.85%,SOCS2;SOCS7;PIK3R5;PIK3R2;PIK3R3;SOCS3;SOCS1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.35074746969886517,0.8192364523140604,0.6925858951175407,0.8848480763971337,1.0,2/13,11.34%,EHHADH;SREBF2
prerank,3'-5' exonuclease activity (GO:0008408),-0.23525816824069243,-0.8191387918380802,0.7927170868347339,0.9634525809278491,1.0,16/45,32.61%,CNOT7;EXOSC9;DIS3;POLG;PAN2;REV3L;ANGEL2;TOE1;PNLDC1;RAD9A;ERI3;RAD50;ANGEL1;NOCT;RAD1;PNPT1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3469109217080707,-0.8190286623492707,0.7019438444924406,0.959129461378316,1.0,2/11,12.20%,SLC2A9;SLC17A5
prerank,sulfate transmembrane transporter activity (GO:0015116),0.3529077564928743,0.8184586270173041,0.6666666666666666,0.8836142431712729,1.0,6/14,26.95%,SLC26A11;SLC26A7;SLC25A30;SLC26A8;SLC25A11;SLC26A2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.31114551910002664,0.8177195328291496,0.6912751677852349,0.8823355103207314,1.0,6/27,16.42%,ANO1;SLC26A11;SLC26A7;XPR1;SLC25A30;GET3
prerank,phosphatase activator activity (GO:0019211),0.342470993484759,0.814176524239384,0.6799276672694394,0.8859586958808331,1.0,6/14,21.32%,BMP2;FRS2;CALM1;PPP2R5B;PHACTR4;PPP2R5E
prerank,calcium activated cation channel activity (GO:0005227),0.3403560366551153,0.8114418979492141,0.6890034364261168,0.8880261591296056,1.0,3/17,5.29%,ANO6;KCNMB1;ANO1
prerank,ankyrin binding (GO:0030506),-0.28850398400283583,-0.8081822510802836,0.7274939172749392,0.9750367333613843,1.0,4/19,15.57%,SLC8A1;CACNA1D;SPTB;KCTD6
prerank,hexose transmembrane transporter activity (GO:0015149),0.362579783200774,0.8069000833544236,0.6963946869070209,0.8930404814717212,1.0,4/12,20.13%,SLC2A4;SLC2A2;SLC5A3;SLC2A6
prerank,gamma-tubulin binding (GO:0043015),0.3268154663315438,0.804998934292785,0.6939130434782609,0.8938536262707654,1.0,1/21,0.52%,RAB11FIP5
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.22874512957194187,-0.8048474488769524,0.8103975535168195,0.9768876689615917,1.0,8/53,12.70%,SLC1A3;SLC36A1;SLC38A7;SLC36A4;SLC1A1;SLC25A22;SLC7A8;CTNS
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.31886964760574665,-0.8047088429555171,0.7268518518518519,0.9726291948193743,1.0,5/13,30.52%,SLC38A7;SLC3A1;SLC7A6;SLC25A29;SLC7A3
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.25130669083331225,0.8046778988628257,0.7677329624478443,0.8918403694677502,1.0,12/74,12.24%,POMK;ADK;PGM2L1;NOL9;FAM20A;CHKB;PIK3C2A;PAPSS2;FGGY;DGKH;PANK1;GALK2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.26686321988379436,0.8043756040271212,0.772133526850508,0.8897248327240395,1.0,15/55,17.47%,ATP2B1;MCU;ANXA2;PSEN1;PKD1L2;TRPV3;TMEM165;TRPM2;ATP2B4;ATP2A2;PKD2;PKD2L1;PANX1;PKD2L2;CUL5
prerank,carboxylic acid binding (GO:0031406),-0.2409649339426829,-0.800082589506892,0.7936962750716332,0.9765257377264523,1.0,11/38,17.08%,GRM7;UBR1;PHYH;GRIN3A;SESN3;GLRB;CASTOR2;MAG;GLRA1;PSAP;GLRA3
prerank,ligand-gated cation channel activity (GO:0099094),-0.2100193886551632,-0.7968919311064858,0.9023569023569024,0.977654338805744,1.0,31/75,37.23%,PTK2B;KCNJ2;GRIA2;GRIK2;GRIA4;GRIN3A;SHROOM2;GRIN2A;KCNN2;KCNK6;KCNJ3;KCNJ10;ASIC1;KCNJ13;GRIA3;KCNJ9;KCNH2;GRIA1;KCNJ12;KCNJ16;KCNN1;P2RX3;KCNJ6;P2RX5;GRIN3B;CHRNA7;ASIC3;SCNN1A;CHRNA5;ASIC4;KCNJ15
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.36268883373458827,0.795854836945755,0.7129455909943715,0.9012044212282533,1.0,1/11,1.96%,RPS3
prerank,methylated histone binding (GO:0035064),-0.2191102843835257,-0.7941011962878772,0.8726114649681529,0.9780903426992386,1.0,24/62,30.47%,BPTF;ING4;ZCWPW1;WDR5;FMR1;DPF2;LRWD1;KDM4A;CBX5;PHF1;PHF2;PHF13;MTF2;TAF1;CXXC1;TTLL12;UHRF1;CBX8;MPHOSPH8;MSH6;TAF7;THAP7;RRP8;MSL3
prerank,NADPH binding (GO:0070402),0.3485464445069165,0.7936741865811432,0.6970260223048327,0.9023840618557188,1.0,3/13,14.65%,HMGCR;LBR;CBR3
prerank,SUMO binding (GO:0032183),-0.31214599237010604,-0.7933021412209887,0.7381974248927039,0.9749481422085851,1.0,1/13,0.40%,HERC2
prerank,CARD domain binding (GO:0050700),0.3408601276098112,0.7899378619602077,0.7168784029038112,0.9060802883903496,1.0,4/14,12.78%,BCL10;CARD16;RIPK2;NOD2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.31081669208270846,-0.787542207312343,0.7511111111111111,0.9806900070651038,1.0,5/13,25.84%,DNA2;ENDOV;SLX4;DNASE1L2;EXO1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.3515610203679508,0.7859578675103797,0.7300380228136882,0.9100228847043305,1.0,3/12,11.32%,FRS2;SH2B3;SHC1
prerank,5'-nucleotidase activity (GO:0008253),0.34724059112097955,0.785816603039778,0.7132216014897579,0.907598923847565,1.0,3/13,14.78%,NT5DC1;NT5C2;ACP3
prerank,lysine N-methyltransferase activity (GO:0016278),-0.2792367211702869,-0.7855052945147896,0.7959183673469388,0.9795095238372173,1.0,10/20,36.09%,EHMT2;SETD4;SETD3;EEF2KMT;SETD2;SETD6;SMYD2;EEF1AKMT2;SETD7;METTL21A
prerank,Hsp70 protein binding (GO:0030544),0.2792448557242092,0.7834797171165658,0.7393364928909952,0.9086206556926467,1.0,3/31,4.05%,RPS3;ERN1;PRKN
prerank,myosin binding (GO:0017022),0.26017594309685926,0.7831664211890168,0.7890044576523031,0.9065637357421023,1.0,12/55,16.11%,SPATA6;RAB10;RHOA;TRIM32;STXBP5;CXCR4;RAB14;KIRREL1;TRAK2;RAB11A;MYBPC3;RAB3B
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.3058169672985086,-0.7816774608059043,0.7680525164113785,0.9817827783950484,1.0,7/14,24.70%,NFU1;NUBPL;ISCU;SDHB;RSAD2;NDUFS1;ACO2
prerank,ribosomal small subunit binding (GO:0043024),0.3290821845948357,0.7809267492910045,0.7375886524822695,0.9076410906765836,1.0,7/17,22.19%,ERAL1;EIF1;EIF4B;MTIF3;PIM1;DHX29;NPM1
prerank,N-acetyltransferase activity (GO:0008080),-0.28420957058607044,-0.7806715015229329,0.7728337236533958,0.9789146896660268,1.0,2/19,4.51%,SAT1;SMARCE1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.3076095004198275,-0.7736899866894953,0.7852631578947369,0.9860032468079057,1.0,6/12,28.18%,STAT1;TBPL1;HDAC1;TAF1;TBP;FOS
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3287621457997556,-0.7731613671702756,0.7850877192982456,0.9825535098564048,1.0,3/11,15.53%,PPP1R11;PPP1R14A;PABIR1
prerank,cAMP response element binding (GO:0035497),-0.33217017181067215,-0.7727225565318021,0.7852631578947369,0.9789206227934775,1.0,3/10,12.02%,E4F1;CREB3L2;JUN
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.29909250517706276,-0.7708520016683827,0.7820224719101123,0.9775391918063879,1.0,10/14,47.49%,KCNJ2;KCNJ3;KCNH2;KCNIP2;KCNE4;KCNJ5;KCND3;KCNA5;KCNJ8;KCNE2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3348893473062047,-0.7678617357529196,0.7828685258964143,0.9778847208516027,1.0,3/10,11.35%,NAA40;NAA60;BRCA2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2397837795177021,0.7643993438148248,0.8375350140056023,0.9308914178925833,1.0,14/69,16.36%,MOGAT2;ZDHHC14;ESCO2;ESCO1;ZDHHC3;CERS6;PLAAT1;CREBBP;EP300;KAT6A;PLAAT3;ZDHHC20;ZDHHC2;GTF2B
prerank,tRNA binding (GO:0000049),-0.2260921934271748,-0.7643689605770949,0.8382352941176471,0.9788412497195103,1.0,23/43,36.52%,AARS1;DALRD3;CARS1;PTCD1;TRNT1;SARS1;DARS2;ALKBH8;TRMT9B;PUS1;HSD17B10;AARS2;TRMT10B;SARS2;THG1L;ALKBH1;KARS1;NEMF;SSB;AIMP1;YRDC;EIF2A;NSUN6
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.3321734539047557,0.7638161478233683,0.7583774250440917,0.9291212560084576,1.0,2/14,7.19%,RARRES1;BST2
prerank,nuclear localization sequence binding (GO:0008139),0.31103263074785004,0.7629551505980303,0.7728813559322034,0.9278527136068067,1.0,8/18,23.82%,KPNA4;KPNA2;NUP153;KPNB1;TNPO1;IPO4;KPNA3;RANBP6
prerank,beta-tubulin binding (GO:0048487),-0.24235473767386767,-0.7614000249532873,0.8579234972677595,0.9791871124905549,1.0,4/31,7.15%,TBCD;FGF13;TTLL7;APPL1
prerank,ion gated channel activity (GO:0022839),0.29693375798923555,0.7591651403636241,0.7469879518072289,0.9308684694834792,1.0,3/24,6.19%,ANO6;ANO1;TTYH3
prerank,serine-type peptidase activity (GO:0008236),-0.19280368552510851,-0.7580708048858739,0.9479553903345725,0.9799698852361256,1.0,8/96,8.54%,KLK2;NAALAD2;ST14;MASP1;HTRA2;PLAU;F3;RHBDL3
prerank,leak channel activity (GO:0022840),-0.27022360543124047,-0.7526534395480405,0.8137472283813747,0.9835465062290146,1.0,8/18,28.62%,NALCN;KCNK2;KCNK12;KCNK9;KCNK6;TMEM175;KCNK10;KCNK3
prerank,nuclear export signal receptor activity (GO:0005049),-0.315296255781509,-0.7521360621182774,0.7906458797327395,0.9801806072954303,1.0,5/11,35.89%,RANBP17;CSE1L;NUP214;EIF4ENIF1;RAN
prerank,sterol binding (GO:0032934),0.24392234006979963,0.7510855870338536,0.8249258160237388,0.9405300147723711,1.0,11/56,16.70%,OSBPL9;STARD3NL;ERLIN1;OSBPL11;OSBPL1A;NPC2;GRAMD1B;OSBPL8;OSBPL10;OSBPL5;GPR183
prerank,phosphotyrosine residue binding (GO:0001784),0.2654031701867849,0.7487090708805617,0.7783094098883573,0.9413352750797629,1.0,5/37,11.32%,RASA1;CRK;SYK;ZAP70;SHC1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.29471220486387895,-0.748081326767738,0.7849462365591398,0.9819713297999134,1.0,2/13,4.65%,PRKAR1A;PRKAR1B
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3260752065879653,-0.7467893870999137,0.8094262295081968,0.9796801198175167,1.0,5/10,20.88%,B3GALT1;B3GALT5;B3GALT2;B4GALT7;B3GALT6
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.3307595883158121,0.745109918823014,0.7536764705882353,0.9438101659784021,1.0,4/12,16.66%,CDK12;CDK6;CDK13;BRD4
prerank,exopeptidase activity (GO:0008238),-0.2144372594676654,-0.7441634480750632,0.8954802259887006,0.9790611161175674,1.0,5/50,5.46%,DPP10;NAALAD2;DPP6;ANPEP;LAP3
prerank,carboxypeptidase activity (GO:0004180),0.2663899836832452,0.7418915870394301,0.8246753246753247,0.9456993477365485,1.0,1/35,0.62%,PEPD
prerank,nucleotidase activity (GO:0008252),0.31557829427070916,0.740880605753019,0.7504587155963303,0.9444384878978456,1.0,3/15,14.78%,NT5DC1;NT5C2;ACP3
prerank,ligand-gated calcium channel activity (GO:0099604),0.29863335124438395,0.7366190633479993,0.7956081081081081,0.9475585941262871,1.0,4/19,19.01%,GRIN2D;TRPM2;ITPR3;P2RX4
prerank,U6 snRNA binding (GO:0017070),0.31207491507655494,0.7358532798244295,0.7966728280961183,0.9460672898863923,1.0,4/14,16.41%,LARP7;LSM4;LSM2;TUT1
prerank,ADP binding (GO:0043531),0.27659881955965065,0.7270572469661485,0.8248299319727891,0.9551855236126825,1.0,2/25,3.17%,PRKAG2;ERN1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.3181739462526333,-0.726868759863109,0.8209876543209876,0.9977145804021879,1.0,5/10,29.39%,GABRA2;GABRG2;GABRA4;GABRG3;GABRE
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.29970943510083603,-0.7251034346524968,0.8314606741573034,0.9958134626237559,1.0,8/12,28.67%,ISCU;SDHB;FXN;ISCA1;FDX1;CIAPIN1;CISD3;CISD1
prerank,potassium ion leak channel activity (GO:0022841),-0.2712844303485643,-0.724369112388527,0.8319502074688797,0.9925191233125333,1.0,7/15,28.62%,KCNK2;KCNK12;KCNK9;KCNK6;TMEM175;KCNK10;KCNK3
prerank,neuropeptide hormone activity (GO:0005184),-0.24939876440265074,-0.7236564621010985,0.8530805687203792,0.9893290135144814,1.0,14/22,50.27%,ADCYAP1;PENK;PNOC;GRP;NPFF;NPY;CRH;GAL;VIP;SPX;CORT;NPPA;GHRH;CALCB
prerank,phosphatase activity (GO:0016791),0.2254068593653684,0.7229615492516517,0.903271692745377,0.9580999724208749,1.0,11/73,15.12%,PTPRJ;PTPN22;DUSP28;DUSP12;OCRL;HDHD2;LHPP;PPP1CA;ACP3;PTPMT1;DUSP23
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.2591405468239768,-0.7229184998365615,0.8560411311053985,0.9862162842183746,1.0,7/20,31.48%,SLC39A11;SLC39A13;SLC39A14;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,myosin V binding (GO:0031489),-0.2716029900507356,-0.7228911013633375,0.8454545454545455,0.9822083574862682,1.0,2/15,4.50%,RAB6B;RAB3C
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.27550035405677525,0.7226935843771242,0.8278688524590164,0.9558232676556403,1.0,5/24,15.81%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,MHC class II protein complex binding (GO:0023026),-0.2984763506704593,-0.7187979081509792,0.8412017167381974,0.9831475127696417,1.0,2/11,4.48%,ATP1B1;PKM
prerank,exoribonuclease activity (GO:0004532),-0.2902216604215505,-0.7180629997626145,0.8163265306122449,0.979950577098338,1.0,2/12,8.12%,CNOT7;EXOSC9
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.28312938132917226,-0.7068487114823396,0.8552631578947368,0.98891775626463,1.0,5/13,20.19%,PIK3CB;PIK3C2B;PIP4K2B;PIP4K2C;PIP5K1B
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.21846163989895065,-0.7058512414317387,0.9198966408268734,0.9859946762010708,1.0,10/33,28.52%,CNOT7;EXOSC9;DIS3;PAN2;ANGEL2;TOE1;PNLDC1;ERI3;ANGEL1;NOCT
prerank,organic anion transmembrane transporter activity (GO:0008514),0.20341020116148273,0.6999498012047495,0.9576923076923077,0.9812448535418027,1.0,23/134,17.68%,SLC16A7;CD36;SLC25A17;SLC38A6;SLC25A24;SLC25A2;ABCC4;ABCC1;RTBDN;SLCO5A1;SLC35B3;SLC38A1;SLC2A2;SLC38A2;GJA1;MFSD2A;SLC23A1;SLC23A2;SLC26A7;SLC6A6;SLC5A6;SLCO2A1;SLC36A2
prerank,kinase activity (GO:0016301),0.2077098862896323,0.6992939068431592,0.9347536617842876,0.9793543981356818,1.0,11/109,9.99%,POMK;LYN;PGM2L1;IP6K3;GSK3B;PKN2;CHKB;PIK3C2A;PAPSS2;PMVK;DGKH
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.291722328454148,0.6980589037672751,0.8421052631578947,0.9780640331383418,1.0,1/15,6.89%,PLA2G2D
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.21750758961282196,-0.6945005681769797,0.9315068493150684,0.9939175980878849,1.0,13/34,31.28%,EHMT2;SETD4;DOT1L;SETD3;SMYD1;EEF2KMT;SETD2;SETD6;TTLL12;EZH2;PRDM9;SMYD2;EEF1AKMT2
prerank,serine-type endopeptidase activity (GO:0004252),-0.1809462345245638,-0.6942212063500353,0.9761904761904762,0.9902359444317788,1.0,6/80,8.54%,KLK2;MASP1;HTRA2;PLAU;F3;RHBDL3
prerank,aminopeptidase activity (GO:0004177),0.2609869907945303,0.6922259646251013,0.8729372937293729,0.9820534249429337,1.0,6/26,17.85%,XPNPEP3;LNPEP;RNPEP;ENPEP;ERAP1;METAP1
prerank,histone acetyltransferase binding (GO:0035035),0.2745641614828656,0.691872489946799,0.8712522045855379,0.979740104928976,1.0,6/21,16.91%,MEF2A;TRIM68;KANSL1;BCAS3;KANSL1L;ZBTB7A
prerank,NF-kappaB binding (GO:0051059),0.26495031193926527,0.6906602526170785,0.8628099173553719,0.9785645483452838,1.0,8/24,22.19%,BCL10;GSK3B;PSMA6;EP300;RELA;BRMS1;FAF1;NPM1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.30008762310004733,0.6901104738349997,0.8371647509578544,0.9766120899883267,1.0,1/13,2.61%,BMP2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.22162302315581417,-0.689828191851257,0.9186991869918699,0.9909185628292956,1.0,11/30,31.48%,SLC40A1;TTYH1;SLC39A11;SLC11A2;SLC39A13;SLC39A14;ATP7B;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.24594957829285824,0.6892425393400222,0.8708133971291866,0.9750082373592316,1.0,8/35,16.45%,FOXP1;NR3C1;KLF10;H3-3A;GTF2A1;MYC;GTF2B;RELA
prerank,syntaxin-1 binding (GO:0017075),-0.23746609861778345,-0.6889558110872418,0.9285714285714286,0.9879271275615313,1.0,6/22,19.36%,UNC13C;SNAP25;CPLX1;VAMP2;SYT1;CPLX2
prerank,four-way junction DNA binding (GO:0000400),-0.24985549973211638,-0.6877766985704727,0.8792710706150342,0.9851843987420996,1.0,7/17,31.85%,BLM;RAD51C;MSH2;HMGB1;HMGB3;MSH6;XRCC2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2260993618448024,-0.6869238099986044,0.9002557544757033,0.9820842105888903,1.0,11/28,27.76%,ENDOV;RPP14;POP1;RNASEH1;RPP21;EDC3;PRORP;POP7;EXO1;NUDT16;DBR1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.24075596463967489,0.6862519896802101,0.8897280966767371,0.9757657475742908,1.0,8/38,15.13%,AXIN1;FRS2;SAV1;SH2B3;NUP62;SHC1;MMS19;RGS14
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.21273556687493825,-0.6861322303095858,0.9432432432432433,0.979085475416345,1.0,10/34,28.52%,CNOT7;EXOSC9;DIS3;PAN2;ANGEL2;TOE1;PNLDC1;ERI3;ANGEL1;NOCT
prerank,BMP receptor binding (GO:0070700),0.30008925857466623,0.6842249711103717,0.8566037735849057,0.9752364578437879,1.0,1/12,2.61%,BMP2
prerank,DNA polymerase binding (GO:0070182),0.28060259769940954,0.6841618284982016,0.8694915254237288,0.9726947498884383,1.0,7/18,20.29%,SMG6;POLG2;HSP90AB1;FANCI;LONP1;RTEL1;PCNA
prerank,fatty acid synthase activity (GO:0004312),-0.2983438311935445,-0.6834626496901525,0.8476394849785408,0.9779421108299727,1.0,7/10,36.78%,OXSM;ELOVL1;ELOVL4;ELOVL7;CBR4;ELOVL6;ELOVL2
prerank,cardiolipin binding (GO:1901612),0.3120809104919902,0.6765057593156646,0.8426966292134831,0.978050474145362,1.0,2/10,16.39%,GSDME;UQCC3
prerank,CoA hydrolase activity (GO:0016289),-0.25098584868477336,-0.6747026399011994,0.9086651053864169,0.9822538903561765,1.0,5/16,25.43%,ACOT9;ACOT7;ACOT11;ACOT8;ACOT1
prerank,nucleosomal DNA binding (GO:0031492),-0.23265465323614515,-0.6735813456601022,0.9160493827160494,0.9795140763341775,1.0,14/21,37.10%,SMARCB1;SMARCC2;SMARCE1;RCC1;HDAC1;CHD4;MBD3;MBD2;SMARCD2;HDAC2;SMARCA4;HMGA2;MTA2;ACTL6A
prerank,chloride channel inhibitor activity (GO:0019869),0.304406460558098,0.6706473392712812,0.8471223021582733,0.9815077904994469,1.0,2/10,8.32%,WNK1;STX7
prerank,receptor antagonist activity (GO:0048019),-0.25052837568711744,-0.6706415206134895,0.8981481481481481,0.9782663822385309,1.0,3/17,19.19%,DKK2;IL18BP;DKK3
prerank,ribonuclease P activity (GO:0004526),-0.2886005311705986,-0.667748718181453,0.8879668049792531,0.9770641220658599,1.0,5/11,24.58%,RPP14;POP1;RPP21;PRORP;POP7
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.268813765039032,-0.6655789875280445,0.8852097130242825,0.9751293293005094,1.0,5/14,24.58%,RPP14;POP1;RPP21;PRORP;POP7
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2552308553212055,0.6601745744567635,0.9,0.9891053687476182,1.0,3/22,10.58%,RNF169;MINDY2;ZRANB3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.23705926318196546,0.6598421043086535,0.9209225700164745,0.9868292219696387,1.0,6/32,15.51%,PHF8;KDM7A;TET3;HSPBAP1;TET2;KDM2A
prerank,Notch binding (GO:0005112),0.2543324963343305,0.6571253421209967,0.9039451114922813,0.9866795530887944,1.0,5/22,20.93%,JAG1;CUL3;SNW1;DTX1;ADAM17
prerank,peptide hormone receptor binding (GO:0051428),-0.2718233070543713,-0.6568652768287434,0.9079497907949791,0.9784765394341172,1.0,5/11,39.92%,ADCYAP1;PSMC5;PTHLH;GNRH1;VIP
prerank,methylation-dependent protein binding (GO:0140034),-0.18146459964075132,-0.6564785409616786,0.9850299401197605,0.9750001524107133,1.0,22/57,32.99%,BPTF;ING4;ZCWPW1;WDR5;FMR1;LRWD1;KDM4A;CBX5;PHF1;PHF2;PHF13;MTF2;CXXC1;UHRF1;CBX8;MPHOSPH8;MSH6;THAP7;RRP8;MSL3;ING5;PHF19
prerank,phospholipase inhibitor activity (GO:0004859),-0.2827053045419564,-0.6524030036077988,0.8896247240618101,0.9743657228730838,1.0,3/10,17.97%,APOC1;ANXA9;ANGPTL3
prerank,thioesterase binding (GO:0031996),0.2926437053843889,0.6523588897451555,0.8697247706422019,0.9884118701673751,1.0,1/11,3.30%,CDC42
prerank,exonuclease activity (GO:0004527),0.21764949936942085,0.6493164341605905,0.9483282674772037,0.9883890421990019,1.0,13/46,22.16%,DCLRE1C;REXO2;CPSF3;ZC3H12A;EXOSC8;EXOSC1;DXO;MRE11;ENPP1;APEX1;REXO5;TRIR;EXOSC3
prerank,lysine-acetylated histone binding (GO:0070577),0.255277780621622,0.6381564394689914,0.9132653061224489,0.9926964709848586,1.0,3/20,11.28%,KMT2A;TRIM24;PHIP
prerank,acetylation-dependent protein binding (GO:0140033),0.255277780621622,0.6381564394689914,0.9132653061224489,0.9926964709848586,1.0,3/20,11.28%,KMT2A;TRIM24;PHIP
prerank,NAD+ binding (GO:0070403),-0.26219358795082776,-0.6365781814075384,0.9100877192982456,0.9821120033871056,1.0,4/12,19.56%,SIRT2;UXS1;SIRT5;PARP9
prerank,cytochrome-c oxidase activity (GO:0004129),0.27531651924639605,0.6310396892570388,0.8957952468007313,0.9957630342107525,1.0,5/15,21.46%,COX7A2L;COX10;NDUFA4;CYB5A;COX5A
prerank,peptidase inhibitor activity (GO:0030414),0.22413430170875287,0.6298348975235954,0.9350237717908082,0.9940641344136694,1.0,7/33,18.74%,PROS1;USP14;CAST;SERPIND1;GPC3;TFPI;RENBP
prerank,steroid hydroxylase activity (GO:0008395),-0.23816797132817863,-0.6295464069469172,0.9372197309417041,0.9828606172690015,1.0,8/16,42.72%,CH25H;CYP2A6;CYP39A1;CYP1A1;CYP46A1;CYP1B1;CYP2R1;CYP2S1
prerank,signal sequence binding (GO:0005048),-0.1898828746547357,-0.6289082417505955,0.9659090909090909,0.9796564135876935,1.0,2/35,2.30%,PEX5L;IPO5
prerank,phosphatase inhibitor activity (GO:0019212),-0.2228348060641332,-0.6245433425538056,0.9567198177676538,0.9788479722532638,1.0,5/20,31.84%,MGAT5;SAG;CABIN1;PPP1R9B;BOD1
prerank,single-stranded DNA binding (GO:0003697),0.1897064249655317,0.6238453767319986,0.9888888888888889,0.9963100439557105,1.0,18/93,18.57%,RBMS1;RBBP8;FAM111A;MCM9;DDX11;RPA1;RAD52;PURA;RPA3;XPC;POLR2D;RAD51B;SAMHD1;FBH1;MCM8;DMC1;APTX;LONP1
prerank,histone methyltransferase activity (GO:0042054),-0.19743673041675647,-0.6197084025726076,0.95822454308094,0.9781032704565273,1.0,14/32,36.08%,EHMT2;DOT1L;PRMT2;CARM1;SMYD1;SETD2;TTLL12;EZH2;PRDM9;SMYD2;PRMT8;FBL;PRMT7;SETD7
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2514580270895654,-0.6197065957954746,0.9379014989293362,0.9744806657511329,1.0,3/12,14.70%,NDUFS7;CRYZL1;AIFM2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.2032705355147844,0.6090223152530668,0.9797395079594791,1.0,1.0,10/55,17.68%,SLC16A7;SLC38A6;ABCC1;SLC38A1;SLC38A2;SLC23A1;SLC23A2;SLC6A11;SLC6A6;SLC36A2
prerank,solute:anion antiporter activity (GO:0140323),0.25853051423074275,0.6047474441881164,0.933579335793358,1.0,1.0,2/14,15.14%,SLC26A11;SLC26A7
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.21944018820118905,0.6013912060622569,0.9509803921568627,1.0,1.0,6/32,17.68%,SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC6A6;SLC36A2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.23803456490230937,0.6007663478490798,0.9452296819787986,1.0,1.0,2/18,9.85%,HSD3B7;HSD17B7
prerank,alpha-tubulin binding (GO:0043014),0.21886290010251006,0.6001212074415014,0.9561815336463224,0.999566344097945,1.0,9/31,22.33%,ARL8A;EFHC1;FYN;TBCE;TBCEL;SNCA;EFHC2;RACGAP1;DLEC1
prerank,methyltransferase activity (GO:0008168),-0.17391350724929777,-0.5989316481435044,0.9861495844875346,0.9821925444244445,1.0,24/46,43.99%,COMT;AS3MT;FTSJ3;MEPCE;DNMT1;BCDIN3D;MRM2;LCMT1;ASMT;METTL3;RRP8;METTL27;PRMT8;GCSH;EEF1AKMT2;LRTOMT;FTSJ1;PRMT7;GAMT;MGMT;DNMT3B;EEF1AKMT4;PRMT5;AMT
prerank,palmitoyltransferase activity (GO:0016409),0.220860192980072,0.5973300496046124,0.9483037156704361,0.9987465757765774,1.0,5/28,15.81%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.26239636398999133,0.5957569059595708,0.922077922077922,0.9971215600557259,1.0,1/12,5.17%,RACK1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2024255570503508,0.5922835688044958,0.9788519637462235,0.9965935686042808,1.0,8/42,15.79%,CCND3;CCNYL1;CCND2;CCNJ;CDKN2C;CCNQ;CCNY;HEXIM2
prerank,ribosome binding (GO:0043022),0.20300358090782525,0.5897941120212721,0.9794952681388013,0.9954993408891061,1.0,9/46,18.02%,RPSA;RACK1;SERBP1;SRP68;ZC3H12A;ETF1;MTIF3;PYM1;EFL1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.2511349804776086,0.5892508804259333,0.9312169312169312,0.9933174398645361,1.0,3/14,18.39%,CMPK1;AK8;AK4
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.18190231372414395,-0.579516235460704,0.9815303430079155,0.9871415522589402,1.0,5/32,13.79%,KCNQ3;KCNQ5;KCNA2;KCNA1;KCNS3
prerank,aspartic-type endopeptidase activity (GO:0004190),0.2571429473396749,0.5742441939278704,0.9423076923076923,0.9984928029257746,1.0,3/12,16.46%,PSEN1;SPPL2B;SPPL2A
prerank,active ion transmembrane transporter activity (GO:0022853),0.20402849851172103,0.5733163181171296,0.966824644549763,0.9964707618842945,1.0,9/37,21.46%,SLC16A7;SLCO5A1;COX7A2L;COX10;UQCRFS1;SLCO2A1;NDUFA4;CYB5A;COX5A
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.2401645789517679,0.5641990787461091,0.9638336347197106,0.9982891989626489,1.0,2/14,11.62%,RACK1;EBAG9
prerank,NAD binding (GO:0051287),0.2163577928973357,0.5585876180248135,0.9688013136288999,0.9982380152130333,1.0,4/26,13.04%,SORD;CRYL1;HADH;GLUD1
prerank,cation transmembrane transporter activity (GO:0008324),0.1879193924511542,0.551486049215046,0.9846153846153847,0.9987911813072687,1.0,8/48,17.68%,SLC38A6;SLC25A2;SLC38A1;SLC8B1;SLC38A2;PKD2L1;SLC6A6;SLC36A2
prerank,ribonuclease P RNA binding (GO:0033204),-0.24317816451306146,-0.5487753102177223,0.9617706237424547,0.9943637525291192,1.0,4/10,24.58%,RPP14;POP1;RPP21;POP7
prerank,galactosyltransferase activity (GO:0008378),0.2441193445335044,0.5486272499693926,0.9391634980988594,0.9974200634473147,1.0,2/11,10.76%,B4GALT6;B4GALT5
prerank,N-methyltransferase activity (GO:0008170),0.21490303908462827,0.5480815808140338,0.964765100671141,0.9951359417759378,1.0,4/20,15.19%,TRMO;GNMT;PRMT1;HNMT
prerank,acetylcholine receptor activity (GO:0015464),-0.19139697659780638,-0.5474739904223249,0.9816933638443935,0.9911691989533757,1.0,10/22,48.88%,CHRM3;ANXA9;CHRFAM7A;CHRNA7;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,voltage-gated sodium channel activity (GO:0005248),-0.1809178402623412,-0.5402398182384465,0.9813519813519813,0.9897258385705592,1.0,3/22,14.24%,SCN1B;SCN8A;SCN1A
prerank,pseudouridine synthase activity (GO:0009982),0.2390337730373172,0.536186279235402,0.9519408502772643,0.9967329865263629,1.0,1/13,5.15%,RPUSD3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.2104337999874443,-0.5234663144114897,0.9686800894854586,0.9903034620533905,1.0,13/13,78.98%,METTL1;TRMT10B;THUMPD3;FTSJ1;TRMT10C;TRMT5;TRMT11;TRMT1;TRMT10A;THUMPD2;TARBP1;TRMT1L;WDR4
prerank,gap junction channel activity (GO:0005243),0.19968229180501054,0.5116023998548888,0.9777397260273972,1.0,1.0,3/22,16.00%,GJB2;GJA1;PANX1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.1693507288422819,0.4938840866533346,0.9985052316890882,1.0,1.0,7/47,17.68%,SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC7A7;SLC6A6;SLC36A2
prerank,wide pore channel activity (GO:0022829),0.18939631886425043,0.48892342209342066,0.9846938775510204,1.0,1.0,23/23,81.09%,GJB2;GJA1;PANX1;GJB6;GJD4;GJC3;GJE1;GJB5;GJB4;GJA10;GJA9;GJA8;GJA3;PANX3;GJA4;GJA5;PRF1;GJD2;PANX2;GJD3;GJC1;GJC2;GJB1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.2180026363693429,0.48308158080819497,0.9823874755381604,1.0,1.0,11/11,78.21%,SLC25A47;SLC25A20;SLC22A5;SLC25A48;SLC22A16;SLC6A20;SLC22A1;SLC25A45;SLC22A3;SLC25A29;SLC22A4
prerank,adenyl nucleotide binding (GO:0030554),0.20843952751297015,0.45853512752047415,0.9923954372623575,0.9989026576803496,1.0,4/11,24.25%,BAG3;PFN1;GRPEL2;HSPH1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.20843952751297015,0.45853512752047415,0.9923954372623575,0.9989026576803496,1.0,4/11,24.25%,BAG3;PFN1;GRPEL2;HSPH1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.20582512083359494,0.45248637408843306,0.9963369963369964,0.997130292261103,1.0,11/11,79.43%,KCNQ1;KCNE3;KCNE1;KCNE5;KCNE2;KCNJ8;KCND3;KCNJ5;KCNE4;KCNH2;KCNJ3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.19064763699940124,-0.44715006772063587,0.9935064935064936,0.9971670223461391,1.0,3/11,20.34%,PRMT2;CARM1;PRMT9
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.17146983110441394,0.4091609708819132,0.9944649446494465,0.9982122488115115,1.0,15/15,82.87%,SLC26A7;SLC26A8;SLC26A2;SLC26A6;SLC26A5;SLC26A1;SLC26A9;SLC39A8;SLC4A8;SLC4A11;SLC26A4;SLC4A1;SLC26A3;SLC4A3;CFTR
